User Image Cart Icon 0 Search Image
  • Home > Blog > Muscle Atrophy (Preventing)

Muscle Atrophy (Preventing)

  1. Oxidative stress and disuse muscle atrophy
  2. The molecular basis of skeletal muscle atrophy
  3. Molecular mechanisms of muscle atrophy
  4. Signaling mechanisms involved in disuse muscle atrophy
  5. Mechanisms of disuse muscle atrophy: role of oxidative stress
  6. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
  7. Signaling in muscle atrophy and hypertrophy
  8. Skeletal muscle hypertrophy and atrophy signaling pathways
  9. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
  10. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
  11. Intracellular signaling during skeletal muscle atrophy
  12. muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function
  13. The effects of exercise training on muscle atrophy in haemodialysis patients.
  14. Identification of ubiquitin ligases required for skeletal muscle atrophy
  15. Mechanisms of skeletal muscle atrophy
  16. IL-6-induced skeletal muscle atrophy
  17. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.
  18. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
  19. A model for hypokinesia: effects on muscle atrophy in the rat
  20. Molecular events underlying skeletal muscle atrophy and the development of effective countermeasures
  21. muscle atrophy and procedures for training after spinal cord injury
  22. Nuclear domains during muscle atrophy: nuclei lost or paradigm lost?
  23. Chronic neck pain, standing balance, and suboccipital muscle atrophy–a pilot study.
  24. Disuse muscle atrophy of lower limbs in hemiplegic patients
  25. Molecular events in skeletal muscle during disuse atrophy
  26. Balancing muscle hypertrophy and atrophy
  27. Early quadriceps strength loss after total knee arthroplasty: the contributions of muscle atrophy and failure of voluntary muscle activation
  28. The initiation factor eIF3‐f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy
  29. Apoptosis in skeletal muscle and its relevance to atrophy
  30. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS
  31. Nuclear factor-kappa B signaling in skeletal muscle atrophy
  32. muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease
  33. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
  34. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
  35. Skeletal muscle atrophy in old rats: differential changes in the three fiber types
  36. Apoptosis in muscle atrophy: relevance to sarcopenia
  37. muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
  38. Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis
  39. Activation of an alternative NF‐ΚB pathway in skeletal muscle during disuse atrophy
  40. Space travel directly induces skeletal muscle atrophy
  41. muscle atrophy and weakness with aging: contraction-induced injury as an underlying mechanism
  42. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy
  43. The role of apoptosis in age-related skeletal muscle atrophy
  44. Comparison of multifidus muscle atrophy and trunk extension muscle strength: percutaneous versus open pedicle screw fixation
  45. Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells
  46. muscle atrophy is prevented in patients with acute spinal cord injury using functional electrical stimulation
  47. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients
  48. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass
  49. A novel ubiquitin‐binding protein ZNF216 functioning in muscle atrophy
  50. Heat stress attenuates skeletal muscle atrophy in hindlimb-unweighted rats
  51. Foot small muscle atrophy is present before the detection of clinical neuropathy
  52. Disuse atrophy of skeletal muscle: animal models
  53. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production
  54. Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies
  55. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle
  56. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy
  57. Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy
  58. In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy
  59. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression
  60. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury
  61. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy
  62. atrophy and fatty infiltration of the supraspinatus muscle: sonography versus MRI
  63. Glucocorticoid-induced muscle atrophy: the role of exercise in treatment and prevention
  64. Retrograde dissection of the temporalis muscle preventing muscle atrophy for pterional craniotomy
  65. Rat supraspinatus muscle atrophy after tendon detachment
  66. Infraspinatus muscle atrophy: implications?
  67. Bone and muscle atrophy with suspension of the rat
  68. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity
  69. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
  70. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1
  71. muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy
  72. Production of rat muscle atrophy by cast fixation.
  73. Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy
  74. Hsp70 overexpression inhibits NF‐κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy
  75. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats
  76. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation
  77. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
  78. Hip, thigh and calf muscle atrophy and bone loss after 5-week bedrest inactivity
  79. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy
  80. Efficacy of a gravity‐independent resistance exercise device as a countermeasure to muscle atrophy during 29‐day bed rest
  81. A model of muscle atrophy using cast immobilization in mice
  82. Age-related quadriceps-dominant muscle atrophy and incident radiographic knee osteoarthritis
  83. Role for IκBα, but not c-Rel, in skeletal muscle atrophy
  84. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
  85. Temporal alterations in protein signaling cascades during recovery from muscle atrophy
  86. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study
  87. muscle atrophy and bone loss after 90 days’ bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study
  88. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei
  89. Effect of branched-chain amino acids on muscle atrophy in cancer cachexia
  90. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy
  91. Asymmetric atrophy of the supraspinatus muscle following tendon tear
  92. The physiology and biochemistry of skeletal muscle atrophy as a function of age
  93. Calf muscle atrophy and muscle function after non-operative vs operative treatment of achilles tendon ruptures
  94. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
  95. Akt signalling through GSK‐3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy
  96. Surgically repaired massive rotator cuff tears: MRI of tendon integrity, muscle fatty degeneration, and muscle atrophy correlated with intraoperative and clinical findings
  97. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression
  98. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1
  99. Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy
  100. Increased antioxidant capacity does not attenuate muscle atrophy caused by unweighting
  101. Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading
  102. Changes in human muscle architecture in disuse-atrophy evaluated by ultrasound imaging.
  103. Lower leg muscle atrophy in ankle osteoarthritis
  104. Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis?
  105. Molecular characterization of muscle atrophy and proteolysis associated with spawning in rainbow trout
  106. Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation
  107. Myostatin, insulin‐like growth factor‐1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy
  108. Incisional herniation induces decreased abdominal wall compliance via oblique muscle atrophy and fibrosis
  109. Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers
  110. Magnetic resonance imaging for supraspinatus muscle atrophy after cuff repair
  111. Infraspinatus muscle atrophy in professional baseball players
  112. Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat
  113. Antioxidant administration attenuates mechanical ventilation‐induced rat diaphragm muscle atrophy independent of protein kinase B (PKB–Akt) signalling
  114. Stable muscle atrophy in long-term paraplegics with complete upper motor neuron lesion from 3-to 20-year SCI
  115. Myostatin expression in age and denervation-induced skeletal muscle atrophy
  116. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice
  117. atrophy responses to muscle inactivity. II. Molecular markers of protein deficits
  118. Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages
  119. atrophy and programmed cell death of skeletal muscle
  120. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
  121. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1
  122. Electrical stimulation prevents immobilization atrophy in skeletal muscle of rabbits
  123. Molecular signaling pathways regulating muscle proteolysis during atrophy
  124. Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy
  125. Fibrillation potential amplitude and muscle atrophy following peripheral nerve injury
  126. Detection of muscle atrophy on routine sonography of the shoulder
  127. Free mobilization and low-to high-intensity exercise in immobilization-induced muscle atrophy
  128. Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats
  129. Asymmetric atrophy of multifidus muscle in patients with unilateral lumbosacral radiculopathy
  130. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest
  131. Overcoming muscle atrophy in a hibernating mammal despite prolonged disuse in dormancy: proteomic and molecular assessment
  132. Age-related muscle atrophy does not affect all muscles and can partly be compensated by physical activity: an ultrasound study
  133. Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation
  134. Insulin-like growth factor I: the yin and yang of muscle atrophy
  135. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex
  136. muscle atrophy in rats following denervation, casting, inflammation, and tenotomy.
  137. Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei
  138. Overexpression of peroxisome proliferator-activated receptor γ co-activator-1α leads to muscle atrophy with depletion of ATP
  139. Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone
  140. Assessment of quadriceps femoris muscle atrophy and hypertrophy in neuromuscular disease in children
  141. muscle atrophy at diagnosis of carpal and cubital tunnel syndrome
  142. Spinal deformities in patients with spinal muscle atrophy: a review of 36 patients.
  143. Oxidative stress during recovery from muscle atrophy
  144. Attenuation of skeletal muscle atrophy via protease inhibition
  145. Determinants of disuse-induced skeletal muscle atrophy: exercise and nutrition countermeasures to prevent protein loss
  146. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy
  147. Selective thigh muscle atrophy in trans-tibial amputees: an ultrasonographic study
  148. Transplanted mouse embryonic stem-cell-derived motoneurons form functional motor units and reduce muscle atrophy
  149. Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats
  150. Ectopic expression of IGF‐I and Shh by skeletal muscle inhibits disuse‐mediated skeletal muscle atrophy and bone osteopenia in vivo
  151. Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy
  152. Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure
  153. Gene expression during inactivity-induced muscle atrophy: effects of brief bouts of a forceful contraction countermeasure
  154. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy
  155. Cerebrovascular muscle atrophy is a feature of Alzheimer’s disease
  156. MRI of rotator cuff muscle atrophy in relation to glenohumeral joint incongruence in brachial plexus birth injury
  157. The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression
  158. Time course of muscle atrophy and recovery following a phenol‐induced nerve block
  159. atrophy responses to muscle inactivity. I. Cellular markers of protein deficits
  160. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors
  161. … -proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy
  162. Partial prevention of glucocorticoid-induced muscle atrophy by endurance training
  163. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway
  164. Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy
  165. Role of Akt/GSK-3β/β-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats
  166. muscle fibre size and number following immobilisation atrophy.
  167. Age-related skeletal muscle atrophy in humans: an immunohistochemical and morphometric study
  168. Morphological changes in rat hindlimb muscle fibres during recovery from disuse atrophy
  169. Skeletal muscle atrophy and peak oxygen consumption in heart failure
  170. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction
  171. muscle atrophy in rheumatoid arthritis.
  172. Changes in blood flow in the common femoral artery related to inactivity and muscle atrophy in individuals with long-standing paraplegia
  173. Glucocorticoid-induced muscle atrophy: mechanisms and therapeutic strategies
  174. atrophy of the multifidus muscle in patients with lumbar disk herniation: histochemical and electromyographic study
  175. Slowing muscle atrophy: putting the brakes on protein breakdown
  176. muscle atrophy and hypoplasia with aging: impact of training and food restriction
  177. Effect of flywheel-based resistance exercise on processes contributing to muscle atrophy during unloading in adult rats
  178. Increased transcription of ubiquitin–proteasome system components: molecular responses associated with muscle atrophy
  179. Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia
  180. Review Article: Mechanisms and Strategies to Counter muscle atrophy
  181. Hindlimb unloading-induced muscle atrophy and loss of function: protective effect of isometric exercise
  182. atrophy of the soleus muscle by hindlimb unweighting
  183. Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids
  184. Id2 and p53 participate in apoptosis during unloading-induced muscle atrophy
  185. Gluteus medius muscle atrophy is related to contralateral and ipsilateral hip joint osteoarthritis
  186. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by …
  187. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene
  188. Anti‐interleukin‐6 receptor antibody prevents muscle atrophy in colon‐26 adenocarcinoma‐bearing mice with modulation of lysosomal and ATP‐ubiquitin‐dependent …
  189. The possible role of myostatin in skeletal muscle atrophy and cachexia
  190. Transcutaneous muscle stimulation as a method to retard disuse atrophy.
  191. Preventive effects of insulinlike growth factor‐I on steroid‐induced muscle atrophy
  192. FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy
  193. Exercise and inhibition of glucocorticoid-induced muscle atrophy
  194. Flight muscle atrophy and predation risk in breeding birds
  195. muscle atrophy during starvation in a marine teleost.
  196. Metabolic consequences of muscle disuse atrophy
  197. Transcutaneous muscle stimulation to retard disuse atrophy after open meniscectomy.
  198. The molecular basis of skeletal muscle atrophy–parallels with osteoporotic signaling
  199. Lung function measurements in young children with spinal muscle atrophy; a cross sectional survey on the effect of position and bracing
  200. Prevention of bone loss and muscle atrophy during manned space flight.
  201. Intermittent acceleration as a countermeasure to soleus muscle atrophy
  202. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription
  203. Epigenetic drugs in the treatment of skeletal muscle atrophy
  204. Different frequency treadmill running in immobilization‐induced muscle atrophy and ankle joint contracture of rats
  205. Decreased polysomal HSP-70 may slow polypeptide elongation during skeletal muscle atrophy
  206. … muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy
  207. Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats
  208. Neuropsychological performance of children with Duchenne muscular dystrophy and spinal muscle atrophy
  209. Growth factor may decrease muscle atrophy secondary to denervation
  210. Thigh muscle atrophy in below-knee amputees.
  211. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway
  212. Mechanical stimulation of the plantar foot surface attenuates soleus muscle atrophy induced by hindlimb unloading in rats
  213. muscle atrophy in titin M-line deficient mice
  214. Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication
  215. Skeletal muscle atrophy increases cell proliferation in mice gastrocnemius during the first week of hindlimb suspension
  216. The effects on spindles of muscle atrophy and hypertrophy
  217. From animals to humans: evidence linking oxidative stress as a causative factor in muscle atrophy
  218. Relationship of skeletal muscle atrophy to functional status: a systematic research review
  219. Masseter muscle atrophy after ostectomy of the mandibular angle in rabbits.
  220. Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve
  221. The role of passive stretch in retarding muscle atrophy
  222. The decrease of the cytoskeleton tubulin follows the decrease of the associating molecular chaperone αB‐crystallin in unloaded soleus muscle atrophy without stretch
  223. Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters
  224. Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure
  225. Serum albumin for estimating creatinine clearance in the elderly with muscle atrophy
  226. Initiating regular exercise protects against muscle atrophy from glucocorticoids
  227. Melatonin is as effective as testosterone in the prevention of soleus muscle atrophy induced by castration in rats
  228. Intermittent reloading attenuates muscle atrophy through modulating Akt/mTOR pathway.
  229. Proteomic analysis of rat soleus muscle undergoing hindlimb suspension‐induced atrophy and reweighting hypertrophy
  230. Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats
  231. Resistance exercise and growth hormone as countermeasures for skeletal muscle atrophy in hindlimb-suspended rats
  232. Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy
  233. Age-related differences in apoptosis with disuse atrophy in soleus muscle
  234. Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
  235. Aerobic exercise as a countermeasure for microgravity-induced bone loss and muscle atrophy in a rat hindlimb suspension model.
  236. Immobilization‐induced muscle atrophy is not reversed by lengthening the muscle
  237. Insulin growth factor‐1 decreases muscle atrophy following denervation
  238. muscle atrophy as a consequence of rotator cuff tears: should we compare the muscles of the rotator cuff with those of the deltoid?
  239. O-GlcNAc level variations are associated with the development of skeletal muscle atrophy
  240. muscle atrophy associated with microgravity in rat: basic data for countermeasures
  241. Trigeminal and polyradiculoneuritis in a dog presenting with masticatory muscle atrophy and Horner’s syndrome
  242. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy
  243. atrophy of the posterior cricoarytenoid muscle as an indicator of recurrent laryngeal nerve palsy
  244. PPARδ agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle
  245. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy
  246. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist
  247. Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase
  248. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions
  249. Fibrillation potential amplitude to quantitatively assess denervation muscle atrophy
  250. muscle atrophy during space flight: research needs and opportunities
  251. Dissociated small hand muscle atrophy in aging: the ‘senile hand’is a split hand
  252. A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy
  253. muscle atrophy and leg length discrepancies in pauciarticular juvenile rheumatoid arthritis
  254. Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy
  255. muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM
  256. Chronic p53 activity leads to skeletal muscle atrophy and muscle stem cell perturbation
  257. Rate of denervation muscle atrophy
  258. FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension
  259. Hand muscle atrophy in multiple sclerosis
  260. Preferential loss of thin filaments during molt-induced atrophy in crab claw muscle
  261. The re-innervation of muscle after various periods of atrophy
  262. Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats
  263. Proteolytic processes underlying molt-induced claw muscle atrophy in decapod crustaceans
  264. Spinal muscle atrophy type 1 (Werdnig-Hoffman disease) with complex cardiac malformation
  265. … expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2 α may signal skeletal muscle atrophy in weight-losing …
  266. Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1
  267. Mechanisms accelerating muscle atrophy in catabolic diseases.
  268. muscle atrophy in transgenic mice expressing a human TSC1 transgene
  269. Conditional activation of MET in differentiated skeletal muscle induces atrophy
  270. Mergla K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway
  271. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.
  272. Electromyographic and phonomyographic patterns in muscle atrophy in man
  273. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats
  274. Continuous muscle stretch prevents disuse muscle atrophy and deterioration of its oxidative capacity in rat tail–suspension models
  275. Type I muscle atrophy caused by microgravity-induced decrease of myocyte enhancer factor 2C (MEF2C) protein expression
  276. Influence of unilateral masseter muscle atrophy on craniofacial morphology in growing rabbits
  277. Calf muscle atrophy and Achilles tendon healing following experimental tendon division and surgery in rats: Comparison of postoperative immobilization of the muscle …
  278. muscle weakness, paralysis, and atrophy after human cervical spinal cord injury
  279. Centrifugal intensity and duration as countermeasures to soleus muscle atrophy
  280. muscle atrophy after treatment with Halovest
  281. Clinical and pathologic findings in two draft horses with progressive muscle atrophy, neuromuscular weakness, and abnormal gait characteristic of shivers syndrome.
  282. Skeletal muscle atrophy in response to 14 days of weightlessness: vastus medialis
  283. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans
  284. Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression
  285. muscle-specific atrophy of the quadriceps femoris with aging
  286. Ultrasound measurement of quadriceps muscle in the first year of life. Normal values and application to spinal muscular atrophy
  287. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
  288. Isolated muscle atrophy of the distal upper extremity in cervical spinal cord compressive disorders.
  289. Estrogen status and skeletal muscle recovery from disuse atrophy
  290. Effect of different dietary protein composition on skeletal muscle atrophy by suspension hypokinesia/hypodynamia in rats
  291. Adaptations in skeletal muscle disuse or decreased-use atrophy
  292. Comparative study of different surgical procedures using sensory nerves or neurons for delaying atrophy of denervated skeletal muscle
  293. The role of passive stretch and repetitive electrical stimulation in preventing skeletal muscle atrophy while reprogramming gene expression to improve fatigue …
  294. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy
  295. Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness
  296. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase‐1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral …
  297. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases
  298. A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways
  299. Rapid atrophy and hypertrophy of an avian flight muscle
  300. atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
  301. Disuse atrophy of human skeletal muscle
  302. Decreased muscle atrophy F‐box (MAFbx) expression in regenerating muscle after muscle‐damaging exercise
  303. Mechanisms stimulating protein degradation to cause muscle atrophy
  304. Glucocorticoid-induced skeletal muscle atrophy in vitro is attenuated by mechanical stimulation
  305. Matrix metalloproteinase‐2 expression and promoter/enhancer activity in skeletal muscle atrophy
  306. A review of muscle atrophy in microgravity and during prolonged bed rest.
  307. Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone.
  308. Sporadic bulbospinal muscle atrophy with facial‐onset sensory neuropathy
  309. Neurogenic muscle atrophy in myasthenia gravis
  310. Therapeutic electrical stimulation (TES) for the treatment of disuse muscle atrophy in cerebral palsy
  311. Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids
  312. Effects of short duration stretching on disuse muscle atrophy in immobilized rat soleus muscles
  313. Apoptotic signaling in skeletal muscle fibers during atrophy
  314. Kinetics of muscle atrophy in different species
  315. Polyubiquitin in crustacean striated muscle: increased expression and conjugation during molt-induced claw muscle atrophy
  316. The genetics of muscle atrophy and growth: the impact and implications of polymorphisms in animals and humans
  317. Interrelations of myogenic response, progressive atrophy of muscle fibers, and cell death in denervated skeletal muscle
  318. Effects of therapeutic magnetic stimulation on acute muscle atrophy in rats after hindlimb suspension
  319. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats
  320. CT findings of atrophy of chest wall muscle after thoracotomy: relationship between muscles involved and type of surgery.
  321. Dystrophia myotonica: A model of combined neural and myopathic muscle atrophy
  322. Eccentric exercise training as a countermeasure to non-weight-bearing soleus muscle atrophy
  323. Effects of muscle immobilization at different lengths on tetrodotoxin-induced disuse atrophy
  324. Patterns of muscle atrophy in the lower limbs in patients with Charcot-Marie-Tooth disease as measured by magnetic resonance imaging
  325. The effects of therapeutic electric stimulation on acute muscle atrophy in rats after spinal cord injury
  326. atrophy of sacrospinal muscle groups in patients with chronic, diffusely radiating lumbar back pain
  327. Skeletal muscle atrophy induced by intramuscular repeated dose of botulinum toxin type A in rats
  328. Rat hindlimb unloading down-regulates insulin like growth factor-1 signaling and AMP-activated protein kinase, and leads to severe atrophy of the soleus muscle
  329. Human muscle atrophy in supportlessness: effects of short-term exposure to dry immersion.
  330. atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period
  331. Towards an understanding of molecular mechanisms of muscle atrophy: editorial comment
  332. muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease
  333. atrophy of non-locomotor muscle in patients with end-stage renal failure
  334. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans
  335. An electron microscope study of denervation atrophy in red and white skeletal muscle fibers
  336. Prevention of disuse muscle atrophy in chronic arthritides.
  337. MYOSTIM‐FES to prevent muscle atrophy in microgravity and bed rest: preliminary report
  338. A new X‐linked syndrome with muscle atrophy, congenital contractures, and oculomotor apraxia
  339. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females
  340. Effect of hormones upon regression of muscle atrophy of nervous origin
  341. muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse
  342. Prevention of muscle disuse atrophy by low-frequency electrical stimulation in rats
  343. Age-related atrophy of rat soleus muscle is accompanied by changes in fibre type composition, bioenergy decline and mtDNA rearrangements
  344. Disuse atrophy of skeletal muscle: loss of functional activity of mitochondria
  345. Ubiquitin and actin expression in claw muscles of land crab, Gecarcinus lateralis, and american lobster, Homarus americanus: Differential expression of ubiquitin in …
  346. Motor function–muscle strength relationship in spinal muscular atrophy
  347. Testosterone fails to prevent skeletal muscle atrophy from glucocorticoids
  348. muscle atrophy induced in broiler chicks by parts of Senna occidentalis seeds
  349. Masticatory muscle function in patients with spinal muscular atrophy
  350. Denervation muscle atrophy: an autolytic system in vitro
  351. Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-κB activation and expression
  352. Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle
  353. Effects of immobilization and continuous passive motion on postoperative muscle atrophy in mature rabbits.
  354. Strategies for suppressing muscle atrophy in chronic kidney disease: mechanisms activating distinct proteolytic systems
  355. Quantification of masticatory muscle atrophy after high-dose radiotherapy
  356. Hormonal control of muscle atrophy and degeneration in the moth Antheraea polyphemus
  357. Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy.
  358. The molecular responses of skeletal muscle satellite cells to continuous expression of IGF-1: implications for the rescue of induced muscular atrophy in aged rats
  359. Exercise interrupts ongoing glucocorticoid-induced muscle atrophy and glutamine synthetase induction
  360. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?
  361. US of the painful hip in childhood: diagnostic value of cartilage thickening and muscle atrophy in the detection of Perthes disease.
  362. atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle
  363. Insights into muscle atrophy and recovery pathway based on genetic models
  364. Protective effect of RenShen compound and DanHuang compound on muscle atrophy in suspended rats
  365. Changes in contractile properties of skeletal muscle during developmentally programmed atrophy and death
  366. Myasthenia gravis presenting with unusual neurogenic muscle atrophy
  367. Skeletal muscle hypertrophy and anti‐atrophy effects of clenbuterol are mediated by the β2‐adrenergic receptor
  368. Getting out of a tight squeeze—enzymatic regulation of claw muscle atrophy in molting
  369. Association of age-related mitochondrial abnormalities with skeletal muscle fiber atrophy
  370. Effects of Ligustrazine and Radix Astragali on activities of myosin adenosine triphosphatase of soleus muscle and muscle atrophy in tail-suspended rats
  371. Experimental study of denervated muscle atrophy following severance of posterior rami of the lumbar spinal nerves.
  372. Cloning of a muscle-specific calpain from the American lobster Homarus americanus: expression associated with muscle atrophy and restoration during moulting
  373. muscle atrophy in ankylosing spondylitis: CT demonstration.
  374. Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy
  375. Thoracic discospondylitis with associated epaxial muscle atrophy in a Quarter Horse gelding
  376. Effects of the β2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat
  377. Hindlimb muscle atrophy of rat induced by neuropathic pain
  378. Myotendinous junction: morphological changes and mechanical failure associated with muscle cell atrophy
  379. Expression of endoplasmic reticulum stress proteins during skeletal muscle disuse atrophy
  380. Tattoo-related brachial plexopathies with adjacent muscle atrophy
  381. Protective effect of glutamine from glucocorticoid-induced muscle atrophy occurs without alterations in circulating insulin-like growth factor (IGF)-I and IGF-binding …
  382. Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy
  383. Isolated and painless (?) atrophy of the infraspinatus muscle: left handed versus right handed volleyball players
  384. Does extended-field-of-view sonography improve interrater reliability for the detection of rotator cuff muscle atrophy?
  385. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
  386. Severe obstructive sleep apnea in a patient with spinal muscle atrophy
  387. Late onset spinal muscle atrophy‐a sex linked variant of Kugelberg‐Welander
  388. muscle atrophy and restoration during molting
  389. atrophy, but not necrosis, in rabbit skeletal muscle denervated for periods up to one year
  390. Androgen cytosol binding in exercise-induced sparing of muscle atrophy
  391. Focal atrophy of the multifidus muscle in lumbosacral radiculopathy
  392. … function, a commentary on” absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy“
  393. atrophy of Multifidus muscle on Low Back Pain Patients.
  394. Facial pain and muscle atrophy secondary to an intracranial tumour
  395. Novel dysferlin mutations and characteristic muscle atrophy in late‐onset Miyoshi myopathy
  396. Mechanism of protein loss in denervation muscle atrophy
  397. muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin.
  398. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in …
  399. Effects of insulin-like growth factor-1/binding protein-3 complex on muscle atrophy in rats
  400. muscle atrophy in severe exacerbation of asthma requiring mechanical ventilation
  401. Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation
  402. muscle atrophy after human spinal cord injury
  403. Magnetic resonance imaging of denervation‐induced muscle atrophy: Effects of clenbuterol in the rat
  404. Changes with Time in Cross-Sectional Areas of Leg muscles in Early Stroke Rehabilitation Patients Disuse muscle atrophy and Its Recovery
  405. Proximal muscle atrophy in adult celiac disease
  406. muscle fiber atrophy after cast immobilization in the rat.
  407. Endoscopic release for carpal tunnel syndrome accompanied by thenar muscle atrophy
  408. Exercise training exacerbates tourniquet ischemia-induced decreases in GLUT4 expression and muscle atrophy in rats
  409. Alcohol accelerates loss of muscle and impairs recovery of muscle mass resulting from disuse atrophy
  410. The activation of apoptosis factor in hindlimb unloading-induced muscle atrophy under normal and low-temperature environmental conditions
  411. CT demonstration of extraocular muscle atrophy.
  412. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy.
  413. Modulation of transglutaminase expression in rat skeletal muscle by induction of atrophy and endurance training
  414. Effect of estrogen on the development of disuse atrophy of bone and muscle induced by tail-supension in rats.
  415. Effect of activities of daily living on fiber type atrophy of the vastus lateralis muscle in patients with joint disorders.
  416. Reduced glycogen phosphorylase activity in denervated hindlimb muscles of rat is related to muscle atrophy and fibre type
  417. Analysis of muscle atrophy after hip fracture in the elderly
  418. Acetylcholine receptor ɛ-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice
  419. Steroid induced muscle atrophy
  420. Anatomical study on the atrophy of supraspinatus muscle belly with cuff tear
  421. The Disuse muscle atrophy in The Hemiplegic Patients The muscle Weakness in The “Unaffected” Extremities
  422. Monomelic muscle atrophy
  423. Galvanism and denervated muscle atrophy
  424. muscle atrophy continues after early cast removal following tendon repair
  425. Effect of Eucommiae Cortex on Hind Limb muscle atrophy of Sciatic Nerve Transectioned Rats
  426. The role of the nervous system in muscle atrophy
  427. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation
  428. RIGHT LEG muscle atrophy AND OSTEOPENIA CAUSED BY RENAL ADENOCARCINOMA IN A COCKATIEL (MELOPSITTACUS, UNDULATUS)
  429. Effect of exercise on age-related muscle atrophy
  430. The contractile apparatus of striated muscle in the course of atrophy and regeneration
  431. Diffuse muscle fiber atrophy in newly diagnosed diabetes.
  432. atrophy of crustacean somatic muscle and the proteinases that do the job. A review
  433. Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function
  434. An approach to counteracting long-term microgravity-induced muscle atrophy
  435. Masticator muscle enhancement in subacute denervation atrophy.
  436. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice
  437. Denervation muscle atrophy. Studies of components required for autolysis in vitro.
  438. atrophy of the nuchal muscle and change in cervical curvature after expansive open-door laminoplasty
  439. Glucocorticoid cytosol binding in exercise-induced sparing of muscle atrophy
  440. Growth hormone improves body mass recovery with refeeding after chronic undernutrition-induced muscle atrophy in aging male rats
  441. Gene therapy with anabolic growth factors to prevent muscle atrophy
  442. Transneuronal induction of muscle atrophy in grasshoppers
  443. atrophy of skeletal muscle in patients with Cushing’s syndrome
  444. Age effects on rat hindlimb muscle atrophy during suspension unloading
  445. Transcriptional reprogramming and ultrastructure during atrophy and recovery of mouse soleus muscle
  446. Influence of the time when weight bearing is started on disuse atrophy in rat soleus muscle
  447. atrophy of the deltoid muscle following rotator cuff surgery
  448. Glucocorticoid-mediated muscle atrophy: alterations in transcriptional activity of skeletal muscle nuclei
  449. Isolated compression of the pectoral nerve resulting in atrophy of the major pectoral muscle
  450. Lysosomes and disuse atrophy of skeletal muscle
  451. The progression of bone and muscle atrophy in mice hind limb with immobilization.
  452. Role of calcium-dependent proteinase in molt-induced claw muscle atrophy
  453. Research opportunities in muscle atrophy
  454. Getting the jump on skeletal muscle disuse atrophy: preservation of contractile performance in aestivating Cyclorana alboguttata (Günther 1867)
  455. Evaluation of disuse atrophy of rat skeletal muscle based on muscle energy metabolism assessed by 31P-MRS
  456. Myogenic induction of taurine transporter prevents dexamethasone-induced muscle atrophy
  457. 9 Ubiquitin-Proteasome Pathway of Intracellular Protein Degradation: Implications for muscle atrophy During Unloading
  458. muscle fiber conduction velocity study as an indicator of muscle atrophy in the hemiplegia
  459. Spinal muscle atrophy in Brown Swiss x Braunvieh cross calves
  460. muscle atrophy and hormonal regulation in women in 120 day bed rest.
  461. Moraxella catarrhalis sepsis in a patient with juvenile spinal muscle atrophy
  462. Dynamics of postdenervation atrophy of young and old skeletal muscles: differential responses of fiber types and muscle types
  463. muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?
  464. muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III
  465. Effects of weight bearing intervals on disuse atrophy of rat soleus muscle
  466. Type I fiber atrophy in the vastus lateralis muscle in dogs with femoral fractures treated by hyperextension
  467. On the possible role of muscle in the pathogenesis of spinal muscular atrophy
  468. Clinical report of oriental medicine treatment with bee venom therapy of progressive muscle atrophy 1 patient
  469. Midgestational sciatic nerve transection in fetal sheep results in absent nerve regeneration and neurogenic muscle atrophy.
  470. muscle atrophy in isolated ACTH deficiency
  471. Glucocorticoid-induced atrophy is not due to impaired excitability of rat muscle
  472. Soleus muscle atrophy in rats induced by cast immobilization: lack of effect by anabolic steroids.
  473. Studies on muscle atrophy: A method of recording power in situ and observations on effect of position of immobilization on atrophy of disuse and denervation
  474. Discovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophy
  475. muscle atrophy by limb immobilization is not caused by insulin resistance
  476. Quadriceps muscle atrophy and long-term recovery after knee ligamentous injury.
  477. Selected Contribution: Identification of differentially expressed genes between young and old rat soleus muscle during recovery from immobilization-induced atrophy
  478. The use of injectable silastic as a prothetic material for muscle atrophy of the thumb web in leprosy
  479. muscle fiber number in immobilization atrophy.
  480. Effect of electric stimulation on denervated skeletal muscle atrophy
  481. muscle fiber conduction velocity in situ (MFCV) in denervation, reinnervation and disuse atrophy
  482. Disuse atrophy of Skeletal muscle
  483. The production of skeletal muscle atrophy and mammary tumors in rats by feeding 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide
  484. Central vestibular involvement in peroneal muscle atrophy: a preliminary report
  485. Bilateral extraocular muscle atrophy in myotonic dystrophy type 1
  486. Compression of the deep branch of the ulnar nerve at the adductor hiatus producing pain without muscle atrophy.
  487. Effect of short duration stretching for prevention of disuse muscle atrophy in mature rats
  488. Disuse atrophy of skeletal muscle in the rat, aggravated by cortisol and various stress conditions
  489. Ultrastructural changes in muscle in spinal muscular atrophy—Werdnig-Hoffmann’s disease
  490. An experimental study on effect of implanting bFGF into denervated skeletal muscle to muscle satellite cell proliferation and muscle atrophy
  491. Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization
  492. Involvement of autophagic degradation in ACTH-induced skeletal muscle atrophy.
  493. Unaltered aerobic power and endurance following glucocorticoid-induced muscle atrophy.
  494. Mechanisms in muscle atrophy in immobilization and aging
  495. Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy
  496. An experimental study on denervated muscle atrophy–effect of electrostimulation and comparison with immobilization muscle atrophy
  497. The fly wheel exercise device (FWED): A countermeasure against bone loss and muscle atrophy
  498. Seronegative myasthenia gravis and muscle atrophy of the tongue
  499. From gene to disease;’survival’motor neuron protein and hereditary proximal spinal muscle atrophy
  500. muscle atrophy in microgravity and during its simulation
  501. Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle
  502. Early biochemical changes in mitochondria from denervated muscle and their relation to the onset of atrophy
  503. Skeletal muscle fiber atrophy: altered thin filament density changes slow fiber force and shortening velocity
  504. Selective atrophy of red muscle fibres in the quadriceps in long-standing knee-joint dysfunction: injuries to the anterior cruciate ligament
  505. Cytochrome c protein-synthesis rates and mRNA contents during atrophy and recovery in skeletal muscle
  506. HUMAN muscle DISUSE atrophy AFTER 28 DAYS OF IMMOBILIZATION IN A LOWER-LIMB WALKING BOOT: A CASE STUDY.
  507. Role of afferent input in muscle atrophy.
  508. Overgrowth of the ischial tuberosity complicating femoral bone and muscle atrophy: implications for a delayed complication of malunited apophyseal avulsion fracture.
  509. Renal hemodynamic studies in patients with extensive paralysis: The influence of weight loss, muscle atrophy, and immobilization
  510. A Patient with Cronkhite‐Canada Syndrome, Myxedema and muscle atrophy
  511. muscle MRI findings of X-linked spinal and bulbar muscular atrophy
  512. atrophy of the quadriceps muscle in children with a painful hip
  513. Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum
  514. Thigh muscle atrophy and postoperative osteoarthrosis after knee ligament tears.
  515. Pulsed Electromagnetic Fields—A Countermeasure for Bone Loss and muscle atrophy
  516. Porcine congenital splayleg is characterised by muscle fibre atrophy associated with relative rise in MAFbx and fall in P311 expression
  517. In vivo measurements of protein turnover during muscle growth and atrophy
  518. Effects of electrically stimulated muscle contractions on bone loss & muscle atrophy
  519. Experimental study on neural stem cell transplantation delaying denervated muscle atrophy
  520. Skeletal muscle calcineurin: influence of phenotype adaptation and atrophy
  521. Effects of muscle atrophy on motor control
  522. Histochemical study on the changes in muscle fibers in relation to the effects of aging on recovery from muscular atrophy caused by disuse in rats
  523. Neurogenic muscle atrophy and osteomalacia in adult Fanconi syndrome
  524. atrophy-resistant fibers in permanent peripheral denervation of human skeletal muscle
  525. Nociceptive atrophy of the rat soleus muscle induced by bone fracture: a morphometric study
  526. Observations on the atrophy of denervated muscle
  527. Mechanisms of accelerated proteolysis in rat soleus muscle atrophy induced by unweighting or denervation
  528. Myonuclei are not lost during muscle atrophy
  529. Disuse atrophy of skeletal muscle: a morphometric study using image analysis
  530. FINE STRUCTURE OF muscle IN HUuMAN DISUSE atrophy: SIGNIFICANCE OF PROXIMAL muscle INVOLVEMENT IN muscle DISORDERS
  531. In vivo T1 characterization of genetically induced muscle atrophy
  532. Preventive effect of isometric contraction exercise on disuse muscle atrophy using tail suspension mice
  533. Immobilization atrophy and membrane properties in rat skeletal muscle fibres
  534. Effects of long-impulse electrical stimulation on atrophy and fibre type composition of chronically denervated fast rabbit muscle
  535. Signs of necrosis and inflammation do not support the concept of apoptosis as the predominant mechanism during early atrophy in immobilized muscle
  536. The effect of transplantation of skeletal muscle satellite cell on retard the denervated muscles atrophy
  537. A case of Marfan’s syndrome phenotype associated with neurogenic muscle atrophy
  538. Thigh muscle atrophy after femoral shortening: vastus intermedius cross-section studied in osteotomized rats
  539. Levels of blood-bourne factors and cytosol glucocorticoid receptors during the initiation of muscle atrophy in rodent hindlimbs
  540. Effect of periodic weight support on Type I muscle of developing suspended rats: Animal experiment for nursing intervention of muscle atrophy in children
  541. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy
  542. Dynamic foot pressure as a countermeasure to muscle atrophy
  543. Teaching NeuroImage: Axial muscle atrophy in adult-onset Pompe disease
  544. Spindle discharge in glucocorticoid-induced muscle atrophy
  545. Molt-induced muscle atrophy decreases the zinc content of the pectoralis of the giant Canada goose (Branta canadensis maxima)
  546. Psychosomatic Aspects of Encephalomyelopathy with muscle atrophy
  547. Histochemical studies on skeletal muscle atrophy, with reference to the relationship between atrophy and muscle tension, and to the effect of electrical stimulation
  548. Genetic regulation of slowly progressing mild muscle atrophy in fast‐twitch muscles of BUF/Mna rats
  549. Prevention of muscle atrophy by Functional Electrical Stimulation
  550. Crustaceans as a model for microgravity-induced muscle atrophy
  551. Effects of Eucommiae Cortex on Myofiber Type Transition and MyoD Expression in Hind Limb muscle atrophy of Rats
  552. Change from a hard to soft diet alters the expression of insulin-like growth factors, their receptors, and binding proteins in association with atrophy in adult mouse …
  553. Daily 4-h head-up tilt is effective in preventing muscle but not bone atrophy due to simulated microgravity.
  554. Excitability changes and muscle atrophy after de-afferentation
  555. Bone fracture induces reflex muscle atrophy which is sex-dependent
  556. atrophy in skeletal muscle
  557. A case of hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome with spastic paraparesis and severe distal muscle atrophy of lower limbs
  558. Skeletal muscle metabolic abnormalities in congestive heart failure are not due to muscle atrophy
  559. Gyrate atrophy of the choroid and retina with hyperornithinemia: tubular aggregates and type 2 fiber atrophy in muscle
  560. Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis
  561. Asymmetric muscle atrophy from childhood polio
  562. Intervention of Ciliary Neurotrophic Factor on Weightlessness-Induced muscle atrophy and Myofiber Phenotype Transition
  563. Inactivity-induced skeletal muscle atrophy: a brief review
  564. Familial autosomal recessive rigid spine syndrome with neurogenic facio-scapulo-peroneal muscle atrophy.
  565. Effects of Chaenomelis fructus Herbal Acupuncture on muscle Fiber in muscle atrophy Rat induced by Hindkimb Suspension
  566. Biochemical and clinical study of muscle atrophy at thenar and hypothenar eminences in patients with cirrhosis
  567. Skeletal muscle atrophy contributes to exercise intolerance in heart failure
  568. Anesthetic management of spinal progressive muscle atrophy (SPMA)
  569. Rabbit masseteric muscle atrophy resulting from triamcinolone for injection [J]
  570. Progressive neurogenic muscle atrophy with fasciculation in mice treated with IDPN
  571. Prophylactic effects of choline chloride on muscle atrophy in tail-suspended rats
  572. Tethered cord syndrome accompanied by unilateral muscle atrophy in the calf muscle
  573. An autopsy case of a syndrome with muscular atrophy, decreased subcutaneous fat, skin eruption and hyper γ-globulinemia: peculiar vascular changes and muscle …
  574. Variations of glucocorticoid receptors in intact or denervated muscles: lack of cause-effect relationship with muscle atrophy in the rat
  575. Effects of intermittent sciatic nerve stimulation on the soleus and medial gastrocnemius muscle atrophy in hindlimb suspended rats
  576. Small hand muscle atrophy as an initial sign in HTLV-I associated myelopathy
  577. Localization of non-specific esterase and acid phosphatase in human fibroblast from skeletal muscle atrophy
  578. Histochemical study on the atrophy of the quadriceps femoris muscle caused by knee joint injuries of rats.
  579. muscle atrophy and histopathology of the soleus in 6-mercaptopurine-treated rats
  580. Effect of thyroparathyroidectomy and thyroxin on rate of atrophy of skeletal muscle
  581. Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy
  582. Mechanical vibrations reduce the intervertebral disc swelling and muscle atrophy from bed rest
  583. A 21-year-old man with distal dominant progressive muscle atrophy
  584. A form of necrobiosis and atrophy of smooth muscle in diabetic gastric autonomic neuropathy
  585. Inhibitor of nitric oxide synthase on the denervated muscle atrophy
  586. Depletion of [3H]Methyltrienolone Cytosol Binding in Glucocorticoid-Induced muscle atrophy
  587. A possible role for endogenous glucocorticoids in orchiectomy-induced atrophy of the rat levator ani muscle: studies with RU 38486, a potent and selective …
  588. Further studies on 6-mercaptopurine-induced muscle atrophy in rats, mice, and hamsters treated as neonates.
  589. Embryonic neurons transplanted into the tibial nerve reinnervate muscle and reduce atrophy but NCAM expression persists
  590. A Review of muscle atrophy
  591. Effects of prostaglandin inhibition, electrical stimulation and local heating on skeletal muscle atrophy
  592. Advances of studies on denervated skeletal muscle atrophy [J]
  593. Effect of ciliary neurotrophic factor on denerveted skeletal muscle atrophy
  594. Medialization laryngoplasty with strap muscle transposition for vocal fold atrophy with or without sulcus vocalis
  595. Effect of exercise and heat stress before hindlimb suspension on prevention of the skeletal muscle atrophy
  596. Development of therapies against neuromuscular diseases causing muscle atrophy
  597. Is Myosin Ubiquitinisation a mechanism of skeletal muscle atrophy in heart failure?
  598. Influence in the Skeletal muscle atrophy Due to Immobilization after Denervation [J]
  599. Inhibitory effect of running exercise on age-induced muscle atrophy
  600. Insulin attenuates atrophy of unweighted soleus muscle by amplified inhibition of protein degradation
  601. Using dynamic foot pressure as a countermeasure to muscle atrophy
  602. Progress in research on the mechanism of denervated skeletal muscle atrophy
  603. The preventive effects of one herbal compound on activities of myosin adenosine triphosphatase of muscle fibers and muscle atrophy in tail-suspended rat
  604. The effect of extracellular ATP on prevention and treatment of denervated muscle atrophy: an experimental study
  605. Do hormonal (stress) and vascular (ischaemia) factors contribute to reflex muscle atrophy induced by chronic nociceptive stimulation in rats?
  606. Experimental study on losartan decreasing denervated skeletal muscle atrophy through reducing cell apoptosis
  607. Occipital horn syndrome (Ehlers-Danlos syndrome type IX) with severe psychomotor retardation and muscle atrophy–a first Japanese case
  608. Influence of atrophy on the efficiency of muscle reinnervation
  609. Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies
  610. Ultrasound imaging for monitoring muscle atrophy in rehabilitation patients: A pilot study
  611. Molecular Mechanisms of muscle Disuse atrophy (and Strategies of Prevention)
  612. Sulphur and phosphorus content in relation to fibre composition and atrophy of skeletal muscle in patients with Parkinson’s disease
  613. Trapezius muscle atrophy after whiplash injury: accessory nerve or cervical plexus lesion?
  614. muscle atrophy following section of the spinal cord in the rat
  615. Effects of Dipsaci Radix on muscle Fiber atrophy and MyoD Expression in Gastrocnemius of MeAO Rats
  616. Antioxidant countermeasure to muscle disuse atrophy.
  617. Effects of passive exercise on neurogenic atrophy in rat skeletal muscle
  618. Isolated atrophy of the infraspinatus muscle in baseball players
  619. Stress responsive miR-23a attenuates skeletal muscle atrophy by targeting Mafbx/atrogin-1
  620. Progress of Apoptosis in Denervation Induced muscle atrophy
  621. Electromyogram and pathological features of adult spinal muscle atrophy: analysis of 46 cases
  622. Skeletal muscle atrophy and fall-related fractures in elderly people
  623. Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese …
  624. Effects of intervention with back-lying exercises with bent knees pointing upwards to prevent disuse muscle atrophy in patients with post-stroke hemiplegia
  625. Juvenile neurogenic muscle atrophy with lysosomal enzyme deficiencies: new disease or variant of mucopolysaccharidosis?
  626. Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters
  627. Study on the Mechanism of muscle atrophy and the Influence of Exercise on It
  628. The effects of age on atrophy and recovery in denervated fiber types of the rat nasolabialis muscle
  629. Comparison of muscle atrophy induced by cast fixation, denervation and suspension of rat hindlimb
  630. Progressive paraspinal muscle atrophy presenting as low-back pain: case report
  631. Leucine supplementation mitigates atrophy of non‐weight‐bearing skeletal muscle in rats
  632. Chronic disuse muscle atrophy: A new metabolic perspective.
  633. A quantitative analysis of the muscle atrophy in osteoarthritis of the hip by computed tomography
  634. Oxidative stress in skeletal muscle atrophy induced by immobilization
  635. Benign infantile neurogenic muscle atrophy predominantly involving the upper extremities
  636. Functional alterations of muscle perfusion in Type II muscle atrophy: Demonstration by lower extremity perfusion scans
  637. Effects of the beta-adrenergic agonist cimaterol on chicken muscle atrophy induced by stretch-release.
  638. Effect of endurance exercise prior to occurrence of muscle atrophy on the mass, myofibrillar protein content and fiber crossectional area of atrophied hindlimb muscles …
  639. Tenascin‐C‐deficiency accelerates mechano‐and age‐dependent skeletal muscle atrophy
  640. 1503 SKELETAL muscle atrophy INDUCED IN NEWBORNS BY CHRONIC PANCURONIUM TREATMENT
  641. A Study of Electric Stimulation Influence on Denervated Skeletal muscle atrophy
  642. Anabolic beta-2-agonist clenbuterol fails to modify muscle atrophy due to femur fracture.
  643. Effect of Nandrolone Decanoate on Disuse muscle atrophy and Bone Beating in Dogs
  644. Inhibition of corticosterone-induced muscle atrophy and reduction in muscle protein synthesis by the anabolic steroid nandrol-one phenylpropionate in female rats
  645. Morphological changes of capillaries associated with muscle-fiber atrophy in the extensor digitorum longus muscle of aged rats
  646. Initial events in the muscle atrophy program
  647. Carbohydrate metabolism and the beta-adrenergic system in disuse muscle atrophy.
  648. muscle atrophy in a horse
  649. Beta adrenoceptor agonists, clenbuterol, and isoproterenol retard denervation atrophy in rat gastrocnemius muscle: use of 3-methylhistidine as a marker of myofibrillar …
  650. Study of the Relation between Hypoxia and muscle atrophy
  651. Camptocormia Due to Selective Paraspinal muscle atrophy
  652. Relationship between hind-limb muscle atrophy and serum enzymes in tail suspended rats.
  653. Study on Delaying Action of Angelica Injection on muscle atrophy after Sciatic Nerve Injury
  654. How to diminish calcium loss and muscle atrophy in space
  655. Deltoid muscle atrophy secondary to hepatitis B injection? a case report
  656. Bilateral neurogenic masseter muscle atrophy in a mare
  657. Degeneration of cocultures of spinal muscular atrophy muscle cells and rat spinal cord explants is not due to secreted factors and cannot be prevented by …
  658. Cholesterol conservation in skeletal muscle associated with age-and denervation-related atrophy
  659. Tattoo-related brachial plexopathies with adjacent muscle atrophy
  660. Effect of ketoleucine treatment on atrophy of skeletal muscle
  661. The castration atrophy of the dorsal bulbocavernosus muscle of rat: an electron microscopic study
  662. muscle atrophy: will it come back and how to treat it?
  663. MECHANICAL BEHAVIOR OF SKELETAL muscle DURING STRETCH: INFLUENCE OF muscle atrophy
  664. Correlation between muscle atrophy, male hypogonadism and DNA expansion in myotonic dystrophy
  665. muscle atrophy as a Source of Increased Sensory Activity
  666. Myasthenia gravis with profound muscle atrophy
  667. Resistance to disuse atrophy in a turtle hindlimb muscle
  668. Evaluation of disuse atrophy of skeletal muscle based on muscle energy metabolism. A 31P-MRS study
  669. Effect of isometric exercise on the soleus muscle atrophy induced by reduced use with reference to ageing
  670. Aging implicated in’postpolio muscle atrophy‘
  671. Ultrasound monitoring of patients with leg muscle atrophy
  672. Countermeasures of muscle atrophy in weightlessness (Single therapy versus Combination therapy)
  673. Analysis on muscle atrophy of the Upper Limbs in Cervical spondylosis
  674. muscle atrophy in case of joint and bone suffering
  675. LATE muscle atrophy IN POLIOMYELITIS
  676. Investigation into the Mechanisms Responsible for muscle atrophy in Cancer
  677. Mechanical Signal Transduction in Countermeasures to muscle atrophy
  678. High force contractions as a countermeasure to muscle atrophy.
  679. Dumbbell Anterolateral Spinocranial Neurofibroma with a Note on Thigh muscle atrophy and Fasciculation
  680. Gene Regions Responding to Skeletal muscle atrophy
  681. Old-age muscle atrophy: Cellular mechanisms and behavioral consequenses
  682. First Dorsal Interosseous muscle atrophy: A Clinical Sign of Impaired Glucose Metabolism.
  683. Studies on amphibian metamorphosis. V. The atrophy of anuran tail muscle during metamorphosis
  684. Alteration of myonuclear number after skeletal muscle atrophy
  685. The effect of rehabilitation training on muscle strength and exercise tolerance in hemodialysis patients with muscle atrophy
  686. The effects of insulin-like growth factor-1 and nerve growth factor on denervated muscle atrophy
  687. Alterations of trabecular bone architecture in the proximal tibia and muscle atrophy after sciatic denervation in rats
  688. Mechanism of microgravity-induced muscle atrophy and development of effective space food against the atrophy
  689. Cellular and molecular mechanisms of apoptosis in skeletal muscle atrophy
  690. Do changes in the vascular bed contribute to the development of denervation atrophy in skeletal muscle
  691. muscle atrophy and hypertrophy signaling pathways in COPD: A role in muscle remodeling?
  692. Nutritional Interventions in Skeletal muscle atrophy
  693. Efficacy of functional electrical stimulation in ameliorating inactivity-induced atrophy in a fast hindlimb muscle in rat
  694. muscle atrophy AFTER FRACTURES
  695. muscle atrophy in a Case of Acute Disseminated Encephalomyelitis
  696. Motor innervation in type II atrophy of skeletal muscle
  697. Lack of skeletal muscle atrophy and myosin isoform changes in a rodent hibernator, Spermophilus lateralis, subjected to activity restriction
  698. Aging implicated in’postpolio muscle atrophy‘
  699. muscle atrophy in Hemiplegic Patients
  700. Skeletal muscle responses to exercise in the prevention of glucocorticoid-induced muscle atrophy.
  701. Magnetic resonance imaging of peripheral vascular disease and muscle atrophy in diabetes
  702. The role of Merg1a potassium ion channel in skeletal muscle atrophy
  703. Effect of retroauricular galvanic stimulation on muscle atrophy in the unweighted rat hindlimb
  704. Effects of skeletal muscle hypertrophy and atrophy on muscle DNA, RNA and protein levels.
  705. Identification of cDNAs of Genes Suppressed during the Process of atrophy in Rat Skeletal muscle
  706. From gene to disease; androgen receptor gene, androgen insensitivity syndrome, and spinal and bulbar muscle atrophy
  707. Effects of Intermittent Sciatic Nerve Stimulation on the Soleus and Medial Gastrocnemius muscle atrophy in Hindlimb Suspended Rats
  708. Effects of muscle atrophy on Motor Control: Cage-size Effects
  709. The effect of reloading on disuse muscle atrophy: Time course of
  710. Effect of skeletal muscle atrophy on sarcolemma lipids and proteins
  711. A case of progressive hemiatrophy with type 2 muscle atrophy in muscle biopsy
  712. Prevention of glucocorticoid-induced muscle atrophy by exercise: Potential mechanisms.
  713. Development of a functional food or drug against unloading-mediated muscle atrophy
  714. Investigation into the mechanisms responsible for muscle atrophy in cancer cachexia
  715. THE THEORETIC AND EXPERIMENTAL STUDY ON THE CHANGEOF EMG POWER SPECTRUM CAUSED BY muscle atrophy
  716. On the Treatment of muscle atrophy with Very High Frequency Impulses
  717. Biochemical assessment of the hibernator skeletal muscle properties in search of a potential countermeasure against muscle atrophy in space microgravity
  718. Effect of trigeminus nerve on facialis-denervated facial muscle atrophy
  719. Involvement of interleukin-6 in activation of lysosomal cathepsin and atrophy of muscle fibers induced by intramuscular injection of turpentine oil in mice
  720. CT findings of cervical spondylosis associated with muscle atrophy in the upper extremity
  721. Ultrastructural and cytological changes in the muscle fibers of the pectoralis of the giant Canada goose (Branta canadensis maxima) in disuse atrophy during molt
  722. Synergistic ablation does not affect atrophy or altered myosin heavy chain expression in the non-weight bearing soleus muscle
  723. Biochemical and Histological Properties of muscle atrophy in C57BL/6J-dy Mice
  724. Osteoid Osteoma with Marked muscle atrophy: A case report
  725. muscle proteinase activities during compensatory growth and atrophy
  726. Pathways of Skeletal muscle atrophy: HIV as a Model System?
  727. THE ROLE OF muscle SPINDLE IN muscle atrophy INDUCTED BY SIMULATED MICROGRAVITY
  728. Experimental Study of the muscle atrophy Following to Tendon Ruptur
  729. Functional changes in single muscle fibers following disuse atrophy
  730. INFLUENCE OF SHORTENED AND LENGTHENED IMMOBILIZATION ON RAT SOLEUS muscle atrophy
  731. muscle atrophy of hand as an initial sign in a patient with protoplasmic astrocytoma: a case report and literature review
  732. Changes of human skeletal muscle volume and cholin/creatin ratio under simulated weightlessness condition and the effect of exercise in muscle atrophy
  733. Changes in intercellular electrical coupling of smooth muscle accompanying atrophy and hypertrophy
  734. Effects of Passive Stretch on Soleus muscle atrophy in Immobilized Rats
  735. Gene Expression Modulation in Rat Skeletal muscle by Denervation-induced atrophy
  736. TO 4 Ribozyme-based gene therapy reverses muscle atrophy in a mouse model of myotonic dystrophy
  737. Using transcriptional profiling and bioinformatics approaches to study skeletal muscle atrophy
  738. Skeletal muscle Apoptosis after Immobilization: A Mechanism for muscle atrophy Via Akt Inactivation
  739. LEUCINE AS AN ANTAGONIST OF GLUCOCORTICOID-INDUCED muscle atrophy 1300
  740. Latent hyperbilirubinemias elicited by nicotinic acid test among the family of a case of Gilbert’s syndrome with a kind of muscle atrophy which is similar to Charcot …
  741. Glucocorticoid-induced skeletal muscle atrophy is
  742. muscle biopsy of a 15-year-old boy with muscle atrophy and weakness of the extremities from infancy
  743. Inhibition of Bone Loss and muscle atrophy by Dynamic muscle Contractions With Rest Periods in a Functional Disuse Mouse Model
  744. Effects of Chaenomelis fructus on the muscle atrophy Induced by Hindlimb Suspinsion in Rats
  745. The prevention of muscle atrophy following peripheral nerve repair using an implantable electrical system.
  746. Counteracting muscle atrophy using Galvanic Stimulation of the Vestibular System
  747. NEW EVIDENCE CONCERNING THE CAUSE OF OESOPHAGEAL SMOOTH muscle atrophy IN SCLERODERMA
  748. muscle atrophy Induced by the Exposure to Microgravity Environment and/or Aging
  749. Infraspinatus muscle atrophy in Relation to Sagittal Extent of Rotator Cuff Tear (SS-38)
  750. Acceleration of age‐related skeletal muscle atrophy and oxidative stress in the mice lacking of CuZnSOD
  751. muscle atrophy-induced changes of cathepsin and dipeptide levels in rats.
  752. Hindlimb unloading-induced muscle atrophy and phenotype transition is attenuated in Smad3+/-mice
  753. Lipomatous muscle atrophy caused by irradiation exposure
  754. DOES muscle FIBRE atrophy AFFECT EMG MEASURES OF BACK muscle FATIGUE?
  755. Study of Opponensplasty in Carpal Tunnel Syndrome with Thenar muscle atrophy
  756. Inhibitory effects of exercise preconditioning on muscle atrophy induced capillary regression in rat soleus muscle
  757. Impact of Hindlimb Unloading on muscle atrophy after Severe Burn in Rats
  758. Effect of atrophy and contractions on myogeninmRNA concentration in chick and RMo muscle cells.
  759. EFFECTS OF CLENBUTEROL IN PREVENTION OF muscle atrophy IN SIMULATED BED REST
  760. Neurological CPC. 57. An 80-year-old woman with four years history of muscle atrophy involving lower extremities predominantly on the right side
  761. The Regulatory Potentials of Dynamic Electrical muscle Simulation on preventing Bone Loss and muscle atrophy
  762. THE EFFECT OF SMALL DOSE OF CLENBUTEROL ON THE DENERVATED muscle atrophy
  763. Control of Protein Balance during Immobilization-Induced Skeletal muscle atrophy
  764. Progressive muscle atrophy with hypokalaemic periodic paralysis and calcium channel mutation
  765. A 54-year-old man with generalized muscle atrophy and oculomotor paresis
  766. HIV-1 transgenic expression in mice induces selective atrophy of fast-glycolytic skeletal muscle fibers
  767. Constant Fiber Number During Skeletal muscle atrophy and Modified Arachidonate Metabolism During Hypertrophy
  768. Characterization of disuse skeletal muscle atrophy and the efficacy of a novel muscle atrophy countermeasure during spaceflight and simulated microgravity
  769. Therapeutic effect of androgen on skeletal muscle atrophy induced by glucocorticoid in rat
  770. Therapeutic effect of androgen on skeletal muscle atrophy induced by glucocorticoid in rat
  771. The combined influence of stretch, mobility and electrical stimulation in the prevention of muscle fiber atrophy caused hypokinesia and hypodynamia
  772. The effects of chronic low frequency stimulation on muscle atrophy and the discharges of muscle spindle after tail suspension [J]
  773. The effects of electrical stimulation on the control of muscle atrophy and strength in meniscectomy patients
  774. Nontraumatic Ankle Pain with Marked Calf muscle atrophy Caused by Hemagiopericytoma
  775. The clinical trial of the effects of clenbuterol on retarding denervation induced muscle atrophy
  776. muscle catabolic mechanisms: from disuse atrophy to cachexia.
  777. What is the role of an ATP stain to detect facial muscle atrophy?
  778. EXPERIMENTAL RESEARCH OF preventing DENERVATED SKELETAL muscle atrophy BY RESTRAINING INCREMENT OF CONNECTIVE TISSUES
  779. Cellular signalling pathways involved in muscle atrophy in cancer cachexia
  780. … exercise in prevention of skeletal muscle atrophy induced by a simulated microgravity environment: A study of the factors influencing the skeletal muscle atrophy …
  781. Motor Neuron Progenitor Cells Prevent Early atrophy of Denervated muscle in a Syngeneic Model
  782. Mouse Strain Dependent Differences in muscle Fiber Type, Fiber Area, and Blood Perfusion in Response to Denervation atrophy
  783. BIOLOGICAL INTERVENTION BASED ON GROWTH FACTORS TO PREVENT muscle atrophy FOLLOWING DENERVATION.
  784. Id-1 as a possible transcriptional mediator of muscle disuse atrophy
  785. muscle atrophy and Histopathology of the Soleus in 6-Mercaptopurine-Treated Rats
  786. Flexor hallucis longus muscle atrophy due to a chronic compartment syndrome of the lower leg.
  787. Oxidative stress induced mitochondrial dysfunction accelerates age related muscle atrophy
  788. Spinal muscle atrophy in the offspring of consanguineous parents
  789. muscle atrophy and Increased Atrogin‐1 Occur in Fast‐but not Slow‐muscle Early in Acute Streptozotocin‐Induced Diabetes
  790. Contractile properties of muscle undergoing “compensatory” hypertrophy and its increased susceptibility to denervation and reflex atrophy
  791. Modulating effect of androgen on ubiquitin ligases in a rat model of skeletal muscle atrophy
  792. A 54-year-old man with progressive proximal muscle atrophy and gynecomastia
  793. Spinal Progressive Muscular atrophy with Proximal muscle Involvement.
  794. A case of primary systemic amyloidosis with skeletal muscle atrophy and congestive heart failure
  795. Differential molt-induced muscle atrophy in the dimorphic claws of male fiddler crab (Uca pugnax).
  796. A study on the change of limb muscle atrophy by the period of limited activities following the heart surgery in congenital heart disease children
  797. Influence of Unilateral Masticatory muscle atrophy on Craniofacial Morphology in Growing Rabbit
  798. Molecular echanism of the effect of clenbuterol on delaying skeletal muscle atrophy following brachial plexus injury
  799. Role of growth hormone underproduction and support load deficit in development of muscle atrophy and osteopenia in tail-suspended rats
  800. Dynamic Foot Stimulation Attenuates Soleus muscle atrophy Induced by Hindlimb Unloading in Rats
  801. Mechanisms of rodent slow-twitch skeletal muscle atrophy in response to complete inactivation by spinal-isolation
  802. Modulating effect of androgen on ubiquitin ligases in a rat model of skeletal muscle atrophy
  803. Cervical Osteochondrosis with muscle atrophy, Particularly in the Shoulder Girdle
  804. Effects of Electroacupuncture and Treadmill Exercise on muscle atrophy and BDNF on the Ischemic Stroke Model of Rats
  805. GP 3.13 Myostatin inhibition increases atrogin-1 expression and accelerates skeletal muscle atrophy under denervated conditions
  806. THE INFLUENCE OF SKELETAL muscle atrophy ON NEEDLE ELECTROMYOGRAPHY AS DEMONSTRATED BY COMPUTED TOMOGRAPHY
  807. Minimal disuse muscle atrophy and seasonal alterations in the calcium handling system in skeletal muscle of hibernating brown bears
  808. TP 1.05 Is a reduced muscle test sufficient to give an overall impression of muscle function in spinal muscle atrophy II?
  809. The Effects of Contralateral Limb Strength Training on muscle atrophy in an Immobilized Upper Extremity
  810. WOUND HEALING: Prevention of disuse muscle atrophy by means of electrical stimulation: Maintenance of protein synthesis
  811. CT Findings of atrophy of Chest Wall muscle After Thoracotomy: Relationship Between muscles Involved and Type of Surgery
  812. Enzyme-and immuno-histochemistry of muscle biopsies in severe infantile spinal muscular atrophy
  813. 44 SKELETAL muscle atrophy, BONE LOSS, AND OXIDATIVE STRESS IN RATS WITH ALDOSTERONISM.
  814. Effect of transplantation of myogenically induced bone marrow-derived mesenchymal stem cells on denervated muscle atrophy
  815. Five Clinical Cases on atrophy of the Lumbar Multifidus muscle on Lumbar Herniation of Nucleus Purposus at CT Imaging
  816. Acetylcholine synthesis, storage, degredation and nicotinic receptores in a rat model for space-induced muscle atrophy
  817. DOES GLUTEUS MEDIUS muscle atrophy CONSTITUTE A PRIMARY RISK FACTOR TO THE DEVELOPMENT OF CONTRALATERAL HIP JOINT …
  818. NEUROMUSCULAR PEDICLE TRANSPLANTATION FOR PREVENTION OF atrophy IN DENERVATED muscle
  819. PROGRESSIVE NEUROPATHIC (PERONEAL) MUSCULAR atrophy (CHARCOT-MARIE-TOOTH DISEASE): Histological Findings in muscle Biopsy Specimens in …
  820. Endogenous muscle atrophy F-box is a Positive Mediator of Cardiac Hypertrophy and Dysfunction in Response to Pressure Overload
  821. o-7. Studies on the Relationship Between the muscle atrophy of the Supraspinatus and the Infraspinatus and the Suprascapular Nerve of the Baseball Players
  822. GP 9.13 Expressions of FOXO1 and FOXO3a in skeletal muscle atrophy associated with neuromuscular diseases
  823. Skeletal muscle protein metabolism under denervation atrophy in dog, canis domesticus
  824. Regulation of ubiquitin-proteasome-dependent protein breakdown in experimental models in muscle atrophy
  825. Effects of Body-weight Support Treadmill Training on Lower Extremity muscle atrophy and Ambulatory Capacity in Complete Spinal Cord Injured Patients
  826. Resistance exercise attenuates skeletal muscle atrophy in hindlimb-suspended rats by downregulation of ubiquitin ligase protein expression
  827. Atrogin-1 Ubiquitin Ligase is Upregulated by Doxorubicin, Leading to muscle atrophy in Cardiac Myocytes
  828. Denervation atrophy: Enzyme changes in the control muscle
  829. Effect of Articular Immobilization-Induced Hindlimb Skeletal muscle atrophy on Autophosphorylation of Tyrosine Kinase of the Insulin Receptor in Rats
  830. … -like growth factors-1 resistance in skeletal muscle. Potential modifications of systems of devolutions of cellular signals leading insulin resistance and muscle atrophy
  831. Endogenous muscle atrophy F-box Mediates Pressure Overload Induced Cardiac Hypertrophy via Activation of NF-κB
  832. Can a rehabilitative strength training program reverse muscle atrophy/weakness associated with androgen ablation therapy in prostate cancer patients?
  833. Polyubiquitin expression and conjugation during molt-cycle induced muscle atrophy in American lobster, Homarus americanus, and Bermuda land crab, Gecarcinus …
  834. Peroneal muscle atrophy with talipes cavus. Pyramidal symptoms and sensory disorders in one family. On the problem of the nosological classification of hereditary …
  835. ARTHRITIS: muscle atrophy AND LEG LENGTH DISCREPANCIES IN PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS
  836. Glenoid inclination is associated with Fatty infiltration and muscle atrophy in Rotator Cuff Tears
  837. Experimental study of the effects of embryonic motoneurons transplanted on atrophy of denervated skeletal muscle in the rat
  838. Ubiquitin Ligase, MuRF-1 regulates myosin heavy chain type IIa transcripts during muscle atrophy under microgravity conditions
  839. Tail-suspension Induces Altered Expression of GAPDH and ZAKI-4β mRNAs in Rat Hindlimbs: Implication for Disuse muscle atrophy
  840. Effects of hind limb unweighting on the expression of physiological markers of muscle atrophy and myofibrillar protein content in the soleus and extensor digitorum …
  841. 45 SPIRONOLACTONE IN THE PREVENTION OF SKELETAL muscle atrophy AND BONE LOSS IN RATS WITH ALDOSTERONISM.
  842. A patient with unilateral atrophy of trigeminal nerve-innervated muscle associated with contralateral glossopharyngeal and vagal neuropathy
  843. GP 19.09 The role of neuraminidase 1 in muscle atrophy
  844. Discovery of substituted human Urocortin 1 analogs with improved CRF2 receptor selectivity and increased efficacy in preventing skeletal muscle atrophy
  845. Mechanical stimulation of the plantar foot surface attenuates soleus muscle atrophy induced by hindlimb unloading in rats
  846. MYOCYTE-SPECIFIC ENHANCER BINDING FACTOR 2 (MEF2) WAS RELATED TO TYPE I muscle atrophy UNDER MICROGRAVITY
  847. Objective: We report four patients with clinical and histopathological features of Spinal muscle atrophy (SMA) and primary mitochondrial DNA (mtDNA) …
  848. Lack of cervical paraspinal muscle involvement in juvenile distal spinal muscular atrophy: an electromyographic study on 15 cases
  849. Magnetic Resonance Imaging of Superior Oblique muscle atrophy in Acquired Trochlear Nerve Palsy
  850. Spatially explicit, nano-mechanical models of the muscle half-sarcomere: Implications for biomechanical tuning in atrophy and fatigue
  851. Congenital total external ophthalmoplegia associated with infantile spinal muscular atrophy. Fine structure of extraocular muscle.
  852. Age-related functional and morphological changes in the anterior tibial muscle of men: Muscular atrophy and decrease in the number of muscle fibers
  853. GP 5 06 Dislocated neuronal nitric oxide synthase results in muscle atrophy during tail suspension
  854. Effect of the intraperitoneal injection of ATP on denervated skeletal muscle atrophy and neurotrophic factor-3 in spinal cord motor neuron after brachial plexus injuries
  855. Anti-Interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma bearing mice with modulation of lysosomal and ATP-ubiquitin …
  856. … aware of all that’s going on and can talk some, but he has severe spasticity in his left elbow, shoulder, and hand, along with muscle atrophy. Would Botox injections …
  857. Hypertrophic intrafusal muscle fibers in infantile spinal muscular atrophy
  858. Endocrine regulation of terminal muscle differentiation: atrophy and degeneration of the intersegmental muscles of Lepidoptera
  859. Work capacity, contractile protein and quantitative electromyogram (EMG) changes following exercise or nandrolone decanoate treatment in experimentally induced …
  860. Comparison of ultrasound muscle thickness measurements in ICU patients in muscle groups known to undergo atrophy vs muscle groups that do not undergo atrophy
  861. Biphasic effects of nitric oxide on skeletal muscle myotube atrophy
  862. METABOLIC RESPONSES OF SKELETAL muscle TO HYPOKINESIA/HYPODYNAMIA (atrophy, AMINO ACID, PROTEIN TURNOVER).
  863. Age-associated changes in atrophy of the extensor digitorum longus muscle in hindlimb-suspended rats
  864. Effect of atrophy and contractions on myogenin mRNA concentration in chick and rat myoblast omega muscle cells
  865. Comparison of the atrophy Velocity of Rat’s Slow and Fast muscle and their Recovery after the Sciatic Nerve Injury
  866. Identification of NF-kappaB/IkappaB transcription factors required for skeletal muscle disuse atrophy
  867. Breakout session 3: issues related to muscle growth, atrophy, and tissue engineering
  868. atrophy of Anuran Tail muscle During Metamorphosis.
  869. ACTIVITY-DEPENDENT CONTROL OF RODENT SKELETAL muscle SLOW MYOSIN ISOFORM EXPRESSION (DISUSE atrophy, WEIGHTLESSNESS, FAST …
  870. Electrical muscle stimulation for the prevention of postoperative upper leg atrophy (Leg).
  871. muscle pathology in hyperornithinemia with gyrate atrophy of the choroid and retina (HOGA)
  872. The role of estrogen signaling in the regulation of skeletal muscle recovery from disuse atrophy
  873. Phosphorylase kinase and MAP kinase regulation during skeletal muscle apoptosis and atrophy
  874. Effects of 28 days of protein and amino acid supplementation and ankle immobilization on gastrocnemius muscle mass and strength and atrophy-and …
  875. Cellular and molecular mechanisms of muscle atrophy
  876. Mechanisms regulating skeletal muscle growth and atrophy
  877. Oxidative stress and disuse muscle atrophy: cause or consequence?
  878. Regulation of muscle atrophy in aging and disease
  879. Glucocorticoid-induced skeletal muscle atrophy
  880. Molecular and cellular mechanisms of skeletal muscle atrophy: an update
  881. Mitochondrial signaling contributes to disuse muscle atrophy
  882. MicroRNA in myogenesis and muscle atrophy
  883. Mechanisms of muscle atrophy induced by glucocorticoids
  884. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
  885. Mitochondrial fission and remodelling contributes to muscle atrophy
  886. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease
  887. Mechanistic links between oxidative stress and disuse muscle atrophy
  888. Mechanisms for fiber-type specificity of skeletal muscle atrophy
  889. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass
  890. Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy
  891. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
  892. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure
  893. Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy
  894. Redox homeostasis, oxidative stress and disuse muscle atrophy
  895. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy
  896. Molecular events and signalling pathways involved in skeletal muscle disuse‐induced atrophy and the impact of countermeasures
  897. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy
  898. Persisting muscle atrophy two years after replacement of the hip
  899. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy
  900. Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases
  901. Does oxidative stress modulate limb muscle atrophy in severe COPD patients?
  902. Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia
  903. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice
  904. Nutritional strategies to counteract muscle atrophy caused by disuse and to improve recovery
  905. Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model
  906. Myogenin regulates denervation‐dependent muscle atrophy in mouse soleus muscle
  907. Aging-related geniohyoid muscle atrophy is related to aspiration status in healthy older adults
  908. Transforming growth factor‐beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin‐1 and scleraxis
  909. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy
  910. The relationship between tear severity, fatty infiltration, and muscle atrophy in the supraspinatus
  911. Extracellular water may mask actual muscle atrophy during aging
  912. Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis
  913. The shoulders of professional beach volleyball players: high prevalence of infraspinatus muscle atrophy
  914. Evidence of MyomiR network regulation of β-myosin heavy chain gene expression during skeletal muscle atrophy
  915. Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy
  916. The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit
  917. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
  918. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70
  919. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure
  920. Serum 25-hydroxyvitamin D and muscle atrophy in the elderly
  921. NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy
  922. Oxidative stress in skeletal muscle causes severe disturbance of exercise activity without muscle atrophy
  923. The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
  924. A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse
  925. Angiotensin II: role in skeletal muscle atrophy
  926. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
  927. Investigation of hand muscle atrophy in stroke survivors
  928. Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system
  929. muscle atrophy and preferential loss of myosin in prolonged critically ill patients
  930. Are antioxidants useful for treating skeletal muscle atrophy?
  931. Effect of early implementation of electrical muscle stimulation to prevent muscle atrophy and weakness in patients after anterior cruciate ligament reconstruction
  932. The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy
  933. Age-related muscle atrophy in the lower extremities and daily physical activity in elderly women
  934. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy
  935. muscle atrophy in experimental cancer cachexia: Is the IGF‐1 signaling pathway involved?
  936. Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4
  937. Skeletal muscle mass recovery from atrophy in IL‐6 knockout mice
  938. Paradoxical sleep deprivation induces muscle atrophy
  939. Electrical stimulation influences satellite cell proliferation and apoptosis in unloading-induced muscle atrophy in mice
  940. Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin-like growth factor …
  941. Increased superoxide in vivo accelerates age‐associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration
  942. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth
  943. muscle atrophy and changes in spinal morphology: is the lumbar spine vulnerable after prolonged bed-rest?
  944. Facts, noise and wishful thinking: muscle protein turnover in aging and human disuse atrophy
  945. Paretic muscle atrophy and non-contractile tissue content in individual muscles of the post-stroke lower extremity
  946. Hsp27 inhibits IKKβ‐induced NF‐κΕ activity and skeletal muscle atrophy
  947. Nuclear factor‐κB signalling and transcriptional regulation in skeletal muscle atrophy
  948. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo
  949. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy
  950. Angiotensin II induced catabolic effect and muscle atrophy are redox dependent
  951. MST1, a key player, in enhancing fast skeletal muscle atrophy
  952. Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy
  953. TWEAK and TRAF6 regulate skeletal muscle atrophy
  954. Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin
  955. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure
  956. Limitations in ultrasound imaging techniques in anesthesia: obesity and muscle atrophy?
  957. CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice
  958. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
  959. Deubiquitinases in skeletal muscle atrophy
  960. Diet‐induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model
  961. Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice
  962. Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway
  963. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1
  964. Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks
  965. The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms
  966. A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program
  967. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy
  968. Recovery of muscle atrophy and bone loss from 90 days bed rest: results from a one-year follow-up
  969. Temporal development of muscle atrophy in murine model of arthritis is related to disease severity
  970. Role of intrinsic muscle atrophy in the etiology of claw toe deformity in diabetic neuropathy may not be as straightforward as widely believed
  971. TNF-α-and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism
  972. Molecular mechanisms of muscle atrophy in myotonic dystrophies
  973. Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington’s disease
  974. Anesthesia and spinal muscle atrophy
  975. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy
  976. Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy
  977. A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle
  978. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure
  979. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy …
  980. Evaluation of Akt/mTOR activity in muscle atrophy after rotator cuff tears in a rat model
  981. Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats
  982. Assessment of association between low back pain and paraspinal muscle atrophy using opposed-phase magnetic resonance imaging: a population-based study …
  983. Mechanisms responsible for disuse muscle atrophy: potential role of protein provision and exercise as countermeasures
  984. Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle
  985. Is oxidative stress a cause or consequence of disuse muscle atrophy in mice? A proteomic approach in hindlimb‐unloaded mice
  986. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy
  987. A longitudinal MRI study of muscle atrophy during lower leg immobilization following ankle fracture
  988. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading
  989. Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice
  990. Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3
  991. Ipsilateral atrophy of paraspinal and psoas muscle in unilateral back pain patients with monosegmental degenerative disc disease
  992. muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling
  993. muscle atrophy is not always sarcopenia
  994. Branched‐chain amino acids protect against dexamethasone‐induced soleus muscle atrophy in rats
  995. Electrical stimulation impairs early functional recovery and accentuates skeletal muscle atrophy after sciatic nerve crush injury in rats
  996. The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice
  997. Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy
  998. Dietary restriction attenuates age‐associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD
  999. Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases
  1000. MnSOD deficiency results in elevated oxidative stress and decreased mitochondrial function but does not lead to muscle atrophy during aging
  1001. Is the supraspinatus muscle atrophy truly irreversible after surgical repair of rotator cuff tears?
  1002. Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients
  1003. muscle atrophy in L imb G irdle M uscular D ystrophy 2 A: a morphometric and molecular study
  1004. Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome
  1005. MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines
  1006. Chronic heart failure-induced skeletal muscle atrophy, necrosis, and changes in myogenic regulatiory factors
  1007. The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins
  1008. Local insulin-like growth factor I prevents sepsis-induced muscle atrophy
  1009. Calpain and caspase-3 play required roles in immobilization-induced limb muscle atrophy
  1010. Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection
  1011. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo
  1012. Avoidance of skeletal muscle atrophy in spontaneous and facultative hibernators
  1013. Proteomic signature of muscle atrophy in rainbow trout
  1014. A comparative analysis of fatty infiltration and muscle atrophy in patients with chronic rotator cuff tears and suprascapular neuropathy
  1015. Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin–proteasome pathway and calpains
  1016. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy
  1017. Leg muscle atrophy in idiopathic congenital clubfoot: is it primitive or acquired?
  1018. Peroxisome proliferator-activated receptor γ coactivator 1α or 1β overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse …
  1019. Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment
  1020. Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
  1021. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin‐1/MAFbx expression during glucocorticoid‐induced skeletal muscle atrophy
  1022. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt-and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression
  1023. muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
  1024. The preventive effect of β-carotene on denervation-induced soleus muscle atrophy in mice
  1025. Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α
  1026. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo
  1027. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study
  1028. Expression of atrophy mRNA relates to tendon tear size in supraspinatus muscle
  1029. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia
  1030. Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity
  1031. Differential expression of mature microRNAs involved in muscle maintenance of hibernating little brown bats, Myotis lucifugus: a model of muscle atrophy …
  1032. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy
  1033. Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series
  1034. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy
  1035. Prophylactic effects of swimming exercise on autophagy-induced muscle atrophy in diabetic rats
  1036. Nrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophy
  1037. Altered gene expression patterns in muscle ring finger 1 null mice during denervation-and dexamethasone-induced muscle atrophy
  1038. MRI quantification of fatty infiltration and muscle atrophy in a mouse model of rotator cuff tears
  1039. Changes in circulating biomarkers of muscle atrophy, inflammation, and cartilage turnover in patients undergoing anterior cruciate ligament reconstruction and …
  1040. Changes in appearance of fatty infiltration and muscle atrophy of rotator cuff muscles on magnetic resonance imaging after rotator cuff repair: establishing new time …
  1041. Calcineurin signaling and PGC-1α expression are suppressed during muscle atrophy due to diabetes
  1042. Electrical muscle stimulation after immediate nerve repair reduces muscle atrophy without affecting reinnervation
  1043. Distinct responses of protein turnover regulatory pathways in hypoxia-and semistarvation-induced muscle atrophy
  1044. Prevention of muscle disuse atrophy by MG132 proteasome inhibitor
  1045. Regenerative cell injection in denervated muscle reduces atrophy and enhances recovery following nerve repair
  1046. muscle atrophy and functional deficits of knee extensors and flexors in people with chronic stroke
  1047. Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice
  1048. Voluntary activation failure contributes more to plantar flexor weakness than antagonist coactivation and muscle atrophy in chronic stroke survivors
  1049. muscle wasting in collagen-induced arthritis and disuse atrophy
  1050. Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism
  1051. Endogenous muscle atrophy F-Box mediates pressure overload–induced cardiac hypertrophy through regulation of Nuclear Factor-κB
  1052. Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1 …
  1053. Repetitive stretch suppresses denervation‐induced atrophy of soleus muscle in rats
  1054. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice
  1055. Cigarette smoke‐induced skeletal muscle atrophy is associated with up‐regulation of USP‐19 via p38 and ERK MAPKs
  1056. Survival probabilities of patients with childhood spinal muscle atrophy
  1057. Regulation of nicotinic acetylcholine receptor turnover by MuRF1 connects muscle activity to endo/lysosomal and atrophy pathways
  1058. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy
  1059. The impact of muscle disuse on muscle atrophy in severely burned rats
  1060. The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy
  1061. Overexpression of the mitochondrial T3 receptor induces skeletal muscle atrophy during aging
  1062. muscle atrophy induced by SOD1 G93A expression does not involve the activation of caspase in the absence of denervation
  1063. The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice
  1064. Disuse atrophy of human skeletal muscle: cell signaling and potential interventions.
  1065. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice
  1066. Effect of vascular endothelial growth factor gene therapy on post-traumatic peripheral nerve regeneration and denervation-related muscle atrophy
  1067. Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy
  1068. Deptor knockdown enhances mTOR Activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy
  1069. Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy
  1070. muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice
  1071. Teres minor innervation in the context of isolated muscle atrophy
  1072. An MRI study on the relations between muscle atrophy, shoulder function and glenohumeral deformity in shoulders of children with obstetric brachial plexus …
  1073. muscle atrophy in cachexia: can dietary protein tip the balance?
  1074. Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats
  1075. Acupuncture ameliorated skeletal muscle atrophy induced by hindlimb suspension in mice
  1076. Loss of SPARC in mouse skeletal muscle causes myofiber atrophy
  1077. Hsp70 prevents disuse muscle atrophy in senescent rats
  1078. The sign of unilateral neck semispinalis capitis muscle atrophy in patients with chronic non-specific neck pain
  1079. Effects of leucine supplementation and resistance exercise on dexamethasone-induced muscle atrophy and insulin resistance in rats
  1080. Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke
  1081. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation
  1082. eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle
  1083. muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy
  1084. Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors
  1085. The worsening of tibialis anterior muscle atrophy during recovery post-immobilization correlates with enhanced connective tissue area, proteolysis, and apoptosis
  1086. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy
  1087. The combined effect of electrical stimulation and resistance isometric contraction on muscle atrophy in rat tibialis anterior muscle
  1088. Nutritional strategies to attenuate muscle disuse atrophy
  1089. Quercetin prevents unloading-derived disused muscle atrophy by attenuating the induction of ubiquitin ligases in tail-suspension mice
  1090. Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: muscle atrophy after motor end plate-targeted injections
  1091. Effect of molecular hydrogen saturated alkaline electrolyzed water on disuse muscle atrophy in gastrocnemius muscle
  1092. muscle atrophy beyond the clinical effect after a single dose of OnabotulinumtoxinA injected in the procerus muscle: a study with magnetic resonance imaging
  1093. Hibernation: the search for treatments to prevent disuse-induced skeletal muscle atrophy
  1094. Short‐term muscle atrophy caused by botulinum toxin‐A local injection impairs fracture healing in the rat femur
  1095. Astragalus polysaccharide improves muscle atrophy from dexamethasone-and peroxide-induced injury in vitro
  1096. Cellular and molecular mechanisms of apoptosis in age-related muscle atrophy
  1097. Diaphragm muscle atrophy in the mouse after long‐term mechanical ventilation
  1098. Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during …
  1099. Absence of functional leptin receptor isoforms in the POUND (Lepr db/lb) mouse is associated with muscle atrophy and altered myoblast proliferation and …
  1100. muscle atrophy caused by limited mobilisation
  1101. muscle atrophy in cancer: a role for nutrition and exercise
  1102. Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats
  1103. Lack of caspase‐3 attenuates immobilization‐induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation
  1104. Role of gelatinases in disuse‐induced skeletal muscle atrophy
  1105. Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy
  1106. Mu RF‐1 and p‐GSK 3β expression in muscle atrophy of cirrhosis
  1107. Connexin-and pannexin-based channels in normal skeletal muscles and their possible role in muscle atrophy
  1108. Influence of muscle length on muscle atrophy in the mouse tibialis anterior and soleus muscles
  1109. Mechanism of Attenuation of Skeletal muscle atrophy by Zinc-α2-Glycoprotein
  1110. Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy
  1111. Tibial nerve transection-a standardized model for denervation-induced skeletal muscle atrophy in mice
  1112. Treadmill running and static stretching improve long-lasting hyperalgesia, joint limitation, and muscle atrophy induced by cast immobilization in rats
  1113. Early effects of muscle atrophy on shoulder joint development in infants with unilateral birth brachial plexus injury
  1114. The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans
  1115. Protective effect of melatonin on TNF‐α‐induced muscle atrophy in L 6 myotubes
  1116. Soy glycinin contains a functional inhibitory sequence against muscle–atrophy-associated ubiquitin ligase Cbl-b
  1117. Skeletal muscle atrophy occurs slowly and selectively during prolonged aestivation in Cyclorana alboguttata (Günther 1867)
  1118. Differential expression of sarcoplasmic and myofibrillar proteins of rat soleus muscle during denervation atrophy
  1119. Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis
  1120. Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats
  1121. Resistance exercise: A non-pharmacological strategy to minimize or reverse sleep deprivation-induced muscle atrophy
  1122. IgM MGUS anti‐MAG neuropathy with predominant muscle weakness and extensive muscle atrophy
  1123. Effects of treadmill exercise on the recovery of dopaminergic neuron loss and muscle atrophy in the 6-ohda lesioned parkinson’s disease rat model
  1124. Chronic exercise training down-regulates TNF-α and atrogin-1/MAFbx in mouse gastrocnemius muscle atrophy induced by hindlimb unloading
  1125. Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice
  1126. Effect of electrical stimulation to prevent muscle atrophy on morphologic and histologic properties of hindlimb suspended rat hindlimb muscles
  1127. Plasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosis
  1128. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans
  1129. Quadriceps muscle atrophy after anterior cruciate ligament transection involves increased mRNA levels of atrogin-1, muscle ring finger 1, and myostatin
  1130. Severe atrophy of slow myofibers in aging muscle is concealed by myosin heavy chain co-expression
  1131. Involvement of the muscle-tendon junction in skeletal muscle atrophy: an ultrastructural study
  1132. Whey proteins are more efficient than casein in the recovery of muscle functional properties following a casting induced muscle atrophy
  1133. Alterations of protein turnover underlying disuse atrophy in human skeletal muscle
  1134. An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy
  1135. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease
  1136. Application of fetal neural stem cells transplantation in delaying denervated muscle atrophy in rats with peripheral nerve injury
  1137. Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia
  1138. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS
  1139. Natural history of fatty infiltration and atrophy of the supraspinatus muscle in rotator cuff tears
  1140. Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies
  1141. STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-κB canonical cascade activation
  1142. Functional and morphological effects of resistance exercise on disuse-induced skeletal muscle atrophy
  1143. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast …
  1144. muscle atrophy in immobilization and senescence in humans
  1145. Comparison of premodulated interferential and pulsed current electrical stimulation in prevention of deep muscle atrophy in rats
  1146. Role of IL-15 in sepsis-induced skeletal muscle atrophy and proteolysis
  1147. Intramuscular technique for gluteal augmentation: determination and quantification of muscle atrophy and implant position by computed tomographic scan
  1148. Daily brief restraint stress alters signaling pathways and induces atrophy and apoptosis in rat skeletal muscle
  1149. Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E–responsive muscle atrophy and weakness
  1150. High‐Intensity Resistance Training with Insufficient Recovery Time Between Bouts Induce atrophy and Alterations in Myosin Heavy Chain Content in Rat Skeletal …
  1151. Validity of mid-arm muscular area measured by anthropometry in nonobese patients with increased muscle atrophy and variation of subcutaneous fat …
  1152. The combined effect of electrical stimulation and high-load isometric contraction on protein degradation pathways in muscle atrophy induced by hindlimb …
  1153. C/EBPβ regulates dexamethasone‐induced muscle cell atrophy and expression of atrogin‐1 and MuRF1
  1154. p38 MAPK participates in muscle-specific RING finger 1-mediated atrophy in cast-immobilized rat gastrocnemius muscle
  1155. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease
  1156. Postoperative temporalis muscle atrophy and the use of electrocautery: a volumetric MRI comparison
  1157. Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice
  1158. Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy
  1159. Cervical Multifidus muscle atrophy in Patients with Unilateral Cervical Radiculopathy.
  1160. Cycle ergometer exercise to counteract muscle atrophy during unilateral lower limb suspension
  1161. AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy
  1162. Electrophysiological correlates of the threshold to detection of passive motion: an investigation in professional volleyball athletes with and without atrophy of …
  1163. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia
  1164. MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis
  1165. Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
  1166. Prevention of post-stroke disuse muscle atrophy with a free radical scavenger
  1167. Ageing is associated with diminished muscle re‐growth and myogenic precursor cell expansion early after immobility‐induced atrophy in human skeletal muscle
  1168. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy
  1169. Effect and possible mechanism of muscle-splitting approach on multifidus muscle injury and atrophy after posterior lumbar spine surgery
  1170. … index in the hemiparetic distal tibia epiphysis among chronic stroke patients: the association with cardiovascular function, muscle atrophy, mobility, and spasticity
  1171. Evaluation of muscle atrophy after axillary lymph node dissection
  1172. Postural muscle atrophy prevention and recovery and bone remodelling through high frequency proprioception for astronauts
  1173. A rehabilitation exercise program to remediate skeletal muscle atrophy in an estrogen-deficient organism may be ineffective
  1174. Hindlimb muscle atrophy occurs from peripheral nerve damage in a rat neuropathic pain model
  1175. Testosterone reduced methylprednisolone-induced muscle atrophy in spinal cord-injured rats
  1176. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF)
  1177. Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy
  1178. atrophy of corrugator supercilii muscle in a patient induced by the onabotulinum toxin injection
  1179. muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy
  1180. Fatty muscle atrophy: prevalence in the hindfoot muscles on MR images of asymptomatic volunteers and patients with foot pain
  1181. Effects of insulin-like growth factor 1 on muscle atrophy and motor function in rats with brain ischemia
  1182. The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy
  1183. Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy
  1184. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation
  1185. Hemin, heme oxygenase-1 inducer, attenuates immobilization-induced skeletal muscle atrophy in mice
  1186. Effect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathy
  1187. Mitochondrial‐targeted antioxidants attenuate immobilization‐induced skeletal muscle atrophy
  1188. Physiologic and molecular bases of muscle hypertrophy and atrophy: impact of resistance exercise on human skeletal muscle (protein and exercise dose effects)
  1189. Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle
  1190. Docosahexaenoic acid protects muscle cells from palmitate-induced atrophy
  1191. Optimal time‐point for neural stem cell transplantation to delay denervated skeletal muscle atrophy
  1192. Role of dietary flavonoids in oxidative stress and prevention of muscle atrophy
  1193. Infraspinatus muscle atrophy as a function of the sagittal extent of rotator cuff tears
  1194. Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
  1195. Anesthetic management of spinal muscle atrophy type II in a parturient
  1196. Effects of exercise training on atrophy gene expression in skeletal muscle of mice with chronic allergic lung inflammation
  1197. Unexplained muscle atrophy as the unique preceding symptom of bilateral linear morphea
  1198. C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy
  1199. Mechanism of activation of dsRNA-dependent protein kinase (PKR) in muscle atrophy
  1200. Unilateral hindlimb casting induced a delayed generalized muscle atrophy during rehabilitation that is prevented by a whey or a high protein diet but not a free …
  1201. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice
  1202. Does protein supplementation prevent muscle disuse atrophy and loss of strength?
  1203. Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy
  1204. Technique to minimize paraspinal muscle atrophy after posterior cervical fusion
  1205. Altered autophagy gene expression and persistent atrophy suggest impaired remodeling in chronic hemiplegic human skeletal muscle
  1206. Effect of Achilles tenotomy on congenital clubfoot-associated calf-muscle atrophy: an ultrasonographic study
  1207. Comparison of MRI and DXA to measure muscle size and age-related atrophy in thigh muscles.
  1208. In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy
  1209. Commentaries on Viewpoint: muscle atrophy is not always sarcopenia
  1210. The KATP channel is a molecular sensor of atrophy in skeletal muscle
  1211. The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation
  1212. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
  1213. muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis
  1214. Myoblast models of skeletal muscle hypertrophy and atrophy
  1215. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3
  1216. Influence of passive stretching on inhibition of disuse atrophy and hemodynamics of rat soleus muscle
  1217. The effect of long term ventilatory support on hemodynamics in children with spinal muscle atrophy (SMA) type II
  1218. A potential indicator of denervated muscle atrophy: the ratio of myostatin to follistatin in peripheral blood
  1219. Mitogen‐activated protein kinase‐activated protein kinase 2 (MK2) in skeletal muscle atrophy and hypertrophy
  1220. Tetracycline therapy for muscle atrophy due to immobilization
  1221. Adult rat mesenchymal stem cells delay denervated muscle atrophy
  1222. muscle plasticity and β2-adrenergic receptors: adaptive responses of β2-adrenergic receptor expression to muscle hypertrophy and atrophy
  1223. Severe muscle atrophy due to spinal cord injury can be reversed in complete absence of peripheral nerves
  1224. … vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice …
  1225. The effect of amino acid infusion on anesthesia-induced hypothermia in muscle atrophy model rats
  1226. Inhibitory effect of a combination of thermotherapy with exercise therapy on progression of muscle atrophy
  1227. Morphological differences in skeletal muscle atrophy of rats with motor nerve and/or sensory nerve injury
  1228. Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining
  1229. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy
  1230. In vivo characterization of the role of tissue‐specific translation elongation factor 1A2 in protein synthesis reveals insights into muscle atrophy
  1231. Emerging ideas: matrix metalloproteinase-2 in muscle atrophy
  1232. Repair of the peripheral nerve gap with epineural sheath conduit to prevent muscle denervation atrophy in the diabetic rat model.
  1233. Activation of serum/glucocorticoid‐induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy
  1234. Regulation of muscle atrophy: wasting away from the outside in: an introduction.
  1235. Influence of fixed muscle length and contractile properties on atrophy and subsequent recovery in the rat soleus and plantaris muscles
  1236. β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats
  1237. Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes
  1238. Impact of diaphragm muscle fiber atrophy on neuromotor control
  1239. muscle ring finger 1 mediates cardiac atrophy in vivo
  1240. Chronic α-hydroxyisocaproic acid treatment improves muscle recovery after immobilization-induced atrophy
  1241. The metabolic modulator trimetazidine triggers autophagy and counteracts stress‐induced atrophy in skeletal muscle myotubes
  1242. The effects of regular exercise program on dialysis efficacy, muscle atrophy and physical performance in hemodialysis patients
  1243. Effect of IR laser on myoblasts: prospects of application for counteracting microgravity-induced muscle atrophy
  1244. Joint-specific changes in locomotor complexity in the absence of muscle atrophy following incomplete spinal cord injury
  1245. The isolated muscle fibre as a model of disuse atrophy: characterization using PhAct, a method to quantify f-actin
  1246. Differential Regulation of MAPK Isoforms during Cast-Immobilization-Induced atrophy in Rat Gastrocnemius muscle
  1247. Molt cycle regulation of protein synthesis in skeletal muscle of the blackback land crab, Gecarcinus lateralis, and the differential expression of a myostatin-like factor …
  1248. Combined spinal epidural anesthesia for cesarean section in a parturient with spinal muscle atrophy type III (Kugelberg–Walendar disease)
  1249. Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery …
  1250. Simulation studies on the motor unit potentials with satellite components in amyotrophic lateral sclerosis and spinal muscle atrophy
  1251. Design and construction of an electrical muscle stimulation system to decrease Forearm muscle atrophy post-fracture
  1252. Protective effects of exercise preconditioning on hindlimb unloading‐induced atrophy of rat soleus muscle
  1253. Clinical and economic characteristics of hip fracture patients with and without muscle atrophy/weakness in the United States
  1254. Disuse muscle atrophy exacerbates motor neuronal degeneration caudal to the site of spinal cord injury
  1255. Hindlimb muscle atrophy occurs from short-term undernutrition in rats
  1256. Severe atrophy and fatty degeneration of the infraspinatus muscle due to isolated infraspinatus tendon tear
  1257. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study
  1258. The effect of reloading on disuse muscle atrophy: time course of hypertrophy and regeneration focusing on the myofiber cross-sectional area and myonuclear change
  1259. Hypo-activity induced skeletal muscle atrophy and potential nutritional interventions: a review
  1260. Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness
  1261. Relationship of trunk muscle atrophy and provocation position in patients with chronic low back pain
  1262. muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18–24‐month‐old) …
  1263. Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization
  1264. Prolonged C2 spinal hemisection-induced inactivity reduces diaphragm muscle specific force with modest, selective atrophy of type IIx and/or IIb fibers
  1265. Preliminary proteomic analysis of peripheral skeletal muscle atrophy in chronic obstructive pulmonary disease
  1266. Effect of Dipsaci Radix on hind limb muscle atrophy of sciatic nerve transected rats
  1267. Effect of DHEA on recovery of muscle atrophy induced by parkinson’s disease
  1268. Isolated supraspinatus muscle atrophy and fatty infiltration associated with recurrent anterior shoulder instability: A case report and review of the literature
  1269. Effect of Puerariae Radix on Hind Limb muscle atrophy of Sciatic Nerve Transectioned Rats
  1270. Mental practice has influence on limitation of motion and muscle atrophy following immobilisation of the radiocarpal joint-a prospective randomised experimental study
  1271. Identification of atrophy-related proteins produced in response to cast immobilization in rat gastrocnemius muscle
  1272. Frailty, muscle atrophy, and sarcopenia
  1273. Perfluorodecalin lavage of a longstanding lung atelectasis in a child with spinal muscle atrophy
  1274. muscle atrophy in patients wirh ckd results from fgf23/klotho-mediated supression of insulin/igf-i signaling
  1275. Influence of elevated temperature on metabolism during aestivation: implications for muscle disuse atrophy
  1276. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass
  1277. Developmental transition of pectoralis muscle from atrophy in late‐term duck embryos to hypertrophy in neonates
  1278. Electrical stimulation counteracts muscle atrophy associated with aging in humans
  1279. Cyclophilin‐D is dispensable for atrophy and mitochondrial apoptotic signalling in denervated muscle
  1280. IκBα degradation is necessary for skeletal muscle atrophy associated with contractile claudication
  1281. The administration of high-dose methylprednisolone for 24 h reduced muscle size and increased atrophy-related gene expression in spinal cord-injured rats
  1282. Role of AP-1 and RE-1 binding sites in matrix metalloproteinase-2 transcriptional regulation in skeletal muscle atrophy
  1283. Diaphragm muscle atrophy in the mechanically ventilated patients
  1284. muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy
  1285. Effects of combination therapy of heat stress and muscle contraction exercise induced by neuromuscular electrical stimulation on disuse atrophy in the rat …
  1286. muscle fiber atrophy
  1287. Myopathic EMG findings and type II muscle fiber atrophy in patients with Lambert-Eaton myasthenic syndrome
  1288. Preventive and therapeutic effect of buyang huanwu decoction on denervated tibial muscle atrophy of rats
  1289. Overexpression of MyoD attenuates denervated rat skeletal muscle atrophy and dysfunction
  1290. A ground-based comparison of the muscle atrophy Research and Exercise System (MARES) and a commercially available isokinetic dynamometer
  1291. High-content screening of human primary muscle satellite cells for new therapies for muscular atrophy/dystrophy
  1292. No muscle atrophy without GSK-3β. Focus on “Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy”
  1293. Locking of the metacarpophalangeal joint caused by idiopathic intrinsic muscle atrophy of the hand: report of three cases
  1294. Signaling pathways that regulate skeletal muscle atrophy and hypertrophy
  1295. The Role of MuRF1 in Glucocorticoid Induced Skeletal muscle atrophy
  1296. Role of calcium-dependent mechanisms in the development of atrophy in postural muscle deprived of gravitational loading
  1297. Relationship between simulated weightlessness-induced muscle spindle change and muscle atrophy
  1298. The effects of Capn1 gene inactivation on skeletal muscle growth, development, and atrophy, and the compensatory role of other proteolytic systems
  1299. Regulation of skeletal muscle atrophy
  1300. Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle
  1301. Association between muscle atrophy/weakness and health care costs and utilization among patients receiving total knee replacement surgery: a retrospective …
  1302. Molecular evidence: EA may inhibit the muscle atrophy
  1303. muscle fiber atrophy and regeneration coexist in collagen VI-deficient human muscle: role of calpain-3 and nuclear factor-κB signaling
  1304. Advances of residual limb muscle atrophy in biomechanics research
  1305. Proteomic analysis of skeletal muscle tissue using SELDI-TOF MS: application to disuse atrophy
  1306. “Hybrid exercise” prevents muscle atrophy in association with a distinct gene expression pattern
  1307. TWEAKing muscle atrophy
  1308. Metabolic adaptation to inactive lifestyle: from muscle atrophy to cardiovascular risk
  1309. Effect of Ligusticum and its two main components on muscle atrophy in a hind limb unloaded rat model
  1310. muscle atrophy; more than one string to MuRF1’s bow?
  1311. Preventive effects of antioxidants on muscle atrophy induced by ischemic reperfusion
  1312. P5. 67 electrical muscle stimulation in early severe critical illness prevents type 2 fiber atrophy
  1313. Research advance on signaling pathways and protein metabolism for skeletal muscle disuse atrophy
  1314. muscle tissue atrophy, extramuscular and intramuscular fat accumulation, and fat gradient after delayed repair of the supraspinatus tendon: A comparative study in the …
  1315. The retrospective study on the correlation between the multifidus muscle atrophy on low back pain patients and the magnetic resonance images
  1316. Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats
  1317. Exercise intervention soon after stroke onset to prevent muscle atrophy
  1318. preventing muscle atrophy with protein and amino acid supplementation
  1319. Prevention of muscle atrophy With Exercise Countermeasures
  1320. Molecular Mechanisms of Inhibiting the muscle atrophy by Electroacupuncture
  1321. Effects of combined stretching and clenbuterol on disuse atrophy in rat soleus muscle
  1322. Space flight/bedrest immobilization and bone. Space flight and bed rest-mediated muscle atrophy
  1323. Reconsideration of exercise prescription as the countermeasure for prevention of muscle atrophy in space
  1324. Molecular basis of muscle hypertrophy and atrophy: Potential therapy for muscular dystrophy
  1325. A study of relations between PPARα gene polymorphism and skeletal muscle atrophy in patient with COPD [J]
  1326. IGF-1 Regulation of skeletal muscle hypertrophy and atrophy
  1327. The Mechanisms of the Cell Growth Factors on Denervated muscle atrophy [J]
  1328. The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease
  1329. Effects of Ischemia and Immobility on muscle atrophy in Rats.
  1330. The effects of tuina on muscle atrophy and muscle satellite cell proliferation after denervation
  1331. Last Word on Viewpoint: muscle atrophy is not always sarcopenia
  1332. POLG mutation in a patient with cataracts, early-onset distal muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic aciduria
  1333. Inhibition of calpain or caspase‐3 protects against immobilization‐induced muscle atrophy
  1334. CrossTalk opposing view: The diaphragm muscle does not atrophy as a result of inactivity
  1335. Adult-onset nemaline myopathy with distal muscle atrophy–case report
  1336. Type II muscle fibers atrophy associated with silent corticotroph adenoma in a dog.
  1337. Electroacupuncture accelerates recovery of muscle atrophy induced by hindlimb suspension in mouse skeletal muscle.
  1338. A germane link between piriformis muscle atrophy and lumbar disc herniation.
  1339. Commentaries on Viewpoint: muscle atrophy is not
  1340. The effect of intense interval cycle-training on unloading-induced dysfunction and atrophy in the human calf muscle
  1341. TCM pathogenesis of muscle atrophy in weightlessness condition
  1342. Effect of Acupuncture on muscle atrophy by Post Injection Sciatic Nerve Injury
  1343. Hand muscle atrophy and digital ischemia as an unusual presentation of an occluded aberrant right subclavian artery: Endovascular or open approach?
  1344. TRAF6 signaling in skeletal muscle atrophy and regeneration.
  1345. Role of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) in denervation-induced atrophy in aged muscle: facts and hypotheses
  1346. Oxidative Stress in muscle atrophy
  1347. Neuromuscular junctions of the posterior cricoarytenoid muscle in multiple system atrophy: a case study
  1348. Prevention of muscle atrophy With Exercise Countermeasures: Where We are and Where We are Going
  1349. Protective effects of ATP and panax ginseng triol set on denerved muscle atrophy and motor end plate [J]
  1350. Weightlessness causes lower limb muscle atrophy
  1351. Altered myoplasmic Ca 2+ handling in rat fast-twitch skeletal muscle fibres during disuse atrophy
  1352. The Factor which Affects Disuse muscle atrophy and its Prevention
  1353. Did combination exercises of LBNP and ergometer prevent the muscle atrophy induced by 15-day bed rest in women?
  1354. Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy
  1355. What Is Really New in Progressive muscle atrophy?—Reply
  1356. What is really new in progressive muscle atrophy?
  1357. Anesthetic management in a patient with spinal progressive muscle atrophy and compromised severe restrictive respiratory dysfunction
  1358. P3. 16 Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
  1359. Delay of skeletal muscle atrophy after transplantation of mesenchymal progenitor cell into transected position
  1360. Role of AKT/FOXOs/Atrogin-1/MuRF1 Signalling Pathway in Skeletal muscle atrophy in COPD Rats
  1361. The effect of electrical stimulation on muscle disuse atrophy
  1362. Impact of vitamin E supplementation during induced cigarette smoking-lung muscle atrophy
  1363. A comparative study of botulinum toxin A and denervation-induced masseter muscle atrophy in rabbits
  1364. Evaluation of markers for skeletal muscle atrophy and calcineurin/NFAT signaling in acute and chronic diabetes mellitis
  1365. The relation between botulinum toxin-A and fracture healing. comment on Hao et al.: short-term muscle atrophy caused by botulinum toxin-A local injection impairs …
  1366. GP 27 muscle atrophy in the GNE myopathy mouse model is associated with oxidative stress
  1367. The Acupuncture Treatment of muscle atrophy
  1368. Investigating TNF inhibition of IGF-1 signalling via JNK in cell culture models of skeletal muscle atrophy
  1369. Skeletal muscle atrophy in acute lung injury: differing mechanisms for wasting both during and after lung injury
  1370. Molecular mechanisms of skeletal muscle atrophy
  1371. muscle atrophy through thick but not thin
  1372. Satellite Cells are not Prerequisite for Skeletal muscle Regrowth Following Unloading‐Induced atrophy
  1373. Dietary BCAAs do not prevent skeletal muscle atrophy in rats injected with glucocorticoid.
  1374. Role of AMP-activated protein kinase (AMPK) in hypercapnia-induced muscle atrophy
  1375. 11 [beta]-HSD1KO mice are protected from glucocorticoid dependent age-associated muscle atrophy
  1376. Mechanisms of muscle atrophy following inactivity
  1377. Thinning of myotube is the structural and functional basis of muscle atrophy caused by weightlessness
  1378. Evidence of Increased muscle atrophy and Impaired Quality of Life
  1379. muscle atrophy in vitro: a lesson from cisplatin
  1380. Clinical aspects and serum concentration creatina kinase and lactate dehydrogenase in dogs submitted to physiotherapy after induced muscle atrophy
  1381. Gene Expression According to Electromyostimulation after atrophy Conditions and muscle atrophy in Skeletal muscle
  1382. Do not miss it: paraspinal muscle atrophy in the concave side of the curve in patients with adult degenerative scoliosis
  1383. Interosseous muscle atrophy
  1384. Role of nSMase-3/Cermide Signaling in muscle atrophy
  1385. Investigating the potential relationship between skeletal muscle atrophy and obesity
  1386. Targeting growth and atrophy pathways to ameliorate muscle atrophy and weakness during disuse
  1387. The Molecule Mechanism and Development of a Cure of the muscle atrophy by Unloading
  1388. The Role of MuRF1 in Glucocorticoid-Induced muscle atrophy
  1389. Thinking and Research Status of Traditional Chinese Medicine on Skeletal muscle atrophy Caused by Weightlessness
  1390. Restoring Specific Lactobacilli Levels Decreases Inflammation and muscle atrophy
  1391. Pathways of muscle atrophy and hypertrophy in chronic kidney
  1392. The Role and Regulation of MAFbx/atrogin-1 and MuRF1 in Skeletal muscle atrophy
  1393. AB0171 muscle atrophy in murine model of arthritis is related to disease score
  1394. Are antioxidants useful to treat skeletal muscle atrophy?
  1395. Temporal Changes in the Acetylation Profile of Skeletal muscle Proteins during atrophy
  1396. Effect of electro-acupuncture on skeletal muscle atrophy in mice
  1397. The role of the Ragulator complex in mediating sepsis-induced muscle atrophy
  1398. Role of ROS in the signal regulation of protein metabolism in disuse-induced muscle atrophy
  1399. SUPPRESSION OF PDK4 IS ASSOCIATED WITH ENHANCED GLUCOSE OXIDATION AND atrophy IN SKELETAL muscle OF ANIMALS WITH CHRONIC LEFT …
  1400. Role of sphingolipids in muscle atrophy
  1401. muscle disuse atrophy is greater in young compared with elderly individuals
  1402. Attenuation of muscle atrophy by triterpentene celastrol
  1403. Effect of serine protease inhibitor on muscle atrophy.
  1404. Detraining, Satellite Cells and muscle atrophy [J]
  1405. atrophy of type II fibres in myasthenia gravis muscle in thymectomized patients: steroid‐induced change with prognostic impact
  1406. A leucine supplementation after an immobilization-induced atrophy in old rats enhanced protein anabolism but failed in muscle mass recovery
  1407. Dynamic foot stimulation attenuates soleus muscle atrophy induced by hindlimb
  1408. The Role of the Glucocorticoid Receptor in Mediating muscle atrophy
  1409. Anti-muscle atrophy action of dietary soy proteins.
  1410. Hot and steady: Elevated temperatures do not enhance muscle disuse atrophy during prolonged aestivation in the ectotherm Cyclorana alboguttata
  1411. UBIQUITIN LIGASES MURF1 AND MAFBX IN HUMAN muscle atrophy
  1412. REDUCTION IN muscle atrophy WITH THE USE OF SIDE-TO-SIDE NERVE BRIDGES
  1413. Neurectomy of the deep branch of the lateral plantar nerve can cause neurogenic atrophy of the muscle fibres in the proximal part of the suspensory ligament (M …
  1414. Validation of experimental models of spinal muscle atrophy (SMA): a neuroanatomical study
  1415. Transcriptional profiling to identify therapeutic targets influencing skeletal muscle atrophy
  1416. Molecular mechanism of unloading-mediated muscle atrophy and development of its countermeasures
  1417. Role of IGF-I in glucocorticoid-induced muscle atrophy
  1418. High Lever of Glucocorticoid Enhanced muscle atrophy Though Atrogin-1 in CKD Mice
  1419. Effect of glucose tolerance on muscle atrophy in streptozotocin‐induced diabetic rats
  1420. Multiple treatments for denervated skeletal muscle atrophy
  1421. RNA degradation is elevated with age‐, but not disuse‐associated skeletal muscle atrophy
  1422. Hypoxia Induces muscle atrophy And Increased muscle Protein Turnover
  1423. No significant muscle atrophy occurs in first dorsal interosseus muscle after incomplete cervical spinal cord injury
  1424. The Effects of Resveratrol on Oxidative Stress and muscle atrophy
  1425. Extracellular Water May Mask Actual muscle atrophy During Aging
  1426. Glucocorticoid receptor signalling contributes to muscle atrophy caused by acute inflammation
  1427. Sub-cellular motor neuron analysis in a model of spinal muscle atrophy
  1428. muscle specific glucocorticoids receptor gene knockout rescue muscle atrophy induced by CKD
  1429. Enhanced expression of EcSOD in skeletal muscle blocks chronic heart failure–induced muscle atrophy and exercise intolerance in mice
  1430. Targeted disruption of Smad3 inhibits weightlessness-induced muscle atrophy and its molecular mechanisms
  1431. Potential for treatment of age‐related muscle atrophy by exogenous nitric oxide and exercise
  1432. Avoidance of Skeletal muscle atrophy in Spontaneous and Facultative Hibernators
  1433. Mitigation of bone loss and muscle atrophy by dynamic hydraulic pressure stimulation
  1434. Effect of exogenous erythropoietin on denervated muscle atrophy
  1435. TO 6 Myostatin inhibitor ActIIb rescues atrophy and protects muscle growth signaling pathways in immobilization but not denervation
  1436. Local IGF‐I Prevents Sepsis‐Induced muscle atrophy
  1437. Pulmonary inflammation‐induced muscle atrophy involves a GSK‐3beta‐GR signaling axis
  1438. Ribosomal Protein S6 (rpS6), muscle atrophy and Hypertrophy
  1439. Changes of interstitial free mononuclear cells in the process of disuse muscle atrophy
  1440. Morphological changes of myotendinous junction generated by muscle disuse atrophy
  1441. Effects of Nitric Oxide on Calcium-induced Skeletal muscle atrophy
  1442. Impact of in vivo electrical stimulation during denervation dis-use muscle atrophy
  1443. The Transcription Factor ATF4 Is an Essential Mediator of Skeletal muscle atrophy
  1444. Lung Injury Induces a Skeletal muscle atrophy Program That Is Qualitatively Different from That Induced by Starvation.
  1445. Gene therapy for improving peripheral nerve regeneration and preventing muscle atrophy after nerve trauma
  1446. Alterations of thoraco-abdominal volumes in patients with spinal muscle atrophy (SMA)
  1447. Respiratory Management and Ethical Issues of an Infant with Type I muscle Fiber atrophy
  1448. Extraocular muscle atrophy and Central Nervous System Involvement in Chronic
  1449. Antagonistic Effects of Different Frequency Sinusoidal Vibration Given To Disused muscle atrophy in Rats
  1450. GP 49 muscle-specific overexpression of caveolin 3 causes muscle atrophy, but not muscular dystrophy
  1451. Severe Aplastic Anemia, a Rare and Severe muscle atrophy in 1 Cases of Peripheral Neuropathy
  1452. Effects of aging on unloading-induced skeletal muscle atrophy and subsequent recovery in rats
  1453. Repetitive stretching prevents muscle atrophy in denervated soleus muscle via Akt/mTOR/p70S6K pathways
  1454. THE PROTECTIVE EFFECTS OF SOY OLIGOPEPTIDE ON muscle atrophy IN WEIGHTLESSNESS-SIMULATED RATS [J]
  1455. Electroacupuncture Attenuated muscle atrophy Induced by Hindlimb Suspension in Rats
  1456. Extracellular Water May Mask Actual muscle atrophy During Aging (Final draft (Post-print) version)
  1457. EFFECTS OF COMBINATION OF HEAT STRESS AND ASTAXANTHIN SUPPLEMENTATION ON DISUSE muscle atrophy
  1458. TWEAK/Fn14 system is a critical regulator of denervation‐induced skeletal muscle atrophy
  1459. PSU8 Disease Burden and Medical Needs in Older Patients with Total Knee Arthroplasties and muscle atrophy or Weakness
  1460. Suppression of calcineurin signaling reduces PGC‐1α expression in a chronic model of muscle atrophy
  1461. Rheb REGULATES CRAB muscle atrophy
  1462. Whole Body Vibration Restores Skeletal muscle Remodeling and protects against disuse atrophy in Rats
  1463. Expression of myostatin propeptide fusion protein and preliminary observation on its activity of prevent ing muscle atrophy
  1464. Plasma From COPD Patients At Maximal Exercise Induces Skeletal muscle atrophy
  1465. Joint-specific changes in locomotor complexity in the absence of muscle atrophy following incomplete spinal cord injury
  1466. Mycobacterium ulcerans infections cause progressive muscle atrophy and loss of force
  1467. Hypoxia‐induced muscle atrophy involves direct and indirect signaling towards protein turnover regulation
  1468. Comparison of rectangular and sine waveforms on electrical stimulation to atrophy of rat soleus muscle
  1469. Skeletal muscle atrophy in critical illness myopathy is associated with muscle fiber type specific apoptotic responses
  1470. Diabetes‐derived muscle atrophy is associated with cellular autophagy, and potential beneficial effects of interventional physical exercise on it
  1471. Regulation of muscle disuse atrophy by energy and protein intake in humans. Insights from bed rest studies
  1472. Octogenarian with Chronic Low Back Ache, Decreased Balance Unilateral Leg muscle atrophy Treated with Physiotherapy–Evidence Based Case Study …
  1473. Preventive effects of premodulated interferential and pulsed currents on muscle atrophy in deep layer of rat hindlimb muscle
  1474. Long term AMPK activation limits obesity induced muscle atrophy
  1475. Influence of magnetic stimulation on muscle atrophy in the rat unloading hindlimb muscles
  1476. TWEAK/Fn14 Regulates Denervation-Induced Skeletal muscle atrophy through an “Inside-Out” Signaling Pathway
  1477. Exoskeleton Solutions to Bone and muscle atrophy Within Microgravity Environments
  1478. Post-stroke muscle atrophy and intramuscular fat content in hemiparetic subjects
  1479. The protective role of PGC‐1α in the recovery of muscle disuse atrophy
  1480. Activation of Caspase-3 Plays a Role in Immobilization-Induced muscle atrophy
  1481. Prevention of muscle fibers atrophy during gravitational unloading: The effect of l-arginine administration
  1482. Delay of Skeletal muscle atrophy after Transplantation of Mesenchymal Progenitor Cells into Transected Position
  1483. Overexpression of the Mitochondrial T3 Receptor Induces Skeletal muscle atrophy
  1484. The effect of Nimodipine on denervated skeletal muscle atrophy in rats
  1485. Plantar fasciitis: Biomechanics, atrophy and muscle energetics
  1486. Effects of aging, insulin resistance, and AKT gene ablation on muscle atrophy related gene expression
  1487. The Research Progress on NF-κB and Skeletal muscle atrophy in Cancer Cachexia
  1488. The Effect of Method of Invigorating Qi to Promote Blood Flow on TGF-β_1 mRNA in Rat with Denervated muscle atrophy
  1489. Genetic Ablation of cIAP2 Results in a Protection Against Denervation-Induced Skeletal muscle atrophy
  1490. The diaphragm rapidly increases expression of muscle atrophy genes following acute cervical spinal cord injury (cSCI)
  1491. Progressive muscle atrophy and Weakness After Treatment by Mantle Field Radiotherapy in Patients with Hodgkin’S Lymphoma
  1492. Genetic ablation of cIAP2 protects against denervation-induced skeletal muscle atrophy
  1493. muscle atrophy produced by spinal cord injury (SCI) in rats decreases muscle protein synthesis without altering mTOR kinase activity
  1494. SymbolThe mRNA alteration and correlation of Calpains and FoxOs during gastrocnemius muscle atrophy induced by sciatic nerve injury and cardiotoxin injection
  1495. Redox Regulation of nNOS Translocation and muscle atrophy During Short‐term Mechanical Unloading
  1496. muscle atrophy and long bone osteopenia are attenuated with n‐3 PUFA in a mouse model of hindlimb suspension
  1497. Losartan decreases denervated skeletal muscle atrophy through nuclear factor-kappaB/muscle RING finger protein 1⋆
  1498. Antagonistic effect of high frequency sinusoidal vibration on immobilization-induced soleus muscle atrophy in rats⋆
  1499. Effects of Different Types of Dietary Fat on muscle atrophy According to muscle Fiber Types and PPAR Expression in Hindlimb-Immobilized Rats
  1500. A Ground-based Comparison of the muscle atrophy Research and Exercise System (MARES) and a Standard Isokinetic Dynamometer
  1501. The Difference of Apoptotic Responses in Denervated muscle atrophy of Aging Rat Skeletal muscles
  1502. Evaluation of muscle atrophy: Comparison between Limb-Girdle Muscular Dystrophies, ALS and Metabolic Myopathies (P07. 197)
  1503. Dietary BCAAs do not prevent skeletal muscle atrophy in rats injected with glucocorticoid.
  1504. Effects of a high protein diet and the timing of protein consumption after exercise on glucocorticoid‐induced muscle atrophy in rats
  1505. Exercise limitation, muscle atrophy and increased angiopoietin mRNA in a mouse model of pulmonary TNFa induced inflammation
  1506. Apoptosis-inducing effect of selective sensory or motor nerve injury on skeletal muscle atrophy
  1507. The Effects of Application Timing for Electromyostimulation on Denervated Skeletal muscle atrophy
  1508. The Relationship of the Exposed Rotator Cuff Footprint and Cuff muscle atrophy
  1509. A research on PPARα mRNA expression in vastus lateralis and serum levels of inflammatory cytokines in patients with COPD accompanied by skeletal muscle atrophy …
  1510. Specific hip muscle atrophy with acetabular labral tears
  1511. The Effects of a Synbiotic Diet on Skeletal muscle atrophy Induced by Hindlimb Unloading in Rats
  1512. Evidence of Increased muscle atrophy and Impaired Quality of Life Parameters in Patients with Uremic Restless Legs…
  1513. Delayed effect of basic fibroblast growth factor on denervated skeletal muscle atrophy: an experimental study.
  1514. … CARE COSTS AND UTILIZATION BETWEEN PATIENTS RECEIVING TOTAL KNEE REPLACEMENT SURGERY WITH AND WITHOUT muscle atrophy …
  1515. Acupuncture ameliorated skeletal muscle atrophy induced by hindlimb suspension and spiral wire immobilization in mice
  1516. Disuse muscle atrophy exacerbates motor neuronal degeneration caudal to the site of spinal cord injury
  1517. Effect of Sijunzi Decoction on Skeletal muscle atrophy and Some Inflammatory Cytokines in Lung Cancer Cachexia Mice
  1518. Docosahexaenoic acid (DHA) prevents atrophy-related signaling in palmitate-treated C2C12 muscle CELLS
  1519. MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis
  1520. Effects of combined Vitamin E supplementation with rehabilitation training on recovery of disuse-induced muscle atrophy in gastrocnemius of rats.
  1521. … in Health and Disease (Gainesville, Florida, February 22nd to 24th 2012)–Day 1:“Cell Signaling Mechanisms Mediating muscle atrophy and Hypertrophy” and …
  1522. Androgenic and estrogenic regulation of skeletal muscle mass and atrophy signaling in male mice
  1523. Electrical stimulation by semi-implantable electrodes decreases the levels of proteins associated with sciatic nerve injury-induced muscle atrophy
  1524. Translational Supression of Atrogin‐1 and MuRF1 by miR‐23a Integrates Resistance to Skeletal muscle atrophy
  1525. AT1 receptor blocker attenuates mechanical ventilation-induced atrophy and oxidative stress in the diaphragm muscle
  1526. The transcription factor ATF4 promotes skeletal muscle fiber atrophy during fasting
  1527. Melatonin prevents muscle atrophy and the alteration of myosin heavy chain in spinal cord injured rats
  1528. Influence of Differences in the Duration of Hindlimb Suspension on the Process of Recovery from Disuse muscle atrophy of Rat Soleus muscles.
  1529. The effect of reloading on disuse muscle atrophy: Time course of hypertrophy and regeneration focusing on the myofiber cross-sectional area and myonuclear change
  1530. P3. 19 Decrease of sarcolemmal nNOS as a molecular marker of muscle atrophy in inherited and acquired forms of myopathy
  1531. Delayed generalized muscle atrophy following unilateral hindlimb casting in old rats is prevented by a whey or a high protein diet but not a free leucine-enriched diet
  1532. Poikilodermia, anhidrosis, hairless body, neurogenic muscle atrophy, and recurrent hematuria: a new syndrome?
  1533. The modulating mechanism of FoXO3a in denervated skeletal muscle atrophy in rats and the treating effects of the Extract of Ginkgo Biloba (EGB761)
  1534. A GLYCOGEN SYNTHASE KINASE-3β-GLUCOCORTICOID RECEPTOR SIGNALING AXIS CONTROLS muscle atrophy INDUCED BY PULMONARY …
  1535. The Role of the Ubiquitin Ligase Nedd4-1 in Skeletal muscle atrophy
  1536. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction and mycolactone impairs satellite cell proliferation
  1537. Myogenic regulatory factor Myf-5 expression at different periods of denervated skeletal muscle atrophy
  1538. Symbol Effects of choline chloride on myostatin mRNA expression in rats with immobilization-induced skeletal muscle atrophy
  1539. Genome-wide identification of Bcl-3 and P50 target genes in disuse muscle atrophy
  1540. Acute Lung Injury Causes Increased Expression of mRNAs Encoding atrophy and Autophagy Genes in Skeletal muscle and the Diaphragm.
  1541. Heat shock protein 70 overexpression attenuates botulinum neurotoxin type A induced skeletal muscle atrophy in rats
  1542. Lithium protects motor neurons at prolonged time intervals in a single knock out double transgenic mouse model of spinal muscle atrophy
  1543. Multifidus muscle Size and atrophy Among Dancers With and Without Low Back Pain
  1544. The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease
  1545. FOXO3a mediates signaling cross‐talk that coordinates ubiquitin and atrogin‐1/MAFbx expression during muscle atrophy
  1546. Identifying gene targets for Bcl‐3 and p50 in unloading induced muscle atrophy
  1547. Endocrine alterations in myotonic dystrophy type 1 and type 2: correlation with markers of muscle fiber atrophy
  1548. Symbol Precaution efficacy of poly-d, l lactic acid/neurotrophic growth factor compound conduit on denervated muscle atrophy
  1549. GLYCOGEN SYNTHASE KINASE-3 INHIBITION PREVENTS SKELETAL muscle atrophy IN AN ANIMAL MODEL OF PULMONARY INFLAMMATION
  1550. Correction: Absence of Functional Leptin Receptor Isoforms in the POUND (Leprdb/lb) Mouse Is Associated with muscle atrophy and Altered Myoblast Proliferation …
  1551. P491Loss of the ubiquitin ligase Atrogin1/MAFbx (muscle atrophy F-box) causes age-related cardiomyopathy and premature death
  1552. Insulin-like growth factor 1 retarding denervated skeletal muscle atrophy through inhibiting NF-kappaB/MuRF1 pathway
  1553. GP 4.06 Dislocation of neuronal nitric oxide synthase contributes to muscle atrophy in amyotrophic lateral sclerosis
  1554. Calcineurin‐NFAT signaling regulates atrogin‐1 and MuRF1 via miR‐23a during glucocorticoid induced muscle atrophy
  1555. 50. muscle disuse atrophy: The expression of Myocyte Enhancer Factor 2 in the skeletal muscle of Spermophilus tridecemlineatus during hibernation
  1556. Calcineurin-NFAT signaling regulates atrogin-1 and MuRF1 via microRNA-23a (miR-23a) during muscle atrophy
  1557. P21. 11 muscle weakness and atrophy as initial symptoms of acquired immunodeficiency syndrome (AIDS): A case report
  1558. Assessment of voluntary activation, atrophy, fatigability and contralateral associated contractions of the first dorsal interosseous muscle after incomplete cervical spinal …
  1559. Lack of 2-adrenoceptors Accelerates Skeletal muscle atrophy in Myocardial Infarcted Mice: Role of Ubiquitin-Proteasome System and Akt/mTOR Pathway
  1560. Accelerating nerve regeneration and reducing muscle atrophy by bridging peripheral nerve defects with tissue-engineering nerve graft from bone marrow derived …
  1561. I-8 muscle maturation and early pathogenic findings in spinal muscular atrophy: any clues for therapy?
  1562. Prevention of skeletal muscle wasting: disuse atrophy and sarcopenia
  1563. … CELLS IN THE EPITHELIAL SPECIFIC ANDROGEN RECEPTOR KNOCKOUT MOUSE CAUSES THE SMOOTH muscle atrophy IN SURROUNDING STROMA
  1564. Seasonal changes in atrophy-associated proteins of the sonic muscle in the big-snout croaker, Johnius macrorhynus (Pisces, Sciaenidae), identified by using a …
  1565. P5. 65 The effects of Omega-3 fatty acid on skeletal muscle atrophy induced by Dexamethasone
  1566. nNos localization, muscle function and atrophy in skeletal muscle disorders
  1567. p97’s roles in muscle atrophy, mitochondrial membrane protein turnover, and the effects of p97 inhibition
  1568. The Effects of Vibration Stimulate in Morphology and Structure of Rats with Skeletal muscle Disuse atrophy
  1569. muscle atrophy induced by mechanical unloading: mechanisms and potential countermeasures
  1570. miR-29b contributes to multiple types of muscle atrophy
  1571. Redox control of skeletal muscle atrophy
  1572. The molecular mechanisms of calpains action on skeletal muscle atrophy.
  1573. muscle memory and a new cellular model for muscle atrophy and hypertrophy
  1574. The role of exercise and TFAM in preventing skeletal muscle atrophy
  1575. Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action
  1576. Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence
  1577. Disease-induced skeletal muscle atrophy and fatigue
  1578. muscle atrophy in mechanically-ventilated critically ill children
  1579. Aging voice and the laryngeal muscle atrophy
  1580. Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy
  1581. Imaging patterns of muscle atrophy
  1582. muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets
  1583. Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy
  1584. Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy
  1585. muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise
  1586. Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance—a qualitative review
  1587. Models of disuse muscle atrophy: therapeutic implications in critically ill patients
  1588. Skeletal muscle atrophy in advanced interstitial lung disease
  1589. Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse
  1590. Denervation does not induce muscle atrophy through oxidative stress
  1591. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy
  1592. Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism
  1593. One week of bed rest leads to substantial muscle atrophy and induces whole-body insulin resistance in the absence of skeletal muscle lipid accumulation
  1594. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia
  1595. Upper and lower limb muscle atrophy in critically ill patients: an observational ultrasonography study
  1596. Supraphysiological levels of GDF 11 induce striated muscle atrophy
  1597. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
  1598. miRNA‐23a/27a attenuates muscle atrophy and renal fibrosis through muscle‐kidney crosstalk
  1599. The role of alterations in mitochondrial dynamics and PGC‐1α over‐expression in fast muscle atrophy following hindlimb unloading
  1600. Comprehensive miRNA profiling of skeletal muscle and serum in induced and normal mouse muscle atrophy during aging
  1601. Multifidus muscle changes after back injury are characterized by structural remodeling of muscle, adipose and connective tissue, but not muscle atrophy
  1602. Creatinine clearance, walking speed, and muscle atrophy: a cohort study
  1603. Regulatory role of MicroRNAs in muscle atrophy during exercise intervention
  1604. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size
  1605. muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study
  1606. muscle atrophy
  1607. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour‐bearing mice
  1608. muscle atrophy contributes to quadriceps weakness after anterior cruciate ligament reconstruction
  1609. Can endurance exercise preconditioning prevention disuse muscle atrophy?
  1610. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
  1611. Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress
  1612. Single muscle fiber proteomics reveals distinct protein changes in slow and fast fibers during muscle atrophy
  1613. muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation
  1614. Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation-or fasting-induced skeletal muscle atrophy
  1615. Lower-extremity muscle atrophy and fat infiltration after chronic spinal cord injury
  1616. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS
  1617. Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems
  1618. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
  1619. Calpain-dependent regulation of the skeletal muscle atrophy following unloading
  1620. High incidence of infraspinatus muscle atrophy in elite professional female tennis players
  1621. Biology of muscle atrophy and of its recovery by FES in aging and mobility impairments: roots and by-products
  1622. Long noncoding RNA lncMUMA reverses established skeletal muscle atrophy following mechanical unloading
  1623. Increasing agrin function antagonizes muscle atrophy and motor impairment in spinal muscular atrophy
  1624. Transcriptomic and epigenetic regulation of disuse atrophy and the return to activity in skeletal muscle
  1625. Low-frequency electrical stimulation attenuates muscle atrophy in CKD—a potential treatment strategy
  1626. Emerging roles for histone deacetylases in age-related muscle atrophy
  1627. Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy
  1628. Loss of Parkin impairs mitochondrial function and leads to muscle atrophy
  1629. Small‐molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia
  1630. Sarcopenia: beyond muscle atrophy and into the new frontiers of opportunistic imaging, precision medicine, and machine learning
  1631. Effects of different types of exercise on skeletal muscle atrophy, antioxidant capacity and growth factors expression following myocardial infarction
  1632. Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy
  1633. Resveratrol improves muscle atrophy by modulating mitochondrial quality control in STZ‐induced diabetic mice
  1634. Angiotensin II Induces Skeletal muscle atrophy by Activating TFEB-Mediated MuRF1 Expression
  1635. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1
  1636. NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy
  1637. Allopurinol partially prevents disuse muscle atrophy in mice and humans
  1638. Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia
  1639. Tendon length, calf muscle atrophy, and strength deficit after acute Achilles tendon rupture: long-term follow-up of patients in a previous study
  1640. Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy
  1641. Dietary astaxanthin supplementation attenuates disuse-induced muscle atrophy and myonuclear apoptosis in the rat soleus muscle
  1642. Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases
  1643. Increased Serpina3n release into circulation during glucocorticoid‐mediated muscle atrophy
  1644. HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy
  1645. Assessments of fatty infiltration and muscle atrophy from a single magnetic resonance image slice are not predictive of 3-dimensional measurements
  1646. Differential sensitivity of oxidative and glycolytic muscles to hypoxia-induced muscle atrophy
  1647. MicroRNA-23a and microRNA-27a mimic exercise by ameliorating CKD-induced muscle atrophy
  1648. Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways
  1649. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1)
  1650. Vitamin D receptor in muscle atrophy of elderly patients: a key element of osteoporosis-sarcopenia connection
  1651. Group I Paks support muscle regeneration and counteract cancer‐associated muscle atrophy
  1652. Role of ATF4 in skeletal muscle atrophy
  1653. Mitochondrial dysfunction launches dexamethasone-induced skeletal muscle atrophy via AMPK/FOXO3 signaling
  1654. Daily heat stress treatment rescues denervation‐activated mitochondrial clearance and atrophy in skeletal muscle
  1655. Factors predicting quadriceps femoris muscle atrophy during the first 12 weeks following anterior cruciate ligament reconstruction
  1656. Does early exercise attenuate muscle atrophy or bone loss after spinal cord injury?
  1657. Reactive oxygen species upregulate expression of muscle atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells
  1658. Perivascular stem cells diminish muscle atrophy following massive rotator cuff tears in a small animal model
  1659. Dihydromyricetin attenuates dexamethasone-induced muscle atrophy by improving mitochondrial function via the PGC-1α pathway
  1660. Prevalence and pattern of gluteus medius and minimus tendon pathology and muscle atrophy in older individuals using MRI
  1661. Dkk3 dependent transcriptional regulation controls age related skeletal muscle atrophy
  1662. Altered satellite cell dynamics accompany skeletal muscle atrophy during chronic illness, disuse and aging
  1663. Preventive effect of dietary quercetin on disuse muscle atrophy by targeting mitochondria in denervated mice
  1664. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
  1665. Randomized, four-arm, dose-response clinical trial to optimize resistance exercise training for older adults with age-related muscle atrophy
  1666. Smad2/3 proteins are required for immobilization-induced skeletal muscle atrophy
  1667. The whole transcriptome involved in denervated muscle atrophy following peripheral nerve injury
  1668. Astaxanthin intake attenuates muscle atrophy caused by immobilization in rats
  1669. Electromyostimulation to fight atrophy and to build muscle: facts and numbers
  1670. Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy
  1671. FoxO‐dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension
  1672. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats
  1673. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice
  1674. Umbilical cord mesenchymal stem cell-conditioned media prevent muscle atrophy by suppressing muscle atrophy-related proteins and ROS generation
  1675. Green tea extracts ameliorate high-fat diet–induced muscle atrophy in senescence-accelerated mouse prone-8 mice
  1676. Three-dimensional culture model of skeletal muscle tissue with atrophy induced by dexamethasone
  1677. A mouse model of delayed rotator cuff repair results in persistent muscle atrophy and fatty infiltration
  1678. Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy
  1679. Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy
  1680. Association between walking ability and trunk and lower-limb muscle atrophy in institutionalized elderly women: a longitudinal pilot study
  1681. Neuromuscular electrophysiological disorders and muscle atrophy in mechanically-ventilated traumatic brain injury patients: New insights from a prospective …
  1682. Advanced glycation end‐products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE‐mediated, AMPK‐down‐regulated, Akt pathway
  1683. Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice
  1684. When motor unit expansion in ageing muscle fails, atrophy ensues
  1685. Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy
  1686. Correlation between intervertebral disc degeneration, paraspinal muscle atrophy, and lumbar facet joints degeneration in patients with lumbar disc herniation
  1687. Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy
  1688. Regulation of muscle atrophy by microRNAs:’AtromiRs’ as potential target in cachexia
  1689. TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy
  1690. Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy
  1691. Interval exercise training increases LIF expression and prevents myocardial infarction-induced skeletal muscle atrophy in rats
  1692. Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy
  1693. Gadd45a protein promotes skeletal muscle atrophy by forming a complex with the protein kinase MEKK4
  1694. Comparison of multifidus muscle atrophy after posterior lumbar interbody fusion with conventional and cortical bone trajectory
  1695. α‐Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway
  1696. Quercetin reduces tumor necrosis factor alpha-induced muscle atrophy by upregulation of heme oxygenase-1
  1697. Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review
  1698. Apigenin ameliorates the obesity‐induced skeletal muscle atrophy by attenuating mitochondrial dysfunction in the muscle of obese mice
  1699. Low-intensity pulsed ultrasound prevents muscle atrophy induced by type 1 diabetes in rats
  1700. Agent-based computational model investigates muscle-specific responses to disuse-induced atrophy
  1701. Identification of the acetylation and ubiquitin-modified proteome during the progression of skeletal muscle atrophy
  1702. Acupuncture plus low-frequency electrical stimulation (Acu-LFES) attenuates denervation-induced muscle atrophy
  1703. Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination
  1704. muscle changes during atrophy
  1705. The role of IGF-1 signaling in skeletal muscle atrophy
  1706. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury
  1707. Heat treatment inhibits skeletal muscle atrophy of glucocorticoid-induced myopathy in rats.
  1708. Spermidine coupled with exercise rescues skeletal muscle atrophy from D-gal-induced aging rats through enhanced autophagy and reduced apoptosis via …
  1709. Nitric oxide treatment attenuates muscle atrophy during hind limb suspension in mice
  1710. Concurrent treatment with ursolic acid and low-intensity treadmill exercise improves muscle atrophy and related outcomes in rats
  1711. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice
  1712. Contrast-enhanced ultrasound determines supraspinatus muscle atrophy after cuff repair and correlates to functional shoulder outcome
  1713. Paraspinal muscle atrophy after lumbar spine surgery
  1714. Tourniquet use during knee replacement surgery may contribute to muscle atrophy in older adults
  1715. Increasing autophagy does not affect neurogenic muscle atrophy
  1716. High‐intensity resistance training attenuates dexamethasone‐induced muscle atrophy
  1717. Effect of acute treadmill exercise on cisplatin-induced muscle atrophy in the mouse
  1718. Sulforaphane prevents dexamethasone-induced muscle atrophy via regulation of the Akt/Foxo1 axis in C2C12 myotubes
  1719. Conessine treatment reduces dexamethasone-induced muscle atrophy by regulating MuRF1 and atrogin-1 expression
  1720. Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway
  1721. muscle atrophy and metal-on-metal hip implants: a serial MRI study of 74 hips
  1722. Local cyclical compression modulates macrophage function in situ and alleviates immobilization-induced muscle atrophy
  1723. Exercise preconditioning diminishes skeletal muscle atrophy after hindlimb suspension in mice
  1724. TLR2 deficiency attenuates skeletal muscle atrophy in mice
  1725. Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy
  1726. Rev-erb-α regulates atrophy-related genes to control skeletal muscle mass
  1727. PGC-1α overexpression via local transfection attenuates mitophagy pathway in muscle disuse atrophy
  1728. Impact of denervation‐induced muscle atrophy on housekeeping gene expression in mice
  1729. Age and sex-based distribution of lumbar multifidus muscle atrophy and coexistence of disc hernia: an MRI study of 2028 patients
  1730. Growth hormone therapy accelerates axonal regeneration, promotes motor reinnervation, and reduces muscle atrophy following peripheral nerve injury
  1731. Notch signaling mediates skeletal muscle atrophy in cancer cachexia caused by osteosarcoma
  1732. Ubiquitin-proteasome pathway and muscle atrophy
  1733. Protective effects of clenbuterol against dexamethasone-induced masseter muscle atrophy and myosin heavy chain transition
  1734. The inhibitory core of the myostatin prodomain: its interaction with both type I and II membrane receptors, and potential to treat muscle atrophy
  1735. Essential amino acid supplementation mitigates muscle atrophy after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial
  1736. Heat stress modulates both anabolic and catabolic signaling pathways preventing dexamethasone‐induced muscle atrophy in vitro
  1737. The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
  1738. muscle atrophy due to nerve damage is accompanied by elevated myofibrillar protein synthesis rates
  1739. miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy
  1740. Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone
  1741. Skeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium
  1742. The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice
  1743. Resveratrol attenuates denervation-induced muscle atrophy due to the blockade of atrogin-1 and p62 accumulation
  1744. Oxidative stress contributes to muscle atrophy in chronic kidney disease patients
  1745. Boosted regeneration and reduced denervated muscle atrophy by NeuroHeal in a pre-clinical model of lumbar root avulsion with delayed reimplantation
  1746. Delphinidin prevents muscle atrophy and upregulates miR-23a expression
  1747. Remarkable preservation of Ca 2+ homeostasis and inhibition of apoptosis contribute to anti-muscle atrophy effect in hibernating Daurian ground squirrels
  1748. Docosahexaenoic acid counteracts palmitate‐induced endoplasmic reticulum stress in C2C12 myotubes: Impact on muscle atrophy
  1749. Reversibility of supraspinatus muscle atrophy in tendon-bone healing after arthroscopic rotator cuff repair
  1750. Pharmacological inhibition of myostatin protects against skeletal muscle atrophy and weakness after anterior cruciate ligament tear
  1751. Grape polyphenols supplementation reduces muscle atrophy in a mouse model of chronic inflammation
  1752. Hormones and muscle atrophy
  1753. Deubiquitinating enzymes in skeletal muscle atrophy—an essential role for USP19
  1754. Hydrogen sulfide donor NaHS improves metabolism and reduces muscle atrophy in type 2 diabetes: implication for understanding sarcopenic …
  1755. Cross talk between androgen and Wnt signaling potentially contributes to age-related skeletal muscle atrophy in rats
  1756. Targeted ablation of p38α MAPK suppresses denervation-induced muscle atrophy
  1757. Exercise and transversus abdominis muscle atrophy after 60-d bed rest
  1758. Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease
  1759. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3
  1760. muscle atrophy and fatty infiltration after an acute rotator cuff repair in a sheep model
  1761. Age related skeletal muscle atrophy and upregulation of autophagy in dogs
  1762. Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib
  1763. Mechanisms of stress-related muscle atrophy in fish: An ex vivo approach
  1764. Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury
  1765. Effects of nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation
  1766. Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
  1767. Paradoxical effect of IKKβ inhibition on the expression of E3 ubiquitin ligases and unloading‐induced skeletal muscle atrophy
  1768. Hindlimb immobilization, but not castration, induces reduction of undercarboxylated osteocalcin associated with muscle atrophy in rats
  1769. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing’s syndrome
  1770. Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients
  1771. A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats
  1772. Docosahexaenoic acid‐supplementation prior to fasting prevents muscle atrophy in mice
  1773. Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro
  1774. Glucocorticoids increase skeletal muscle NF‐κB inducing kinase (NIK): links to muscle atrophy
  1775. Does magnetic resonance imaging appearance of supraspinatus muscle atrophy change after repairing rotator cuff tears?
  1776. Increased mitochondrial turnover in the skeletal muscle of fasted, castrated mice is related to the magnitude of autophagy activation and muscle atrophy
  1777. Day-night oscillation of Atrogin1 and timing-dependent preventive effect of weight-bearing on muscle atrophy
  1778. Does successful rotator cuff repair improve muscle atrophy and fatty infiltration of the rotator cuff? A retrospective magnetic resonance imaging study performed shortly …
  1779. The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal muscle atrophy in a Rat Model of Sarcopenia.
  1780. Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic …
  1781. Sensorimotor control of the shoulder in professional volleyball players with isolated infraspinatus muscle atrophy
  1782. Identification of the optimal dose and calpain system regulation of tetramethylpyrazine on the prevention of skeletal muscle atrophy in hindlimb unloading rats
  1783. Do neurogenic and cancer-induced muscle atrophy follow common or divergent paths?
  1784. l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats
  1785. A new model of skeletal muscle atrophy induced by immobilization using a hook-and-loop fastener in mice
  1786. Changes in FOXO and proinflammatory cytokines in the late stage of immobilized fast and slow muscle atrophy
  1787. Past, present, and future perspective of targeting myostatin and related signaling pathways to counteract muscle atrophy
  1788. Myriocin prevents muscle ceramide accumulation but not muscle fiber atrophy during short-term mechanical unloading
  1789. Insulin signaling and skeletal muscle atrophy and autophagy in transition dairy cows either overfed energy or fed a controlled energy diet prepartum
  1790. Pyrrolidine dithiocarbamate (PDTC) attenuates cancer cachexia by affecting muscle atrophy and fat lipolysis
  1791. Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
  1792. A soluble activin receptor IIB fails to prevent muscle atrophy in a mouse model of spinal cord injury
  1793. Tetramethylpyrazine ameliorated disuse-induced gastrocnemius muscle atrophy in hindlimb unloading rats through suppression of Ca2+/ROS-mediated apoptosis
  1794. Skeletal muscle atrophy and degeneration in a mouse model of traumatic brain injury
  1795. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
  1796. Altered protein turnover signaling and myogenesis during impaired recovery of inflammation-induced muscle atrophy in emphysematous mice
  1797. muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington’s disease
  1798. Temporal study following burn injury in young rats is associated with skeletal muscle atrophy, inflammation and altered myogenic regulatory factors
  1799. Hypoxia impairs adaptation of skeletal muscle protein turnover-and AMPK signaling during fasting-induced muscle atrophy
  1800. MiR-206 attenuates denervation-induced skeletal muscle atrophy in rats through regulation of satellite cell differentiation via TGF-β1, Smad3, and HDAC4 …
  1801. mRNA-seq reveals skeletal muscle atrophy in response to handling stress in a marine teleost, the red cusk-eel (Genypterus chilensis)
  1802. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia
  1803. Optimizing electrical stimulation for promoting satellite cell proliferation in muscle disuse atrophy
  1804. Tracheobronchial smooth muscle atrophy and separation
  1805. Exposure to microgravity for 30 days onboard Bion M1 caused muscle atrophy and impaired regeneration in murine femoral Quadriceps
  1806. Isoform-specific Na, K-ATPase alterations precede disuse-induced atrophy of rat soleus muscle
  1807. GNE myopathy with novel mutations and pronounced paraspinal muscle atrophy
  1808. Transplantation of embryonic spinal cord derived cells helps to prevent muscle atrophy after peripheral nerve injury
  1809. Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury
  1810. Effects of post-fracture non-weight-bearing immobilization on muscle atrophy, intramuscular and intermuscular adipose tissues in the thigh and calf
  1811. muscle atrophy: present and future
  1812. GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury
  1813. PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading
  1814. Chronic alcohol exposure induces muscle atrophy (myopathy) in zebrafish and alters the expression of microRNAs targeting the Notch pathway in skeletal muscle
  1815. Effects of exercise on soleus in severe burn and muscle disuse atrophy
  1816. MicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6
  1817. Physiological culture conditions alter myotube morphology and responses to atrophy treatments: implications for in vitro research on muscle wasting
  1818. Standardized Kaempferia parviflora Wall. ex Baker (Zingiberaceae) extract inhibits fat accumulation and muscle atrophy in ob/ob mice
  1819. Dexamethasone‐induced skeletal muscle atrophy increases O‐GlcNAcylation in C2C12 cells
  1820. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3–E3 ubiquitin ligase-dependent pathway
  1821. Icaritin requires Phosphatidylinositol 3 kinase (PI3K)/Akt signaling to counteract skeletal muscle atrophy following mechanical unloading
  1822. Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species
  1823. Botulinum toxin and muscle atrophy: a wanted or unwanted effect
  1824. Pyropia yezoensis protein supplementation prevents dexamethasone-induced muscle atrophy in c57bl/6 mice
  1825. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model
  1826. Ligand-induced rapid skeletal muscle atrophy in HSA-Fv2E-PERK transgenic mice
  1827. Early electrical field stimulation prevents the loss of spinal cord anterior horn motoneurons and muscle atrophy following spinal cord injury
  1828. Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia
  1829. Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice
  1830. muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy
  1831. Reduction of cellular nucleic acid binding protein encoded by a myotonic dystrophy type 2 gene causes muscle atrophy
  1832. Small molecule adiponectin receptor agonist GTDF protects against skeletal muscle atrophy
  1833. The angiotensin-(1–7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice
  1834. Transcriptional activation of muscle atrophy promotes cardiac muscle remodeling during mammalian hibernation
  1835. Condylar degradation from decreased occlusal loading following masticatory muscle atrophy
  1836. AMP-activated kinase α2 deficiency protects mice from denervation-induced skeletal muscle atrophy
  1837. Role of altered proteostasis network in chronic hypobaric hypoxia induced skeletal muscle atrophy
  1838. Short-term, high-fat diet accelerates disuse atrophy and protein degradation in a muscle-specific manner in mice
  1839. An herbal formula consisting of Schisandra chinensis (Turcz.) Baill, Lycium chinense Mill and Eucommia ulmoides Oliv alleviates disuse muscle atrophy in rats
  1840. The analysis of antioxidant expression during muscle atrophy induced by hindlimb suspension in mice
  1841. Angiotensin-(1–7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism
  1842. Congenital myopathy with “corona” fibres, selective muscle atrophy, and craniosynostosis associated with novel recessive mutations in SCN4A
  1843. miR-628 promotes burn-induced skeletal muscle atrophy via targeting IRS1
  1844. Effect of a specific exercise strategy on strength and proprioception in volleyball players with infraspinatus muscle atrophy
  1845. Evaluation of the site specificity of acute disuse muscle atrophy developed during a relatively short period in critically ill patients according to the activities of daily …
  1846. Pyrroloquinoline quinone resists denervation-induced skeletal muscle atrophy by activating PGC-1α and integrating mitochondrial electron transport chain …
  1847. Glucocorticoid receptor signaling impairs protein turnover regulation in hypoxia-induced muscle atrophy in male mice
  1848. Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid‐induced muscle cell atrophy
  1849. Leucine protects against skeletal muscle atrophy in lipopolysaccharide-challenged rats
  1850. Supplementation of magnolol attenuates skeletal muscle atrophy in bladder cancer-bearing mice undergoing chemotherapy via suppression of FoxO3 …
  1851. Tail nerve electrical stimulation and electro-acupuncture can protect spinal motor neurons and alleviate muscle atrophy after spinal cord transection in rats
  1852. In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography
  1853. Pattern difference of dissociated hand muscle atrophy in amyotrophic lateral sclerosis and variants
  1854. Deletion of NAD (P) H oxidase 2 prevents angiotensin II-induced skeletal muscle atrophy
  1855. The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans
  1856. The involvement of transient receptor potential canonical type 1 in skeletal muscle regrowth after unloading‐induced atrophy
  1857. Hepatocyte growth factor regulates the miR-206-HDAC4 cascade to control neurogenic muscle atrophy following surgical denervation in mice
  1858. New mouse model of skeletal muscle atrophy using spiral wire immobilization
  1859. muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog
  1860. Therapeutic potential of eccentric exercises for age-related muscle atrophy
  1861. Ampelopsin attenuates the atrophy of skeletal muscle from d-gal-induced aging rats through activating AMPK/SIRT1/PGC-1α signaling cascade
  1862. Changes of muscle atrophy according to the immediate postoperative time point in magnetic resonance imaging after arthroscopic rotator cuff repair
  1863. Use of mRNA expression signatures to discover small molecule inhibitors of skeletal muscle atrophy
  1864. Decreased grip strength, muscle pain, and atrophy occur in rats following long‐term exposure to excessive repetitive motion
  1865. Physical exercise for muscle atrophy
  1866. Regulation of Hspb7 by MEF2 and AP-1: implications for Hspb7 in muscle atrophy
  1867. Cold shock protein RBM3 attenuates atrophy and induces hypertrophy in skeletal muscle
  1868. The effects of preconditioning with ischemic exercise on quadriceps femoris muscle atrophy following anterior cruciate ligament reconstruction: a quasi-randomized …
  1869. Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophy
  1870. Apigenin inhibits sciatic nerve denervation–induced muscle atrophy
  1871. Skeletal muscle inflammation and atrophy in heart failure
  1872. Low-intensity aerobic exercise training: inhibition of skeletal muscle atrophy in high-fat-diet-induced ovariectomized rats
  1873. muscle atrophy in chronic kidney disease
  1874. Leucine minimizes denervation-induced skeletal muscle atrophy of rats through akt/mtor signaling pathways
  1875. Inhibition of skeletal muscle atrophy during torpor in ground squirrels occurs through downregulation of MyoG and inactivation of Foxo4
  1876. The effect of Bu Zhong Yi Qi decoction on simulated weightlessness‑induced muscle atrophy and its mechanisms
  1877. To contrast and reverse skeletal muscle atrophy by full-body in-bed gym, a mandatory lifestyle for older olds and borderline mobility-impaired persons
  1878. Short-term, daily exposure to cold temperature may be an efficient way to prevent muscle atrophy and bone loss in a microgravity environment
  1879. … gluteal muscles in end-stage osteoarthritis of the hip: intra-and interobserver reliability and agreement of MRI assessments of muscle atrophy and fatty degeneration
  1880. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis
  1881. An overview of muscle atrophy
  1882. Effect of bone marrow mesenchymal stem cells on satellite cell proliferation and apoptosis in immobilization-induced muscle atrophy in rats
  1883. Electrical stimulation of denervated rat skeletal muscle retards capillary and muscle loss in early stages of disuse atrophy
  1884. The roles of muscle stem cells in muscle injury, atrophy and hypertrophy
  1885. New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration
  1886. Bone morphogenetic protein signaling in rotator cuff muscle atrophy and fatty infiltration
  1887. Delphinidin prevents disuse muscle atrophy and reduces stress-related gene expression
  1888. Quantitative measurement of muscle atrophy and fat infiltration of the supraspinatus muscle using ultrasonography after arthroscopic rotator cuff repair
  1889. Loquat (Eriobotrya japonica) extract prevents dexamethasone-induced muscle atrophy by inhibiting the muscle degradation pathway in Sprague Dawley rats
  1890. 8-Prenylnaringenin promotes recovery from immobilization-induced disuse muscle atrophy through activation of the Akt phosphorylation pathway in mice
  1891. Overexpression of NF90-NF45 represses myogenic microRNA biogenesis, resulting in development of skeletal muscle atrophy and centronuclear muscle fibers
  1892. Secreted frizzled-related protein 2 and inflammation-induced skeletal muscle atrophy
  1893. Redox homeostasis in age-related muscle atrophy
  1894. Fatty infiltration and muscle atrophy of the rotator cuff in stemless total shoulder arthroplasty: a prospective cohort study
  1895. Small molecular weight soybean protein-derived peptides nutriment attenuates rat burn injury-induced muscle atrophy by modulation of ubiquitin–proteasome system …
  1896. Does muscle atrophy and fatty infiltration plateau or persist in chronic spinal cord injury?
  1897. Sarcomere structure: the importance of desmin protein in muscle atrophy
  1898. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ‐deficient mouse, a model of congenital myasthenic syndrome with …
  1899. Training at non‐damaging intensities facilitates recovery from muscle atrophy
  1900. CUG-BP1 regulates RyR1 ASI alternative splicing in skeletal muscle atrophy
  1901. Hypogonadism associated with muscle atrophy, physical inactivity and ESA hyporesponsiveness in men undergoing haemodialysis
  1902. Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1
  1903. muscle mass, quality, and composition changes during atrophy and sarcopenia
  1904. Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy
  1905. Buyang Huanwu Tang improves denervation-dependent muscle atrophy by increasing ANGPTL4, and increases NF-κB and MURF1 levels
  1906. The complex of PAMAM-OH dendrimer with Angiotensin (1–7) prevented the disuse-induced skeletal muscle atrophy in mice
  1907. Inhibition of the androgen receptor by antiandrogens in spinobulbar muscle atrophy
  1908. Nutritional Considerations in preventing muscle atrophy
  1909. Schisandrae Fructus supplementation ameliorates sciatic neurectomy-induced muscle atrophy in mice
  1910. Preventive effects of the dietary intake of medium-chain triacylglycerols on immobilization-induced muscle atrophy in rats
  1911. The effects of dokhwalgisaeng-tang against disuse muscle atrophy in gastrocnemius of rats
  1912. Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive …
  1913. Implantation of muscle satellite cells overexpressing myogenin improves denervated muscle atrophy in rats
  1914. A model of muscle atrophy based on live microscopy of muscle remodelling in Drosophila metamorphosis
  1915. Differential expression of perilipin 2 and 5 in human skeletal muscle during aging and their association with atrophy-related genes
  1916. Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction
  1917. Rotator cuff muscle degeneration and tear severity related to myogenic, adipogenic, and atrophy genes in human muscle
  1918. Shoulder muscle atrophy and its relation to strength loss in obstetrical brachial plexus palsy
  1919. Butyrate prevents muscle atrophy after sciatic nerve crush
  1920. Celastrol overcomes HSP72 gene silencing-mediated muscle atrophy and induces myofiber preservation
  1921. Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty
  1922. Protective effect of branched chain amino acids on hindlimb suspension-induced muscle atrophy in growing rats
  1923. N-myristoylated ubiquitin ligase Cbl-b inhibitor prevents on glucocorticoid-induced atrophy in mouse skeletal muscle
  1924. Calpain 3 expression pattern during gastrocnemius muscle atrophy and regeneration following sciatic nerve injury in rats
  1925. Panduratin A prevents tumor necrosis factor-alpha-induced muscle atrophy in L6 rat skeletal muscle cells
  1926. Molecular insights into muscle homeostasis, atrophy and wasting
  1927. … the fatty fraction from T2*-corrected Dixon fat/water separation volume-interpolated breathhold examination (VIBE) in the assessment of muscle atrophy in rotator cuff …
  1928. Human adipocytes induce inflammation and atrophy in muscle cells during obesity
  1929. Anti-skeletal muscle atrophy effect of Oenothera odorata root extract via reactive oxygen species-dependent signaling pathways in cellular and mouse model
  1930. Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy
  1931. Quantitative Dixon MRI sequences to relate muscle atrophy and fatty degeneration with range of motion and muscle force in brachial plexus injury
  1932. Vitamin D attenuates FOXO1-target atrophy gene expression in C2C12 muscle cells
  1933. muscle Bmal1 is dispensable for the progress of neurogenic muscle atrophy in mice
  1934. GCN2 deficiency protects mice from denervation-induced skeletal muscle atrophy via inhibiting FoxO3a nuclear translocation
  1935. Ultrasonography detects early laryngeal muscle atrophy in an equine neurectomy model
  1936. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in …
  1937. muscle atrophy and fatty infiltration in rotator cuff tears: Can surgery stop muscular degenerative changes?
  1938. Overview of FES-assisted cycling approaches and their benefits on functional rehabilitation and muscle atrophy
  1939. Maternal conjugated linoleic acid supplementation reverses high-fat diet-induced skeletal muscle atrophy and inflammation in adult male rat offspring
  1940. Korean mistletoe (Viscum album coloratum) extract regulates gene expression related to muscle atrophy and muscle hypertrophy
  1941. Fbxw7β is an inducing mediator of dexamethasone-induced skeletal muscle atrophy in vivo with the axis of Fbxw7β-myogenin–atrogenes
  1942. Proteomic and bioinformatic analyses of spinal cord injury‑induced skeletal muscle atrophy in rats
  1943. Angiotensin-(1-7) prevents skeletal muscle atrophy induced by transforming growth factor type beta (TGF-β) via Mas receptor activation
  1944. Dietary supplementation with alkylresorcinols prevents muscle atrophy through a shift of energy supply
  1945. Effect of a combination of astaxanthin supplementation, heat stress, and intermittent reloading on satellite cells during disuse muscle atrophy
  1946. Dietary genistein prevents denervation-induced muscle atrophy in male rodents via effects on estrogen receptor-α
  1947. What is the appropriate reference for evaluating the recovery of supraspinatus muscle atrophy after arthroscopic rotator cuff repair? The occupation ratio of the …
  1948. Impaired muscle mitochondrial biogenesis and myogenesis in spinal muscular atrophy
  1949. Ibandronate concomitantly blocks immobilization-induced bone and muscle atrophy
  1950. Pattern differences of small hand muscle atrophy in amyotrophic lateral sclerosis and mimic disorders
  1951. Inhibition of calpain delays early muscle atrophy after rotator cuff tendon release in sheep
  1952. Neck muscle atrophy and soft-tissue fibrosis after neck dissection and postoperative radiotherapy for oral cancer
  1953. atrophy, ultra-structural disorders, severe atrophy and degeneration of denervated human muscle in SCI and Aging. Implications for their recovery by Functional …
  1954. Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy
  1955. Whole grain cereal attenuates obesity-induced muscle atrophy by activating the PI3K/Akt pathway in obese C57BL/6N mice
  1956. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis
  1957. Serum miRNAs miR-23a, 206, and 499 as potential biomarkers for skeletal muscle atrophy
  1958. IPSCs, a promising tool to restore muscle atrophy
  1959. Polar bears experience skeletal muscle atrophy in response to food deprivation and reduced activity in winter and summer
  1960. Cervical paraspinal muscle atrophy rates following laminoplasty and laminectomy with fusion for cervical spondylotic myelopathy
  1961. Extracellular polysaccharides purified from Aureobasidium pullulans SM‑2001 (Polycan) inhibit dexamethasone‑induced muscle atrophy in mice
  1962. Not all disuse protocols are equal: new insight into the signalling pathways to muscle atrophy
  1963. Protective effect of tea grape extract on cisplatin-induced muscle atrophy: a morphological study
  1964. Electrical stimulation attenuates morphological alterations and prevents atrophy of the denervated cranial tibial muscle
  1965. Therapeutic effect of microcurrent on calf muscle atrophy in immobilized rabbit
  1966. Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD
  1967. Nutritional support to counteract muscle atrophy
  1968. Can the babysitter procedure improve nerve regeneration and denervated muscle atrophy in the treatment of peripheral nerve injury?
  1969. Developmental biology and regenerative medicine: addressing the vexing problem of persistent muscle atrophy in the chronically torn human rotator cuff
  1970. Reverse split hand syndrome: dissociated intrinsic hand muscle atrophy pattern in Hirayama disease/brachial monomelic amyotrophy
  1971. Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions
  1972. The intersection of disuse-induced muscle atrophy and satellite cell content: reply to Snijders, Nederveen, and Parise
  1973. Prevention of skeletal muscle atrophy in vitro using anti-ubiquitination oligopeptide carried by atelocollagen
  1974. Dynamic changes in the mouse skeletal muscle proteome during denervation-induced atrophy
  1975. Characteristics of hip fracture patients with and without muscle atrophy/weakness: predictors of negative economic outcomes
  1976. Agonist muscle adaptation accompanied by antagonist muscle atrophy in the hindlimb of mice following stretch-shortening contraction training
  1977. muscle atrophy and recovery of individual thigh muscles as measured by magnetic resonance imaging scan during treatment with cast for ankle or foot fracture
  1978. Petri net-based prediction of therapeutic targets that recover abnormally phosphorylated proteins in muscle atrophy
  1979. The role of mechanobiology in progression of rotator cuff muscle atrophy and degeneration
  1980. Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle
  1981. Assessment of Paraspinal muscle atrophy Percentage after Minimally Invasive Transforaminal Lumbar Interbody Fusion and Unilateral Instrumentation Using …
  1982. Critical role of miRNAs in mediating skeletal muscle atrophy
  1983. Transcutaneous carbon dioxide application with hydrogel prevents muscle atrophy in a rat sciatic nerve crush model
  1984. The molecular mechanisms and prevention principles of muscle atrophy in aging
  1985. Extensive type II muscle fiber atrophy in elderly female hip fracture patients
  1986. Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of skeletal muscle fibers in middle-aged adults
  1987. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD
  1988. Rotator cuff tear morphologic parameters at magnetic resonance imaging: relationship with muscle atrophy and fatty infiltration and patient-reported function and …
  1989. TLR4‐defective (C3H/HeJ) mice are not protected from cast immobilization‐induced muscle atrophy
  1990. The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber type-specific skeletal muscle atrophy
  1991. Aberrant autophagic response in the muscle of a knock-in mouse model of spinal and bulbar muscular atrophy
  1992. Astragalus polysaccharide, a component of traditional Chinese medicine, inhibits muscle cell atrophy (cachexia) in an in vivo and in vitro rat model of chronic …
  1993. Effectiveness of daily eccentric contractions induced via kilohertz frequency transcutaneous electrical stimulation on muscle atrophy
  1994. Increased expression of MuRF1 is associated with radiation-induced laryngeal muscle atrophy
  1995. Discordance in recovery between altered locomotion and muscle atrophy induced by simulated microgravity in rats
  1996. Morphological and molecular aspects of immobilization-induced muscle atrophy in rats at different stages of postnatal development: the role of autophagy
  1997. Third-degree hindpaw burn injury induced apoptosis of lumbar spinal cord ventral horn motor neurons and sciatic nerve and muscle atrophy in rats
  1998. Association of gluteus medius and minimus muscle atrophy and fall-related hip fracture in older individuals using computed tomography
  1999. Towards a better understanding of the role played by mitochondrial dynamics and morphology in skeletal muscle atrophy
  2000. Pulsed electromagnetic fields alleviate streptozotocin‑induced diabetic muscle atrophy
  2001. Alcohol intake aggravates adipose browning and muscle atrophy in cancer-associated cachexia
  2002. The myonuclear domain is not maintained in skeletal muscle during either atrophy or programmed cell death
  2003. The protective effects of Dangguibohyul-tang (Dangguibuxuetang) against disuse muscle atrophy in rats
  2004. Interventional strategies to combat muscle disuse atrophy in humans: focus on neuromuscular electrical stimulation and dietary protein
  2005. muscle atrophy in cancer
  2006. Balanced diet-fed Fat-1 transgenic mice exhibit lower hindlimb suspension-induced soleus muscle atrophy
  2007. Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma
  2008. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy
  2009. Embryonic stem cells improve skeletal muscle recovery after extreme atrophy in mice
  2010. Heat stress attenuates skeletal muscle atrophy of extensor digitorum longus in streptozotocin-induced diabetic rats
  2011. Skeletal muscle atrophy is induced by Fbxw7β via atrogene upregulation
  2012. Chinese herbal medicine Baoyuan Jiedu Decoction inhibited muscle atrophy of cancer cachexia through Atrogin-l and MuRF-1
  2013. Master and commander? FoxO’s role in muscle atrophy
  2014. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients
  2015. Ethanol extract of Schisandra chinensis (Turcz.) Baill. reduces AICAR-induced muscle atrophy in C2C12 myotubes
  2016. The Effects of Acupuncture at GB34 on Disuse muscle atrophy in Rats
  2017. Effect of Oenothera odorata root extract on microgravity and disuse-induced muscle atrophy
  2018. Phosphodiesterase 4B knockout prevents skeletal muscle atrophy in rats with burn injury
  2019. Hypospadias as a novel feature in spinal bulbar muscle atrophy
  2020. The evolution of and risk factors for neck muscle atrophy and weakness in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a …
  2021. Diagnostic clinical, electrodiagnostic and muscle pathology features of spinal and bulbar muscular atrophy
  2022. Evaluation of paravertebral muscle atrophy and fatty degeneration in ankylosing spondylitis
  2023. Epac2a-knockout mice are resistant to dexamethasone-induced skeletal muscle atrophy and short-term cold stress
  2024. Direct optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophy
  2025. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy
  2026. Effects of the beta2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia
  2027. Losing pieces without disintegrating: Contractile protein loss during muscle atrophy
  2028. Acute resistance exercise reduces increased gene expression in muscle atrophy of ovariectomised arthritic rats
  2029. Shift from androgen to estrogen action causes abdominal muscle fibrosis, atrophy, and inguinal hernia in a transgenic male mouse model
  2030. MRI evidence of cerebellar and extraocular muscle atrophy differently contributing to eye movement abnormalities in SCA2 and SCA28 diseases
  2031. Glucocorticoids alter CRTC-CREB signaling in muscle cells: impact on PGC-1α expression and atrophy markers
  2032. atrophy, inducible satellite cell activation, and possible denervation of supraspinatus muscle in injured human rotator-cuff muscle
  2033. Expression of atrophy-related transcription factors in the process of intrinsic laryngeal muscle atrophy after denervation
  2034. Regenerative effects of basic fibroblast growth factor on restoration of thyroarytenoid muscle atrophy caused by recurrent laryngeal nerve transection
  2035. … Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for muscle atrophy
  2036. Effects of aging on basement membrane of the soleus muscle during recovery following disuse atrophy in rats
  2037. Quantitative evaluation of denervated muscle atrophy with shear wave ultrasound elastography and a comparison with the histopathologic parameters in an animal …
  2038. Involvement of released sphingosine 1-phosphate/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy
  2039. From physical inactivity to immobilization: Dissecting the role of oxidative stress in skeletal muscle insulin resistance and atrophy
  2040. Preventive effects of kilohertz frequency electrical stimulation on sepsis-induced muscle atrophy
  2041. … : Nutrition and Food Science: Effects of Alpha-hydroxy-isocaproic acid upon Body Composition in a Type I Diabetic Patient with muscle atrophy–A Case Study
  2042. Effect of 20-hydroxyecdysone on proteolytic regulation in skeletal muscle atrophy
  2043. muscle atrophy at presentation of cubital tunnel syndrome: demographics and duration of symptoms
  2044. Effects of Schisandrae Fructus Supplementation on Apoptosis and Inflammatory Response in Gastrocnemius muscle of Dexamethasone-Induced muscle atrophy Mice
  2045. Protective role of testicular hormone INSL3 from atrophy and weakness in skeletal muscle
  2046. Transfection of neurotrophin‑3 into neural stem cells using ultrasound with microbubbles to treat denervated muscle atrophy
  2047. Dietary supplementation with shiikuwasha extract attenuates dexamethasone-induced skeletal muscle atrophy in aged rats
  2048. Soluble milk proteins improve muscle mass recovery after immobilization-induced muscle atrophy in old rats but do not improve muscle functional property restoration
  2049. Rectus femoris muscle atrophy and recovery caused by preoperative pretibial traction in femoral shaft fractures-comparison between traction period
  2050. Pathogenic role of anti–signal recognition protein and anti–3‐Hydroxy‐3‐methylglutaryl‐C o A reductase antibodies in necrotizing myopathies: Myofiber atrophy and …
  2051. Physical inactivity induces the atrophy of skeletal muscle of rats through activating AMPK/FoxO3 signal pathway
  2052. The effects of Daeyeoung-jeon on the prevention of disuse muscle atrophy in rats
  2053. Resistance training prevents muscle fibrosis and atrophy via down‐regulation of C1q‐induced Wnt signaling in senescent mice
  2054. Noncoding RNAs in muscle atrophy
  2055. Activin receptor type IIB inhibition improves muscle phenotype and function in a mouse model of spinal muscular atrophy
  2056. Relationship of changes in strain rate indices estimated from velocity‐encoded MR imaging to loss of muscle force following disuse atrophy
  2057. The effect of exercise hypertrophy and disuse atrophy on muscle contractile properties: a mechanomyographic analysis
  2058. Chronic treatment with the AMPK agonist AICAR prevents skeletal muscle pathology but fails to improve clinical outcome in a mouse model of severe spinal …
  2059. Myostatin propeptide gene delivery by gene gun ameliorates muscle atrophy in a rat model of botulinum toxin-induced nerve denervation
  2060. Advances of molecular mechanisms on obesity inducing muscle atrophy
  2061. The Effects of Daekumeumja on Alcohol-induced muscle atrophy in Rats
  2062. Mesenchymal stem cells suppress muscle atrophy induced by hindlimb suspension
  2063. l‐glutamine Improves Skeletal muscle Cell Differentiation and Prevents Myotube atrophy After Cytokine (TNF‐α) Stress Via Reduced p38 MAPK Signal Transduction
  2064. FGGY carbohydrate kinase domain containing is upregulated during neurogenic skeletal muscle atrophy
  2065. Identification and small molecule inhibition of an activating transcription factor 4 (ATF4)-dependent pathway to age-related skeletal muscle weakness and …
  2066. Short-term muscle disuse atrophy is not associated with increased intramuscular lipid deposition or a decline in the maximal activity of key mitochondrial enzymes in …
  2067. Marked decrease of aquaporin-4 protein is independent of the changes in α1-syntrophin and TRPV4 levels in response to denervation-induced muscle atrophy in vivo
  2068. Chinese Herbal Medicine Effects on muscle atrophy Induced by Simulated Microgravity
  2069. The influence of aging on the effectiveness of heat stress in preventing disuse muscle atrophy
  2070. muscle atrophy at high altitude
  2071. Effect of salbutamol on respiratory muscle strength in spinal muscular atrophy
  2072. Effect of pure muscle retraction on multifidus injury and atrophy after posterior lumbar spine surgery with 24 weeks observation in a rabbit model
  2073. Changes in oxidative stress severity and antioxidant potential during muscle atrophy and reloading in mice
  2074. muscle atrophy measurement as assessment method for low back pain patients
  2075. Proteomic analysis reveals the distinct energy and protein metabolism characteristics involved in myofiber type conversion and resistance of atrophy in the extensor …
  2076. FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy
  2077. The effect of 4 weeks resistance training on murf1 gene expression and muscle atrophy in diabetic wistar rats
  2078. Research progress of muscle atrophy animal models
  2079. Electrical stimulation of denervated rat skeletal muscle ameliorates bone fragility and muscle loss in early-stage disuse musculoskeletal atrophy
  2080. Can leucine supplementation attenuate muscle atrophy? A literature review
  2081. Onabotulinum Toxin A Injections Into the Salivary Glands for Spinal muscle atrophy Type I: A Prospective Case Series of 4 Patients
  2082. Induction of muscle atrophy by Dexamethasone and Hydrogen Peroxide in Differentiated C2C12 Myotubes
  2083. Multifidus muscle atrophy not observed following two-segment anterior interbody fusion: a rabbit model study with a 12-month follow-up
  2084. B57 GENE REGULATION: MIRNAS AND EPIGENETICS: Regulation Of muscle atrophy-Related Micrornas In Limb muscles Of COPD Patients
  2085. Facial and bulbar muscle atrophy in acetylcholine receptor antibody-positive myasthenia gravis
  2086. Relationship between muscle dissection method and postoperative muscle atrophy in the lateral suboccipital approach to vestibular schwannoma surgery
  2087. Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy
  2088. preventing muscle atrophy following strokes: a reappraisal
  2089. Lumbar paraspinal muscle atrophy during long duration spaceflight
  2090. Modeling of muscle atrophy and exercise induced hypertrophy
  2091. Branched chain amino acids and muscle atrophy protection
  2092. ROS and nNOS in the regulation of disuse-induced skeletal muscle atrophy
  2093. Therapeutic Effects of Multimodal Biophysical Stimulation on muscle atrophy in a Mouse Model
  2094. Vitamin D Receptor in muscle atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection
  2095. Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation
  2096. Tetratricopeptide 39C (TTC39C) is upregulated during skeletal muscle atrophy and is necessary for muscle cell differentiation
  2097. Preservation technique of the piriformis tendon is superior to reattachment technique in terms of contiguity and muscle atrophy: using magnetic resonance imaging
  2098. Quantitative analysis concerning atrophy and fat infiltration of the multifidus muscle with magnetic resonance spectroscopy in chronic low back pain
  2099. Biomechanical implications of skeletal muscle hypertrophy and atrophy: a musculoskeletal model
  2100. The effects of electromyostimulation application timing on denervated skeletal muscle atrophy
  2101. Effects of growth hormone therapy on axonal regeneration, muscle atrophy, Schwann cell proliferation and end-organ reinnervation following nerve injury and repair
  2102. Beyond muscle wasting: an easy approach with CT scan in differential diagnosis of muscle atrophy.
  2103. Immobilization‐induced rat skeletal muscle atrophy enhances histone modification through HDAC4
  2104. An autopsy case of progressive generalized muscle atrophy over 14 years due to post-polio syndrome
  2105. -Omic Approaches to Understanding muscle Biology: Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor …
  2106. Disuse atrophy accompanied by intramuscular ectopic adipogenesis in vastus medialis muscle of advanced osteoarthritis patients
  2107. In Vitro Modeling of Microgravity-Induced muscle atrophy and Spaceflight Radiation
  2108. Effect of electroacupuncture on denervated skeletal muscle atrophy and expression of IGF-1/PI3K/AKT in rats
  2109. Repeated bouts of fast velocity eccentric contractions induce atrophy of gastrocnemius muscle in rats
  2110. The Protective Effects of Pueraria Radix against Chronic Alcohol-induced muscle atrophy in Rats
  2111. The Mechanisms of Cobaltous Chloride-Induced Hypoxia on muscle atrophy
  2112. … Reticulum Functions in Cell Physiology and Disease: Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of …
  2113. Melatonin attenuates chronic immobilization stress-induced muscle atrophy in rats: Influence on lactate-to-pyruvate ratios and Na+/K+ ATPase activity
  2114. The presence of a rotator cuff tear interferes with age-dependent muscle atrophy of intact shoulder muscles. An MRI study with 3 years’ follow-up
  2115. Myositis, Ganglioneuritis, and Myocarditis with Distinct Perifascicular muscle atrophy in a 2-Year-Old Male Boxer
  2116. Distinct Effects of Dietary Whey Peptide and Soy Protein on Denervation Mediated muscle atrophy
  2117. Distal sensory to distal motor nerve anastomosis can protect lower extremity muscle atrophy in a murine model
  2118. Temporal muscle atrophy: Not only the approach but the way you get it
  2119. Laser therapy modulates systemic inflammatory processes and muscle atrophy in an experimental model of sepsis in rats
  2120. Automated analysis of whole skeletal muscle for muscular atrophy detection of ALS in whole-body CT images: preliminary study
  2121. Molecular Mechanism and Nutritional Approach for Unloading-mediated muscle atrophy (JSNFS Award for Excellence in Research (2016))
  2122. Investigating the Efficacy Of Frequency and Pulse Width Modulation for muscle atrophy Rehabilitation
  2123. Study protocol for single-center, open-label, randomized controlled trial to clarify the preventive efficacy of electrical stimulation for muscle atrophy after trauma
  2124. Attenuating effects of clenbuterol, β2-agonist, on immobilization-induced atrophy of rat hindlimb muscle fibers
  2125. Section II Basic aspects of muscle atrophy 4. muscle changes during atrophy
  2126. The Impact of MicroRNA 23/27 on muscle atrophy in Diabetic Mice
  2127. Mitral dysplasia with papillary muscle atrophy in a dog
  2128. Effect of mesenchymal stem cells on induced skeletal muscle chemodenervation atrophy in adult male albino rats
  2129. PRECLINICAL MODELS OF INACTIVITY AND BEDREST TO INVESTIGATE muscle atrophy
  2130. The Effects of Shihosogan-san on Alcohol-induced muscle atrophy in Rats
  2131. Models of disuse muscle atrophy: therapeutic implications in critically ill patients
  2132. Discussion: growth hormone therapy accelerates axonal regeneration, promotes motor reinnervation, and reduces muscle atrophy following peripheral nerve injury
  2133. Changes of insulin-like growth factor 1 axis in chronic kidney disease and its role in skeletal muscle atrophy
  2134. Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats
  2135. Prospective MRI comparison of muscle atrophy after total hip arthroplasty
  2136. Understanding The Mechanisms Of muscle atrophy
  2137. Ciliary neurotrophic factor upregulates follistatin and Pak1, causes overexpression of muscle differentiation related genes and downregulation of established atrophy …
  2138. The molecular mechanisms of calpains on muscle atrophy
  2139. Green tea component EGCG, insulin and IGF-1 promote nuclear efflux of atrophy-associated transcription factor Foxo1 in skeletal muscle fibers
  2140. Astaxanthin supplementation attenuates disuse muscle atrophy and myonuclear apoptosis in rat skeletal muscle
  2141. TRB3 Regulates Denervation‐induced muscle atrophy and Insulin Resistance in Mouse Skeletal muscle
  2142. Gluteal muscle fatty atrophy is not associated with elevated blood metal ions or pseudotumors in patients with a unilateral metal-on-metal hip replacement
  2143. Multifidus muscle undergoes structural remodeling of muscle, adipose and connective tissue, but not atrophy after injury: molecular and morphological evidence
  2144. Selective extraocular muscle atrophy secondary to chronic oculomotor denervation
  2145. Remarkable plasticity of Na+, K+-ATPase, Ca 2+-ATPase and SERCA contributes to muscle disuse atrophy resistance in hibernating Daurian ground …
  2146. Copper nanoclusters trigger muscle cell apoptosis and atrophy in vitro and in vivo
  2147. Comparison of alginate and microcarriers for in vitro modeling of microgravity-induced muscle atrophy
  2148. atrophy of type I and II muscle fibers is reversible in the case of grade> 2 fatty degeneration of the supraspinatus muscle: an experimental study in rabbits
  2149. Hyperglycemia Promotes muscle atrophy through the WWP1/KLF15 Pathway
  2150. Basal level of p70S6k phosphorylation is higher in aged rats and inversely related to muscle atrophy
  2151. 4933 PPAR gamma mediates angiotensin II-induced muscle atrophy by increasing miR-29b
  2152. Electroacupuncture therapy for muscle atrophy in CKD: is there a needle in the haystack?
  2153. Exercise preconditioning and TFAM overexpression diminish skeletal muscle atrophy.
  2154. Defective acetylcholine receptor subunit switch precedes atrophy of slow-twitch skeletal muscle fibers lacking erk1/2 kinases in soleus muscle
  2155. Unloading‐induced atrophy and decreased oxidative capacity of the soleus muscle in rats are reversed by pre‐and postconditioning with mild hyperbaric oxygen
  2156. MURF contributes to skeletal muscle atrophy through suppressing autophagy
  2157. Effects of electroacupuncture on denervated skeletal muscle atrophy and muscle fibrosis
  2158. Lower limb muscle atrophy on MRI as a guide in the diagnosis of muscle diseases
  2159. Serum amyloid A induces Toll-like receptor 2-dependent inflammatory cytokine expression and atrophy in C2C12 skeletal muscle myotubes
  2160. Skeletal muscle in Spinal Muscular atrophy As an Opportunity for Therapeutic Intervention
  2161. Overexpression of SIRT6 Suppresses TNFα‐induced muscle Cell atrophy via NFκB Inhibition
  2162. Experimental detection of muscle atrophy initiation Using sEMG signals
  2163. Therapeutic target prediction for muscle atrophy by using Petri-net simulation on phosphorylation networks
  2164. High‐fat diet augments muscle atrophy by changes of muscle atrophy‐related genes in mice
  2165. Special Issue “Aging and Skeletal muscle atrophy”
  2166. FOXO1‐induced atrophy Changes in Phospholipid Profiles of Skeletal muscle
  2167. Icaritin requires phosphatidylinositol 3kinase/Akt signaling to counteract skeletal muscle atrophy following mechanical unloading
  2168. Increased autophagy and reduced protein synthesis signaling are involved in pulmonary inflammation-induced skeletal muscle atrophy
  2169. Ethanol Extract of Mori Folium Inhibits AICAR-induced muscle atrophy Through Inactivation of AMPK in C2C12 Myotubes
  2170. Lumbar muscle atrophy caused by harness replacement in a chronic calf model of total artificial heart implantation
  2171. Dual Specificity Phosphatase and Pro Isomerase Domain Containing 1 (Dupd1) is Upregulated During Neurogenic Skeletal muscle atrophy and is Differentially …
  2172. Inhibition of lncRNA MAAT Contributes to Multiple Types of muscle atrophy
  2173. Paralysis with muscle atrophy
  2174. Dissociated small hand muscle atrophy occurs in amyotrophic lateral sclerosis: Split hand
  2175. Quantitative analysis of hemodynamic state and muscle atrophy of residual limb after trans-femoral amputation
  2176. Inducible motor neuron specific deletion of CuZn Superoxide dismutase accelerates muscle atrophy in mice
  2177. Early Onset of muscle atrophy in Women with Chronic Alcoholic Myopathy
  2178. Identification of bovel mechanisms mediating skeletal muscle atrophy
  2179. Parascapular muscle atrophy as a delayed effect of radiation treatment
  2180. Rheumatoid arthritis-increased gene expressions in muscle atrophy are restored back to control as a response to acute resistance exercise
  2181. SERCA ACTIVATION AS AN INTERVENTION TO REDUCE muscle atrophy AND WEAKNESS
  2182. Calpain 3 and CaMKII β signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy
  2183. Skin physiology in microgravity: a 3-month stay aboard ISS induces dermal atrophy and affects cutaneous muscle and hair follicles cycling in mice
  2184. Weight gain due to muscle atrophy
  2185. Identification of new pathways driving muscle atrophy and biomarkers reflecting muscle atrophy in cancer cachexia
  2186. Adverse muscle Changes and Possible Therapeutic Targets for Rotator Cuff muscle atrophy and Fatty Infiltration
  2187. Chiari I Malformation Presenting as Shoulder Pain, Weakness, and muscle atrophy in a Collegiate Athlete
  2188. Ultrasound elastography in detection of supraspinatus muscle atrophy and fatty degeneration in the reference to MRI
  2189. The Mechanism of Exercise preventing Skeletal muscle atrophy
  2190. The Effect of Iron on Skeletal muscle atrophy in Chronic Kidney Disease
  2191. The molecular pathogenesis of skeletal muscle atrophy
  2192. GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy
  2193. The Effects of Stimulation of Acupuncture Point ST36 on Disuse muscle atrophy in Rats
  2194. muscle atrophy And Clinical Outcomes In Patients With ARDS
  2195. TFAM Overexpression Prevents Skeletal muscle atrophy
  2196. Isolated Brachialis muscle atrophy
  2197. MOLECULAR SIGNALING PATHWAYS IN THE CONTROL OF SKELETAL muscle atrophy
  2198. Characterization of Later Childhood/Adult Spinal muscle atrophy Patients and Their Transitions of Care within US Hospitals (P4. 454)
  2199. Effect of Buyang Huanwu decoction on NF-κB/MuRFl expression in rats with denervated tibial muscle atrophy
  2200. Simulating muscle atrophy due to Microgravity and Ionizing Radiation
  2201. P-bodies are Elevated with Age-, but Not Disuse-associated Skeletal muscle atrophy
  2202. Change of lymphatic vessel density by induced muscle atrophy
  2203. Theoretical discussion of Bushen Jianpi Huoxue Method in Prevention and Treatment of Disuse muscle atrophy
  2204. microRNA-29b Contributes to Multiple Types of muscle atrophy
  2205. Early mitochondrial degeneration in the development of disuse‐induced muscle atrophy
  2206. Measurement and prevention of muscle atrophy in acute spinal cord injury
  2207. Deep-Tissue Heating as a Therapeutic Intervention to Prevent Skeletal muscle atrophy in Humans
  2208. EFFECTS OF A NOVEL PROTEIN SUPPLEMENT ON DISUSE muscle atrophy (STUDY IN BODY WEIGHT AND SOLEUS muscle)
  2209. Regenerative effect of microcurrent according to intensity on calf muscle atrophy in immobilised rabbit
  2210. Transcriptional profile of muscle following acute induction of symptoms in a mouse model of Kennedy’s disease/spinobulbar muscular atrophy
  2211. Parkin Overexpression Attenuates Aging‐related muscle atrophy in Mice
  2212. Early detection of skeletal muscle atrophy using a multiple plasma-free amino acid index in the advanced aged patients with advanced pancreatic cancer
  2213. Effects of static interventions on disuse atrophy of the rat soleus muscle at different sites along its longitudinal axis
  2214. Progress on the mechanism of muscle atrophy induced by motor neuron injury
  2215. Assessment of muscle atrophy and fatty infiltration of symptomatic rotator cuff tear: a prospective study of 150 shoulders
  2216. Rad is an Agent of Skeletal muscle atrophy
  2217. Research progress of induced pluripotent stem cells in treatment of muscle atrophy
  2218. Advance in Model Establishment for Denervated Skeletal muscle atrophy
  2219. Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle
  2220. Role of Pathogen Sensor on Inactivity-Induced muscle atrophy
  2221. Patient’s perception around disease progression and influential factors in spinal muscle atrophy
  2222. Novel Natural Compounds with Potential to Prevent and Treat Skeletal muscle atrophy
  2223. Effects of conjugated linoleic acid/n-3 and resistance training on muscle quality and expression of atrophy-related ubiquitin ligases in middle-aged mice with …
  2224. Treatment with Pueraria mirifica Extract Prevented muscle atrophy and Restored muscle Strength in Ovariectomized Rats
  2225. Exogenous Delta-Like 1 Homolog (DLK1)-Fc Treatment Attenuates muscle atrophy in Both Dexamethasone and High-Fat Diet–Induced Obesity Mice Models
  2226. Prognostic Value of the Posterior Cricoarytenoid muscle atrophy in Computerized Tomography scans for Unilateral Vocal Fold Paralysis Recovery
  2227. Establishment of a cynomolgus monkey model of gastrocnemius muscle atrophy
  2228. Autophagosome‐proteolysis contribute to CKD‐induced muscle atrophy
  2229. TREATMENT OF muscle INHIBITION AND atrophy AFTER INJURY OR SURGERY OF LOWER LIMBS
  2230. Circulating micrornas as potential biomarkers of muscle atrophy
  2231. The Effect of 4-weeks’ Alcohol Supplementation on the muscle atrophy in Rat
  2232. Fat Grafting for Esthetic Correction of the muscle atrophy Secondary to Ulnar Nerve Lesion
  2233. The effective intensity of exercise load for facilitating recovery from muscle atrophy in mice
  2234. PGC-1α is important for maintaining the balance of muscle mass and myofiber types in unloaded muscle atrophy
  2235. Nucleoprotein‐enriched diet prevents disuse‐induced muscle atrophy in soleus muscle of rats
  2236. IGF-1 attenuates hypoxia-induced atrophy but inhibits myoglobin expression in C2C12 skeletal muscle myotubes
  2237. ZIP14 (SLC39A14) protects against muscle atrophy and attenuates inflammatory responses in murine skeletal muscle
  2238. Effects of Transcutaneous Application of Carbon Dioxide on diabetic muscle atrophy
  2239. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P. 78Clinical and molecular features of proximal spinal muscle atrophy in Portugal: a multicentre …
  2240. Anti‐inflammatory Cytokine Receptor Prevents muscle atrophy
  2241. PO-264 Target Mitochondria Metabolism and Energy Expenditure in muscle atrophy, Sarcopenia and Cachexia
  2242. A Molecular Study on Some Genes Known to be Related to Disuse muscle atrophy in the African Lungfish, Protopterus annectens, during Three Phases of …
  2243. Investigations Into Causes of muscle atrophy and Improving Clinical Outcomes Following Lower Limb Surgeries
  2244. Eccentric Loading Rehabilitation of Patient with Severe Post-Operative muscle atrophy
  2245. A numerical analysis of the effects of the lower-limb prosthetic socket on muscle atrophy of the residual limb
  2246. atrophy of muscle Cells Results in a Selective Packaging of Proteins into Exosomes
  2247. A case of muscle atrophy with extended sensitivity disorders (Syringomyelia)
  2248. Time-course influence of weight-bearing stimulation on muscle fibers with disuse muscle atrophy: based on longitudinal regions in rat soleus muscle
  2249. Role of the UPS proteolytic pathway during muscle atrophy: from animal models to human diseases
  2250. The Impact of Disuse muscle atrophy on Perivascular Stem Cell Quantity and Function
  2251. Stem cells for nerve repair and prevention of muscle atrophy
  2252. … that impaired motor conduction in the bilateral ulnar and tibial nerves underlies cervical spondylotic amyotrophy in patients with unilateral deltoid muscle atrophy
  2253. The pathophysiology of Spinal Bulbar Muscular atrophy: a longitudinal analysis of muscle and spinal cord
  2254. The Role of DNA Methylation in the Regulation of Skeletal muscle atrophy, Hypertrophy and Epigenetic ‘Memory’
  2255. The effects of physical activity on muscle atrophy in cancer cachexia
  2256. The Nuclear Sirtuin, Sirt6 Mitigates muscle atrophy Associated With Cancer
  2257. Effect of MicroRNA-143 on Myofiber of Denevated muscle atrophy in Mouse
  2258. Transcriptome-wide RNA sequencing analysis of immobilisation-induced muscle atrophy
  2259. Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib
  2260. Absence of Correlation Between mRNA Expression of muscle-Specific E3 Ligases and the Degree of muscle atrophy in the Early Stage of Immobilization
  2261. Presentation of the article.“A case of muscle atrophy with extended sensitivity disorders (Syringomyelia)”
  2262. Impaired ribcage muscles function alters ribcage structure in spinal muscle atrophy (SMA) children
  2263. Potential Nitric Oxide Treatment for Alleviating muscle atrophy in Hindlimb-Suspended Mice
  2264. TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy
  2265. Experimental Study of Acupuncture Progress Related to Skeletal muscle atrophy on IGF-1 Pathway
  2266. Effect of Sine Wave Vibration on the muscle atrophy Induced by Sports Injury
  2267. Can leucine supplementation attenuate muscle atrophy? A literature review
  2268. Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD [Corrigendum …
  2269. muscle MRI STIR signal intensity and atrophy are correlated to focal lower limb neuropathy severity
  2270. Lowering metabolic rate mitigates muscle atrophy in western fence lizards
  2271. Clinical effect of bundled care in the prevention of muscle atrophy in elderly patients in bed
  2272. Original Research Article Heat stress modulates both anabolic and catabolic signaling pathways preventing dexamethasone-induced muscle atrophy in vitro
  2273. Hemodynamic biomarkers levels are not dependent on physical exercise in patients with muscle atrophy
  2274. Testing the Potential for Nitric Oxide Treatment to Prevent Disuse atrophy in muscle During Suspension
  2275. VITAMIN C DEFICIENCY LEADS TO SKELETAL muscle atrophy AND muscle FIBER TRANSFORMATION
  2276. Attenuation of muscle atrophy Through Amino Acid Supplementation in Patients Following Total Knee Arthroplasty
  2277. Spontaneous breathing pattern in children with spinal muscle atrophy (SMA)
  2278. Effect Of (−)‐Epicatechin On muscle atrophy After Spinal Cord Injury In Rat
  2279. The influence of fatty infiltration and muscle atrophy of the rotator cuff muscles on mid-term functional outcomes in total shoulder resurfacing at 6 years follow up.
  2280. Heart Failure with Reduced Ejection Fraction Causes Limb muscle atrophy in Males, but Not Female Rats
  2281. Contribution of skeletal muscle defects in spinal muscular atrophy
  2282. L‐carnitine supplement and running training improve skeletal muscle recovery after hindlimb suspension induced muscle atrophy
  2283. Transcriptional Regulation of Skeletal muscle atrophy-Induced Gene Expression by muscle Ring Finger-1 and Myogenic Regulatory Factors
  2284. The Effect of Micro-current Electrical Therapy on muscle atrophy and Delayed Wound Healing Process Induced Rat Caused by Traumatic Peripheral Nerve Injury
  2285. WITHDRAWN: Relationship between the regulation of muscle atrophy and mitochondrial turnover during chronic disuse
  2286. Quantitative analysis of muscle atrophy under hyperglycemic conditions using C. Elegans model in a scalable microfluidic device
  2287. Gluteal muscle atrophy and fatty deposits increase with advancing hip osteoarthritis
  2288. Novel mechanisms and interventions addressing locomotor muscle atrophy and reduced oxidative capacity in severe COPD patients.
  2289. muscle atrophy after total hiparthroplasty in asymptomatic patients and comparison between different hiparthroplasties using a posterolateral approach.
  2290. hanges of muscle Insulin-like Growth Factor-I and Concentrations of Inflammatory Cytokines in Rat Skeletal muscle Following Denervation and Diabetes-induced …
  2291. Mechanisms of Botulinum Neurotoxin Induced Skeletal muscle atrophy
  2292. Acute resistance exercise reduces increased gene expression in muscle atrophy of ovariectomised arthritic rats
  2293. PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
  2294. Can early exercise attenuate muscle atrophy or bone loss after SCI?
  2295. Low‐Frequency Electrical Stimulation (Acu‐LFES) attenuates denervation‐induced muscle atrophy by increasing muscle regeneration
  2296. Study of Wide Pulse Wave Electroacupuncture at Zusanli (ST36) for preventing and Treating Lower Limb muscle atrophy
  2297. Use of Aquatic Based Physical Therapy in Treating an Adolescent with Severe Type II Spinal muscle atrophy: A Case Report
  2298. Changes of muscle Insulin-like Growth Factor-I and Concentrations of Inflammatory Cytokines in Rat Skeletal muscle Following Denervation and Diabetes-induced …
  2299. Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling
  2300. The role of ER stress in skeletal muscle atrophy in amyotrophic lateral sclerosis
  2301. Hyperbaric oxygen therapy attenuates muscle atrophy in streptozotocin‐induced diabetic rat
  2302. Visual, cognitive and motor skills in children with type I spinal muscle atrophy
  2303. MLS LASER TREATMENT: A TOOL TO COUNTERACT MICROGRAVITY-INDUCED muscle atrophy
  2304. Editorial Commentary: muscle atrophy After Arthroscopic Rotator Cuff Repair—Reversible?
  2305. The role of myostatin signaling pathway in improvement of skeletal muscle atrophy in type 2 diabetic rats after 4 weeks of eccentric endurance exercise
  2306. PQQ relieves muscle atrophy induced by denervation via inhibiting ROS
  2307. The transcriptomic signature of muscle atrophy after knee immobilisation most closely resembles the transcriptomic signatures of frailty and age
  2308. Quantitative evaluation of muscle atrophy and fatty infiltration in chronic supraspinatus tendon tear
  2309. The effectiveness of AMBU-bag to recruit ribcage volume in spinal muscle atrophy
  2310. Oxidative Stress and Ubiquitin Ligases: their involvement in skeletal muscle atrophy
  2311. Transcriptional Regulation of Skeletal muscle atrophy‐induced Gene Expression by muscle‐Specific RING Finger 1 (MuRF1)
  2312. The Role of Neuromuscular Electrical Stimulation in Reversing Age-related and Pathological muscle atrophy
  2313. The effect of the KATP channel opener Nicorandil in lipid‐peroxidation in skeletal muscle atrophy
  2314. S‐nitrosylation Is Responsible for muscle atrophy and Weakness in GNE Myopathy
  2315. … OF AUTOPHAGY AND THE UBIQUITIN-PROTEASOME SYSTEM BY THE FoxO TRANSCRIPTIONAL NETWORK DURING muscle atrophy
  2316. Glycoprotein (Gp130) Protein Expression During Mouse Skeletal muscle Disuse atrophy
  2317. Mouse model of muscle atrophy with water‐immersion restraint stress
  2318. ATTENUATING muscle atrophy USING ESSENTIAL AMINO ACID SUPPLEMENTATION BEFORE AND AFTER TOTAL KNEE ARTHROPLASTY
  2319. MOLECULAR BASIS OF SKELETAL muscle atrophy IN MYOTONIC DYSTROPHY
  2320. Fasudil Attenuates Chronic Kidney Disease-Induced muscle atrophy in Mice
  2321. Sarcopenia and muscle atrophy with Aging-impact of exercise training
  2322. MRI Features of Psoas Major muscles in Patients with Paraspinal muscle atrophy
  2323. Effects of Taurine Application on the Prostaglandin and Malondialdehyde Levels in Skeletal muscle atrophy Induced by Denervation
  2324. Mechanism of Nuclear Factor-κB in Skeletal muscle atrophy during Prevention and Treatment of Exercise in Pa-tients with Chronic Obstructive Pulmonary Disease
  2325. Characterization and survival of patients with spinal muscle atrophy type 1 on home mechanical ventilation program of ministry of health, Chile
  2326. Heat stress-induced protection against skeletal muscle atrophy via suppression of the apoptotic and proteolytic systems
  2327. MITOCHONDRIAL DEGENERATION PRECEDES CANCER-INDUCED muscle atrophy
  2328. muscle synergies patterns as biomarkers for children and teens with type II spinal muscular atrophy
  2329. TRPV4 mutation causing dominantly inherited scapuloperoneal spinal muscle atrophy
  2330. OR-031 Mechanism of free-wheeling exercise attenuating muscle atrophy in SAMP8 mice
  2331. The Function of TGF-beta1 in ICUAW and the Characterization of Sfrp2, a TGF-beta1 Target, in Skeletal muscle atrophy
  2332. … -WIDE TRANSCRIPTOMICS AS A PLATFORM FOR UNDERSTANDING THE UNUSUAL RESISTANCE TO muscle atrophy IN HIBERNATING DORMICE
  2333. Preventive effects of middle frequency electrical stimulation on cachexia‐induced muscle atrophy
  2334. A95 CRITICAL CARE: RECOVERY OF PHYSICAL FUNCTION AFTER CRITICAL ILLNESS: muscle atrophy And Clinical Outcomes In Patients With Ards
  2335. Triggering Nox2/ROS Signaling During Disuse-Induced Skeletal muscle atrophy
  2336. Possible reappraisal of the angina pectoris drug trimetazidine in the treatment of skeletal muscle atrophy
  2337. Effects of static interventions on disuse atrophy of rat soleus muscle depend on the longitudinal sites
  2338. Multiple Tripartite Motif E3 Ubiquitin Ligases Facilitate Skeletal muscle atrophy
  2339. Hydrogen Sulfide Donor NaHS Improves Metabolism and Reduces muscle atrophy in Type 2 Diabetes: Implication for Understanding Sarcopenic Pathophysiology
  2340. The Effect of Microcurrent Electrical Stimulation on muscle atrophy Suppression in a Sciatic Nerve Injured Rat Model; Comparative Study by Current Intensity
  2341. New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration
  2342. Comparison of MRI features of psoas muscles in patients with/without paraspinal muscle atrophy
  2343. EVALUATION OF LUMBAR PARASPINAL muscle atrophy IN PATIENTS WITH SARCOPENIA: GP102
  2344. MP42-09 ATROGIN IS A NOVEL MARKER OF AGE-RELATED URETHRAL SPHINCTER muscle atrophy
  2345. Perivascular Stem Cells Diminish muscle atrophy and Retain Viability in a Rotator Cuff Tear Model
  2346. Application of basic fibroblast growth factor gene-transfected bone marrow mesenchymal stem cells in denervated muscle atrophy
  2347. Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize muscle atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair
  2348. Quantitative Dixon and qualitative t1 MRI sequences to relate muscle atrophy and fatty degeneration with range of motion and muscle force in brachial plexus …
  2349. Thyroid hormone T3 protects mice from fasting induced skeletal muscle atrophy by counteracting autophagy
  2350. Systems-based discovery of tomatidine as a small molecule inhibitor of skeletal muscle atrophy
  2351. E2-Ub-conjugating enzymes in skeletal muscle atrophy
  2352. Sarcolipin is Upregulated in Response to Soleus Unloading Caused by Tenotomy and Opposes muscle atrophy
  2353. Influenza infection results in upregulation of inflammatory and atrophy genes in murine skeletal muscle (VIR5P. 1146)
  2354. Schisandrae Fructus: A Potential Candidate Functional Food Against muscle atrophy and Osteoarthritis Prevention
  2355. Activation of Signaling Pathways for Protein Synthesis by Korean Mistletoe (Viscum album coloratum) Extract in a Mouse Model of muscle atrophy
  2356. S-nitrosylation of muscle contractile proteins and metabolic enzymes causes muscle atrophy and weakness in GNE myopathy
  2357. Unconventional SNARE in the ER 1 (Use1) is Expressed in Skeletal muscle and is Upregulated in Response to Skeletal muscle atrophy
  2358. DHA-supplementation prior to fasting prevents muscle atrophy in mice
  2359. Evidence of Increased muscle atrophy and Impaired Quality of Life Parameters in Patients with Uremic Restless Legs Syndrome
  2360. The Molecular Mechanism of Bcl‐3 Co‐transactivation in Skeletal muscle atrophy
  2361. The preventive effect of β-carotene on denervation-induced soleus muscle atrophy in mice
  2362. Sarcolipin Deletion Exaggerates muscle atrophy and Weakness Induced by Phospholamban Overexpression
  2363. Cytokine-induced skeletal muscle atrophy: protective effect of resveratrol
  2364. Kynurenine, a tryptophan metabolite that increases with age, induces skeletal muscle atrophy and reactive oxygen species.
  2365. The impact of bed rest versus leg immobilization on muscle disuse atrophy
  2366. Heat treatment inhibits skeletal muscle atrophy of glucocorticoid-induced myopathy in
  2367. The effect of melatonin treatment on doxorubicin-induced skeletal muscle atrophy within a cancer model
  2368. Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta-glucocorticoid receptor signaling axis
  2369. C107 NEW INTERVENTIONS AND OUTCOMES IN PULMONARY REHABILITATION: Involvement Of Saa1 In Limb muscle atrophy Associated With Stable COPD And …
  2370. Transcriptional Activation of Zing Finger Protein 593 (Zfp593) During Neurogenic Skeletal muscle atrophy
  2371. Heat treatment inhibits skeletal muscle atrophy of glucocorticoid-induced myopathy in rats
  2372. … of an artificial nerve repair construct and nerve grafting when used in combination with intramuscular injections of stem cells for reduction of muscle atrophy
  2373. PO-109 Resistance Training prevents Skeletal muscle atrophy Induced by hypoxia through regulating Akt-FoxO1 pathway
  2374. 11 [beta] HSD1 mediates therapeutic glucocorticoid-induced muscle atrophy in chronic inflammatory disease
  2375. Chronic Inflammatory Demyelinating Polyneuropathy: muscle atrophy Associated with Denervation and Neuromuscular Transmission Instability
  2376. Shenshuai Yingyang Capsule Ameliorates muscle atrophy in Rats With Chronic Renal Failure: Role of Wnt7a-Akt/mTOR Signal Pathway
  2377. Large/Massive Tears, Fatty Infiltration, and Rotator Cuff muscle atrophy: A Review Article With Management Options Specific to These Types of Cuff Deficiencies
  2378. Quadratus femoris muscle atrophy in ischio-femoral impingement-an often overlooked cause of unexplained and refractory hip pain
  2379. TACSM Abstract Mediation of the Translocation of nNOSμ During Unloading-Induced atrophy of Skeletal muscle via NOX2 Inhibition
  2380. Comparing atrophy‐Inducing Signals on ER Stress in C1 C1 2 muscle Cells
  2381. K (Lysine) Acetyltransferase 6B (Kat6B) is Upregulated during Neurogenic Skeletal muscle atrophy and is Differentially Expressed in MuRF1‐null Mice
  2382. EXENDIN-4 ATTENUATES DEXAMETHASONE-INDUCED muscle atrophy THROUGH REGULATING atrophy-RELATED GENES EXPRESSION
  2383. AMP Deaminase 3 in Skeletal muscle atrophy: Regulation of Protein Degradation and Contractile Performance
  2384. Mediation of the Translocation of nNOSμ During Unloading-Induced atrophy of Skeletal muscle via NOX2 Inhibition
  2385. The evolution of the denervated gastrocnemii and it’s miR-206 and myoD expression during skeletal muscle atrophy in rats
  2386. B109 HIGHLIGHTS AND ADVANCES IN PULMONARY REHABILITATION: Skeletal muscle atrophy Occurs Early And Rapidly In The First 5 Days After Emergency …
  2387. Overexpression of NF90-NF45 represses myogenic microRNA biogenesis, developing skeletal muscle atrophy and centronuclear muscle fibers
  2388. … OF PASSIVE MOVEMENT ON EXPRESSION OF miRNA-1 AND DIFFERENTIATION OF MYOBLASTS IN DENERVATION-INDUCED SKELETAL muscle atrophy …
  2389. LUMBAR PARASPINAL muscle atrophy AND FATTY INFILTRATION FOLLOWING BOTULINUM TOXIN INJECTIONS IN A RABBIT MODEL: P133
  2390. Polyglucosan bodies in intramuscular nerves: Association with muscle fiber denervation atrophy
  2391. The Role of the Wedge Vertebra, Short Vertebral Body, Multifidus muscle atrophy in Isthmic Spondylolisthesis; an MRI Study
  2392. Beta-hydroxy-beta-methylbutyrate supplementation prevents muscle atrophy and aerobic fitness decrease induced by hindlimb suspension in mice
  2393. PROGRESSION OF LUMBAR PARASPINAL muscle atrophy FOLLOWING BILATERAL BOTULINUM TOXIN INJECTIONS IN A RABBIT MODEL: GP122
  2394. Influence of Autophagy to muscle Cells form Metrology in the Process of Denervated muscles atrophy Treated by Electric Acupuncture in Rats
  2395. Role of transglutaminase 2 in acute colitis and skeletal muscle atrophy
  2396. TACSM Abstract Treatment with EUK-134 Enhance Anabolic Akt/mTOR/p70S6kinase Pathways, Protecting Against muscle atrophy in the Rat Soleus in a 7 Day …
  2397. Trimetazidine counteracts stress-induced atrophy in C2C12 myotubes and improves muscle function in mice bearing the C26 tumor and in aged mice
  2398. Treatment with EUK-134 Enhance Anabolic Akt/mTOR/p70S6kinase Pathways, Protecting Against muscle atrophy in the Rat Soleus in a 7 Day Hindlimb Unloading
  2399. Reply to” Can We Avoid Rectus Abdominis muscle atrophy and Midline Shift After Colostomy Creation?”
  2400. Deletion of NAD (P) H Oxidase 2 Attenuates Angiotensin II-induced Skeletal muscle atrophy
  2401. Congenital myopathy with selective muscle atrophy, necklace-like fibres/central cores and craniosynostosis associated with recessive mutations in SCN4A
  2402. N-myristoylated ubiquitin ligase Cbl-b inhibitor prevents on glucocorticoid-induced atrophy in mouse skeletal muscle
  2403. Neurogenic atrophy‐Induced Nicotinic Acetylcholine Receptor ε to γ Subunit Switching is Impaired in muscle RING Finger 1 (MuRF1) Null Mice
  2404. Chronic treatment with the AMPA agonist AICAR prevents skeletal muscle pathology but fails to improve clinical outcome in a mouse model of severe spinal muscular …
  2405. Characterizing the Role of muscle‐Specific RING Finger 1 (MuRF1) as a Regulator of atrophy‐Induced Gene Expression
  2406. Type-specific selectivity pattern of skeletal muscle images in spinal muscular atrophy
  2407. Genetic and Pharmacologic Inhibition of Cellular Inhibitor of Apoptosis 1 (cIAP1) Protein Expression Protects Against Denervation-Induced Skeletal muscle atrophy In …
  2408. Metabolic suppression by 3-iodothyronamine induced muscle cell atrophy via activation of FoxO-proteasome signaling and downregulation of Akt1-S6K signaling
  2409. Reverse Split Hand Syndrome: Dissociated Intrinsic Hand muscle atrophy Pattern in Monomelic Amyotrophy Spectrum Disorder (P4. 100)
  2410. The Role of muscle and Nerve in Spinal Muscular atrophy
  2411. Role of muscle satellite cells in Spinal muscular atrophy physiopathology
  2412. muscle‐Specific RING Finger 1 (MuRF1) Dependent Activation of Dual‐specificity Phosphatase 4 (Dusp4) Under Neurogenic atrophy Conditions
  2413. Interventional strategies to combat muscle disuse atrophy
  2414. Electric acupuncture intervention on the effects of disuse muscular atrophy muscle fiber types of mice
  2415. Interventional strategies to combat muscle disuse atrophy
  2416. Muscular hypertrophy and atrophy in normal rats provoked by the administration of normal and denervated muscle extracts.
  2417. Biceps muscle fatty infiltration and atrophy. A midterm review after arthroscopic tenotomy of the long head of the biceps
  2418. Role of Ca2+ signaling in skeletal muscle hypertrophy and atrophy
  2419. Gene regulation in skeletal muscle function; exercise and atrophy
  2420. Characterizing the Role of HuR in Skeletal muscle of Mice with Spinal Muscular atrophy
  2421. Role of ecdysteroids on Myostatin and mTOR signaling gene expression in molt-dependent growth and atrophy of skeletal muscle in Gecarcinus lateralis and …
  2422. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P. 79The relationship between function and muscle strength in the upper limb in a cohort of …
  2423. Effects of static interventions on disuse atrophy of the rat soleus muscle at different sites along its longitudinal axis.
  2424. Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle
  2425. Proximal Neuropathy and Associated Skeletal muscle Changes Resembling Denervation atrophy in Hindlimbs of Chronic Hypoglycaemic Rats
  2426. Functional Roles of β2-Adrenergic Receptors in Skeletal muscle Hypertrophy and atrophy
  2427. Effect of Local Cooling and Blood Flow Restriction on muscle Weakness and atrophy Caused by Detraining
  2428. The role of exercise and amino acid supplementation in disuse-induced muscle and tendon atrophy and subsequent active recovery
  2429. Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy
  2430. Analogs of Microgravity: Space Research without Leaving the Planet: Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of …
  2431. Novel applications of flow cytometry to assess whole murine skeletal muscle and myonuclei number responses to atrophy and recovery.
  2432. In Mouse Model, Researchers Use Optogenetics to Control muscle Contraction and Prevent atrophy of Paralyzed muscle: Potential Use for Neuromuscular Disorders
  2433. Mechanisms underlying inhibition of muscle disuse atrophy during aestivation in the green-striped burrowing frog, Cyclorana alboguttata
  2434. Profound hypotonia, muscle weakness, global developmental delays with stepwise regression, and cerebellar atrophy: expansion of the LONP1-related disease …
  2435. A55 RECENT DEVELOPMENTS IN PULMONARY REHABILITATION: BROADENING THE SCOPE: Persistent Skeletal muscle Weakness And atrophy After Lung …
  2436. The role of muscle-derived neurotrophic factors in spinal bulbar muscular atrophy
  2437. Tribbles 3 Regulates Skeletal muscle Mass in Fasting‐induced atrophy
  2438. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
  2439. Skeletal muscle atrophy: discovery of mechanisms and potential therapies
  2440. muscle atrophy in critically ill patients: a review of its cause, evaluation, and prevention
  2441. Mitochondrial dysregulation and muscle disuse atrophy
  2442. Polyphenols and their potential role in preventing skeletal muscle atrophy
  2443. NeuroHeal reduces muscle atrophy and modulates associated autophagy
  2444. Edward F. Adolph Distinguished Lecture. Skeletal muscle atrophy: Multiple pathways leading to a common outcome
  2445. Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: A review of the causes and effects
  2446. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes
  2447. FoxO transcription factors are critical regulators of diabetes-related muscle atrophy
  2448. LncIRS1 controls muscle atrophy via sponging miR‐15 family to activate IGF1‐PI3K/AKT pathway
  2449. Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
  2450. Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis
  2451. DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy
  2452. Aging-and obesity-related peri-muscular adipose tissue accelerates muscle atrophy
  2453. Promotion of oxidative stress is associated with mitochondrial dysfunction and muscle atrophy in aging mice
  2454. Emerging molecular mediators and targets for age-related skeletal muscle atrophy
  2455. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model
  2456. Loss of mitochondrial energetics is associated with poor recovery of muscle function but not mass following disuse atrophy
  2457. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy
  2458. muscle atrophy and the sestrins
  2459. Redox control of proteolysis during inactivity-induced skeletal muscle atrophy
  2460. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
  2461. One week of hospitalization following elective hip surgery induces substantial muscle atrophy in older patients
  2462. Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
  2463. muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice
  2464. Microarray analysis of gene expression provides new insights into denervation-induced skeletal muscle atrophy
  2465. Cellular and molecular features of neurogenic skeletal muscle atrophy
  2466. Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness
  2467. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis
  2468. Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
  2469. Low levels of serum tryptophan underlie skeletal muscle atrophy
  2470. Musclin, a myokine induced by aerobic exercise, retards muscle atrophy during cancer cachexia in mice
  2471. Identification and Characterization of Fbxl22, a novel skeletal muscle atrophy-promoting E3 ubiquitin ligase
  2472. Molecular mechanisms responsible for the rescue effects of pamidronate on muscle atrophy in pediatric burn patients
  2473. CRISPR/Cas9-mediated miR-29b editing as a treatment of different types of muscle atrophy in mice
  2474. MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease
  2475. Increased adenine nucleotide degradation in skeletal muscle atrophy
  2476. Vitamin D deficiency is associated with muscle atrophy and reduced mitochondrial function in patients with chronic low back pain
  2477. Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space
  2478. Development of an automatic muscle atrophy measuring algorithm to calculate the ratio of supraspinatus in supraspinous fossa using deep learning
  2479. Massage as a mechanotherapy promotes skeletal muscle protein and ribosomal turnover but does not mitigate muscle atrophy during disuse in adult rats
  2480. Preventive effects of low‐intensity exercise on cancer cachexia–induced muscle atrophy
  2481. Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model of sarcopenia
  2482. Nutritional strategies to offset disuse-induced skeletal muscle atrophy and anabolic resistance in older adults: From whole-foods to isolated ingredients
  2483. Ultralight conductive and elastic aerogel for skeletal muscle atrophy regeneration
  2484. Skeletal muscle atrophy was alleviated by salidroside through suppressing oxidative stress and inflammation during denervation
  2485. … diet based on olive tree phenolic compounds from two different geographical areas have protective effects on early osteoarthritis, muscle atrophy and hepatic steatosis
  2486. Bedside ultrasonography can and should be used in the intensive care unit to evaluate muscle atrophy
  2487. Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration
  2488. Neutralizing mitochondrial ROS does not rescue muscle atrophy induced by hindlimb unloading in female mice
  2489. Diagnosing muscle atrophy by use of a comprehensive method of assessing the elastic properties of muscle during passive stretching
  2490. Skeletal muscle disuse atrophy and the rehabilitative role of protein in recovery from musculoskeletal injury
  2491. Development of muscle atrophy and loss of function in a Gulf-War illness model: underlying mechanisms
  2492. Master Regulators of muscle atrophy: Role of Costamere Components
  2493. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
  2494. Inducible Rpt3, a proteasome component, knockout in adult skeletal muscle results in muscle atrophy
  2495. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
  2496. Glabridin inhibits dexamethasone-induced muscle atrophy
  2497. MyomirDB: A unified database and server platform for muscle atrophy myomiRs, coregulatory networks and regulons
  2498. The role of calpains in skeletal muscle remodeling with exercise and inactivity-induced atrophy
  2499. Transcriptional changes in muscle of hibernating arctic ground squirrels (Urocitellus parryii): implications for attenuation of disuse muscle atrophy
  2500. Isoquercitrin Delays Denervated Soleus muscle atrophy by Inhibiting Oxidative Stress and Inflammation
  2501. Impaired autophagic flux contributes to muscle atrophy in obesity by affecting muscle degradation and regeneration
  2502. Role of calpains in promoting desmin filaments depolymerization and muscle atrophy
  2503. Loss of melusin is a novel, neuronal NO synthase/FoxO3‐independent master switch of unloading‐induced muscle atrophy
  2504. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy
  2505. Protective effects of ghrelin on fasting-induced muscle atrophy in aging mice
  2506. Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice
  2507. Depletion of HuR in murine skeletal muscle enhances exercise endurance and prevents cancer-induced muscle atrophy
  2508. CACNA1H downregulation induces skeletal muscle atrophy involving endoplasmic reticulum stress activation and autophagy flux blockade
  2509. Profiles Combining muscle atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
  2510. The mechanisms of skeletal muscle atrophy in response to transient knockdown of the vitamin D receptor in vivo
  2511. Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor
  2512. TNF Receptor‐Associated Factor 6 Mediates TNFα‐Induced Skeletal muscle atrophy in Mice During Aging
  2513. Salidroside attenuates denervation-induced skeletal muscle atrophy through negative regulation of pro-inflammatory cytokine
  2514. Kynurenine, a tryptophan metabolite that increases with age, induces muscle atrophy and lipid peroxidation
  2515. Intramuscular brown fat activation decreases muscle atrophy and fatty infiltration and improves gait after delayed rotator cuff repair in mice
  2516. Neuromuscular electrical stimulation as a potential countermeasure for skeletal muscle atrophy and weakness during human spaceflight
  2517. Dexamethasone exacerbates cisplatin‐induced muscle atrophy
  2518. Drp1 knockdown induces severe muscle atrophy and remodelling, mitochondrial dysfunction, autophagy impairment and denervation
  2519. Comparative plasma proteomics in muscle atrophy during cancer‐cachexia and disuse: The search for atrokines
  2520. The body region specificity in murine models of muscle regeneration and atrophy
  2521. The redox environment and mitochondrial dysfunction in age-related skeletal muscle atrophy
  2522. Effect of electrical stimulation on muscle atrophy and spasticity in patients with spinal cord injury–a systematic review with meta-analysis
  2523. Isobavachalcone attenuates myotube atrophy induced by TNF‐α through muscle atrophy F‐box signaling and the nuclear factor erythroid 2‐related factor 2 cascade
  2524. Giving combined medium‐chain fatty acids and glucose protects against cancer‐associated skeletal muscle atrophy
  2525. 4‐Aminopyridine attenuates muscle atrophy after sciatic nerve crush injury in mice
  2526. Trichostatin A inhibits skeletal muscle atrophy induced by cigarette smoke exposure in mice
  2527. Upregulation of ubiquitinated proteins and their degradation pathway in muscle atrophy induced by cisplatin in mice
  2528. Z-ajoene from crushed garlic alleviates cancer-induced skeletal muscle atrophy
  2529. Tinospora cordifolia protects from skeletal muscle atrophy by alleviating oxidative stress and inflammation induced by sciatic denervation
  2530. Food deprivation during active phase induces skeletal muscle atrophy via IGF-1 reduction in mice
  2531. Perlecan Facilitates Neuronal Nitric Oxide Synthase Delocalization in Denervation-Induced muscle atrophy
  2532. Nicotinamide protects against skeletal muscle atrophy in streptozotocin-induced diabetic mice
  2533. Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse
  2534. High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death
  2535. Two Weeks of Smoking Cessation Reverse Cigarette Smoke-Induced Skeletal muscle atrophy and Mitochondrial Dysfunction in Mice
  2536. Corticotropin releasing factor-overexpressing mouse is a model of chronic stress-induced muscle atrophy
  2537. Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy
  2538. Urinary titin is a novel biomarker for muscle atrophy in nonsurgical critically ill patients: a two-center, prospective observational study
  2539. Changes in tendon elongation and muscle atrophy over time after Achilles tendon rupture repair: a prospective cohort study on the effects of early functional …
  2540. Characterising the efficacy and bioavailability of bioactive peptides identified for attenuating muscle atrophy within a Vicia faba-derived functional ingredient
  2541. Fam83d modulates MAP kinase and AKT signaling and is induced during neurogenic skeletal muscle atrophy
  2542. PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways
  2543. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα
  2544. Beneficial effects of metformin on muscle atrophy induced by obesity in rats
  2545. Nerve damage induced skeletal muscle atrophy is associated with increased accumulation of intramuscular glucose and polyol pathway intermediates
  2546. Promotion of myotube differentiation and attenuation of muscle atrophy in murine C2C12 myoblast cells treated with teaghrelin
  2547. Vitamin C deficiency causes muscle atrophy and a deterioration in physical performance
  2548. Hydrogen sulphide ameliorating skeletal muscle atrophy in db/db mice via muscle RING finger 1 S‐sulfhydration
  2549. Vitamin D protects against immobilization-induced muscle atrophy via neural crest-derived cells in mice
  2550. High altitude mediated skeletal muscle atrophy: protective role of curcumin
  2551. Supplementation with fermented rice bran attenuates muscle atrophy in a diabetic rat model
  2552. Effect of oral branched-chain amino acids and glutamine supplementation on skeletal muscle atrophy after total gastrectomy in rat model
  2553. CKD autophagy activation and skeletal muscle atrophy—a preliminary study of mitophagy and inflammation
  2554. muscle atrophy induced by overexpression of ALAS2 is related to muscle mitochondrial dysfunction
  2555. RANKL mediates muscle atrophy and dysfunction in a cigarette smoke-induced model of COPD
  2556. Resistance exercise with anti-inflammatory foods attenuates skeletal muscle atrophy induced by chronic inflammation
  2557. Effects of astaxanthin supplementation and electrical stimulation on muscle atrophy and decreased oxidative capacity in soleus muscle during hindlimb …
  2558. Case study: muscle atrophy, hypertrophy, and energy expenditure of a premier League soccer player during rehabilitation from anterior cruciate ligament injury
  2559. P38α-MAPK signaling inhibition attenuates soleus atrophy during early stages of muscle unloading
  2560. Antioxidant effect of human placenta hydrolysate against oxidative stress on muscle atrophy
  2561. A subset of microRNAs in the Dlk1‐Dio3 cluster regulates age‐associated muscle atrophy by targeting Atrogin‐1
  2562. Myostatin and muscle atrophy during chronic kidney disease
  2563. Counteracting muscle atrophy on Earth and in Space via Nanofluidics Delivery of Formoterol
  2564. Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ
  2565. The dependency of autophagy and ubiquitin proteasome system during skeletal muscle atrophy
  2566. Limiting deconditioned muscle atrophy and strength loss with appropriate nutrition: can it be done?
  2567. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and …
  2568. Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice
  2569. Modified expression of vitamin D receptor and CYP27B1 in denervation-induced muscle atrophy
  2570. Corylifol A from Psoralea corylifolia L. enhances myogenesis and alleviates muscle atrophy
  2571. Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies
  2572. muscle atrophy‐related myotube‐derived exosomal microRNA in neuronal dysfunction: Targeting both coding and long noncoding RNAs
  2573. Do not neglect the role of circadian rhythm in muscle atrophy
  2574. Ttc39c is upregulated during skeletal muscle atrophy and modulates ERK1/2 MAP kinase and hedgehog signaling
  2575. TRB3 regulates skeletal muscle mass in food deprivation–induced atrophy
  2576. MOTS-c reduces myostatin and muscle atrophy signaling
  2577. Sabinene Prevents Skeletal muscle atrophy by Inhibiting the MAPK–MuRF-1 Pathway in Rats
  2578. Preventive effects of dulaglutide on disuse muscle atrophy through inhibition of inflammation and apoptosis by induction of Hsp72 expression
  2579. miR-125b-5p targeting TRAF6 relieves skeletal muscle atrophy induced by fasting or denervation
  2580. Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis
  2581. Upper limb muscle atrophy associated with in-hospital mortality and physical function impairments in mechanically ventilated critically ill adults: a two-center …
  2582. Acteoside improves muscle atrophy and motor function by inducing new myokine secretion in chronic spinal cord injury
  2583. Mechanical loading of tissue engineered skeletal muscle prevents dexamethasone induced myotube atrophy
  2584. muscle atrophy After ACL Injury: Implications for Clinical Practice
  2585. Redox modification of ryanodine receptor contributes to impaired Ca2+ homeostasis and exacerbates muscle atrophy under high altitude
  2586. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy
  2587. Denervation‐induced muscle atrophy suppression in renalase‐deficient mice via increased protein synthesis
  2588. Cinnamaldehyde regulates H2O 2‐induced skeletal muscle atrophy by ameliorating the proteolytic and antioxidant defense systems
  2589. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis
  2590. Masseter muscle atrophy impairs bone quality of the mandibular condyle but not the alveolar process early after induction
  2591. Skeletal muscle atrophy in simulated microgravity might be triggered by immune-related microRNAs
  2592. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients
  2593. Longitudinal RNA-Seq analysis of acute and chronic neurogenic skeletal muscle atrophy
  2594. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma
  2595. Neuromuscular electrical stimulation in critically ill traumatic brain injury patients attenuates muscle atrophy, neurophysiological disorders, and weakness: a …
  2596. Single cell analysis reveals the involvement of the long non-coding RNA Pvt1 in the modulation of muscle atrophy and mitochondrial network
  2597. Oral L-glutamine pretreatment attenuates skeletal muscle atrophy induced by 24-h fasting in mice
  2598. Red bean extract inhibits immobilization-induced muscle atrophy in C57BL/6N mice
  2599. Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux
  2600. Atrogin1-induced loss of aquaporin 4 in myocytes leads to skeletal muscle atrophy
  2601. Glucocorticoid aggravates bone micro-architecture deterioration and skeletal muscle atrophy in mice fed on high-fat diet
  2602. Response of resistance exercise-induced muscle protein synthesis and skeletal muscle hypertrophy are not enhanced after disuse muscle atrophy in rat
  2603. A novel oleanolic acid derivative HA-19 ameliorates muscle atrophy via promoting protein synthesis and preventing protein degradation
  2604. Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy
  2605. Sulforaphane ameliorates serum starvation‐induced muscle atrophy via activation of the Nrf2 pathway in cultured C2C12 cells
  2606. … extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophy
  2607. Leucine attenuates muscle atrophy and autophagosome formation by activating PI3K/AKT/mTOR signaling pathway in rotator cuff tears
  2608. Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophy
  2609. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy
  2610. The influence of isoflavone for denervation-induced muscle atrophy
  2611. Adipose‐derived stem cells delay muscle atrophy after peripheral nerve injury in the rodent model
  2612. Type 2 diabetes causes skeletal muscle atrophy but does not impair resistance training‐mediated myonuclear accretion and muscle mass gain in rats
  2613. D-methionine ameliorates cisplatin-induced muscle atrophy via inhibition of muscle degradation pathway
  2614. Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
  2615. Protective effects of Liuwei dihuang water extracts on diabetic muscle atrophy
  2616. High-dose leucine supplementation does not prevent muscle atrophy or strength loss over 7 days of immobilization in healthy young males
  2617. Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes
  2618. A Chalcone from Ashitaba (Angelica keiskei) stimulates myoblast differentiation and inhibits dexamethasone-induced muscle atrophy
  2619. Effects of ursolic acid on muscle mass and bone microstructure in rats with casting-induced muscle atrophy
  2620. Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal muscle atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model
  2621. High-molecular-weight polyphenol-rich fraction of black tea does not prevent atrophy by unloading, but promotes soleus muscle mass recovery from atrophy in mice
  2622. Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling
  2623. Dual-specificity phosphatase 4 is upregulated during skeletal muscle atrophy and modulates extracellular signal-regulated kinase activity
  2624. 4-PBA prevents diabetic muscle atrophy in rats by modulating ER stress response and ubiquitin-proteasome system
  2625. Camphene Attenuates Skeletal muscle atrophy by Regulating Oxidative Stress and Lipid Metabolism in Rats
  2626. Differential effects of pre‐exercise on cancer cachexia‐induced muscle atrophy in fast‐and slow‐twitch muscles
  2627. Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy
  2628. Avenanthramides attenuate inflammation and atrophy in muscle cells
  2629. Juzentaihoto suppresses muscle atrophy in streptozotocin-induced diabetic mice
  2630. Urinary titin N-fragment as a biomarker of muscle atrophy, intensive care unit-acquired weakness, and possible application for post-intensive care syndrome
  2631. Panax ginseng Total Protein Facilitates Recovery from Dexamethasone-Induced muscle atrophy through the Activation of Glucose Consumption in C2C12 …
  2632. Whey protein supplementation with vibration exercise ameliorates lumbar paraspinal muscle atrophy in prolonged bed rest
  2633. Magnoflorine prevent the skeletal muscle atrophy via Akt/mTOR/FoxO signal pathway and increase slow-MyHC production in streptozotocin-induced diabetic rats
  2634. muscle metabolism and atrophy: let’s talk about sex
  2635. muscle atrophy and regeneration associated with behavioural loss and recovery of function after sciatic nerve crush
  2636. Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy
  2637. Progressive skeletal muscle atrophy in muscular dystrophies: a role for toll-like receptor-signaling in disease pathogenesis
  2638. 2020 Chitranjan S. Ranawat Award: Perioperative essential amino acid supplementation suppresses rectus femoris muscle atrophy and accelerates early functional …
  2639. Knee effusion evaluated by ultrasonography warns knee osteoarthritis patients to develop their muscle atrophy: a three-year cohort study
  2640. Current Studies and Future Directions of Exercise Therapy for muscle atrophy Induced by Heart Failure
  2641. muscle alterations in the development and progression of cancer-induced muscle atrophy: a review
  2642. Alternative splicing transitions associate with emerging atrophy phenotype during denervation‐induced skeletal muscle atrophy
  2643. Preclinical Evaluation of a Food-Derived Functional Ingredient to Address Skeletal muscle atrophy
  2644. Inhibition of lncRNA MAAT Controls Multiple Types of muscle atrophy by cis-and trans-Regulatory Actions
  2645. An oleanolic acid derivative reduces denervation-induced muscle atrophy via activation of CNTF-mediated JAK2/STAT3 signaling pathway
  2646. muscle atrophy marker expression differs between rotary cell culture system and animal studies
  2647. Comparative Analyses of mTOR/Akt and muscle atrophy-Related Signaling in Aged Respiratory and Gastrocnemius muscles
  2648. The Positive Impact of Vitamin D on Glucocorticoid-Dependent Skeletal muscle atrophy
  2649. Antioxidant Apigenin Relieves Age-Related muscle atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal muscle of Mice
  2650. Juzentaihoto hot water extract alleviates muscle atrophy and improves motor function in streptozotocin-induced diabetic oxidative stress mice
  2651. miR-23b-3p acts as a counter-response against skeletal muscle atrophy
  2652. Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the ‘split-leg’sign
  2653. Prevention of denervated muscle atrophy with accelerated nerve‐regeneration by babysitter procedure in rat facial nerve paralysis model
  2654. Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence
  2655. Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets
  2656. Knee muscle atrophy is a risk factor for development of knee osteoarthritis in a rat model
  2657. The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
  2658. S-allyl cysteine: A potential compound against skeletal muscle atrophy
  2659. Long noncoding RNA SMUL suppresses SMURF2 production-mediated muscle atrophy via nonsense-mediated mRNA decay
  2660. Superoxide-mediated oxidative stress accelerates skeletal muscle atrophy by synchronous activation of proteolytic systems
  2661. Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension
  2662. Glenoid retroversion associates with asymmetric rotator cuff muscle atrophy in those with Walch B-type Glenohumeral osteoarthritis
  2663. Oleamide rescues tibialis anterior muscle atrophy of mice housed in small cages
  2664. Heparin-Mimicking Polymer-Based In Vitro Platform Recapitulates In Vivo muscle atrophy Phenotypes
  2665. Congenital exercise ability ameliorates muscle atrophy but not spinal cord recovery in spinal cord injury mouse model
  2666. Single, high‐dose local injection of bFGF improves thyroarytenoid muscle atrophy after paralysis
  2667. ESB Clinical Biomechanics Award 2018: muscle atrophy-related increased joint loading after total hip arthroplasty and their postoperative change from 3 to 50 months
  2668. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation
  2669. Preventive Effects of Schisandrin A, A Bioactive Component of Schisandra chinensis, on Dexamethasone-Induced muscle atrophy
  2670. Triptolide prevents lipopolysaccharide‐induced skeletal muscle atrophy via inhibiting NF‐κB/TNF‐α and regulating protein synthesis/degradation pathway
  2671. Long-term physical inactivity exacerbates hindlimb unloading-induced muscle atrophy in young rat soleus muscle
  2672. Exogenous miR-29a attenuates muscle atrophy and kidney fibrosis in unilateral ureteral obstruction mice
  2673. An analysis of differentially expressed coding and long non-coding rnas in multiple models of skeletal muscle atrophy
  2674. Chrysanthemum zawadskil Herbich attenuates dexamethasone-induced muscle atrophy through the regulation of proteostasis and mitochondrial function
  2675. Obesity Augments Glucocorticoid-Dependent muscle atrophy in Male C57BL/6J Mice
  2676. Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
  2677. The implications of paraspinal muscle atrophy in low back pain, thoracolumbar pathology, and clinical outcomes after spine surgery: a review of the literature
  2678. Ketogenic diet induces skeletal muscle atrophy via reducing muscle protein synthesis and possibly activating proteolysis in mice
  2679. Limited oxidative stress favors resistance to skeletal muscle atrophy in hibernating brown bears (Ursus arctos)
  2680. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal muscle atrophy: Published as part of the Biochemistry series “ …
  2681. IL-8 Released from human pancreatic cancer and tumor-associated stromal cells signals through a CXCR2-ERK1/2 axis to induce muscle atrophy
  2682. Carboxyl-terminal modulator protein regulates Akt signaling during skeletal muscle atrophy in vitro and a mouse model of amyotrophic lateral sclerosis
  2683. Flavonoids: nutraceutical potential for counteracting muscle atrophy
  2684. Regulation of Skeletal muscle atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs
  2685. Role of Sphingosine 1-Phosphate Signalling Axis in muscle atrophy Induced by TNFα in C2C12 Myotubes
  2686. Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal muscle atrophy
  2687. Characteristics of Early Internal Laryngeal muscle atrophy After Recurrent Laryngeal Nerve Injurie s in Rats
  2688. muscle disuse atrophy caused by discord of intracellular signaling
  2689. Molecular mechanisms of cancer cachexia‑induced muscle atrophy
  2690. Clinical findings and outcome of dogs with unilateral masticatory muscle atrophy
  2691. Temporal muscle-specific disuse atrophy during one week of leg immobilization
  2692. Prognostic value of the posterior cricoarytenoid muscle atrophy in computerized tomography scans for unilateral vocal fold paralysis recovery
  2693. Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal muscle atrophy
  2694. Weight-bearing exercise prevents skeletal muscle atrophy in ovariectomized rats
  2695. Exercise preconditioning attenuates hind limb unloading-induced gastrocnemius muscle atrophy possibly via the HDAC4/Gadd45 axis in old rats
  2696. ALDH2 mutation promotes skeletal muscle atrophy in mice via accumulation of oxidative stress
  2697. muscle‐specific changes in protein synthesis with aging and reloading after disuse atrophy
  2698. KLF5 regulates chicken skeletal muscle atrophy via the canonical Wnt/β-catenin signaling pathway
  2699. Experimental Model of HindLimb Suspension-Induced Skeletal muscle atrophy in Rodents
  2700. FGF19 protects skeletal muscle against obesity‐induced muscle atrophy, metabolic derangement and abnormal irisin levels via the AMPK/SIRT‐1/PGC‐α pathway
  2701. Urotensin II Induces Mice Skeletal muscle atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) …
  2702. Dioscorea nipponica extracts enhance recovery from skeletal muscle atrophy by suppressing NF-κB expression
  2703. Serum extracellular vesicle miR-203a-3p content is associated with skeletal muscle mass and protein turnover during disuse atrophy and regrowth
  2704. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia …
  2705. Non-uniform loss of muscle strength and atrophy during bed rest: a systematic review
  2706. Ficus carica L. Attenuates Denervated Skeletal muscle atrophy via PPARα/NF-κB Pathway
  2707. Autophagy-lysosomal signaling responses to heat stress in tenotomy-induced rat skeletal muscle atrophy
  2708. Role of astaxanthin supplementation in prevention of disuse muscle atrophy: a review
  2709. The Treatment of muscle atrophy After Rotator Cuff Tears Using Electroconductive Nanofibrous Matrices
  2710. muscle contractility in spinobulbar muscular atrophy
  2711. Hip muscle atrophy in patients with acetabular labral joint pathology
  2712. Thyroid Hormone Protects from Fasting-Induced Skeletal muscle atrophy by Promoting Metabolic Adaptation
  2713. ISLR regulates skeletal muscle atrophy via IGF1-PI3K/Akt-Foxo signaling pathway
  2714. Case report: exome sequencing achieved a definite diagnosis in a Chinese family with muscle atrophy
  2715. Soluble Whey Protein Hydrolysate Ameliorates muscle atrophy Induced by Immobilization via Regulating the PI3K/Akt Pathway in C57BL/6 Mice
  2716. Involvement of receptor for advanced glycation end products in microgravity-induced skeletal muscle atrophy in mice
  2717. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα
  2718. β-Cryptoxanthin Improves p62 Accumulation and muscle atrophy in the Soleus muscle of Senescence-Accelerated Mouse-Prone 1 Mice
  2719. Repeated stretch–shortening contraction of the triceps surae attenuates muscle atrophy and liver dysfunction in a rat model of inflammation
  2720. … REVIEW OF THE EFFECTS OF BLOOD FLOW RESTRICTION TRAINING ON QUADRICEPS muscle atrophy AND CIRCUMFERENCE POST ACL …
  2721. The Effect of Total Hip Arthroplasty Surgical Technique on Postoperative muscle atrophy
  2722. The role of nutrition in attenuating age-related skeletal muscle atrophy
  2723. TFAM overexpression diminishes skeletal muscle atrophy after hindlimb suspension in mice
  2724. Disturbances in Calcium Homeostasis Promotes Skeletal muscle atrophy: Lessons From Ventilator-Induced Diaphragm Wasting
  2725. Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue
  2726. Omega‐3 multiple effects increasing glucocorticoid‐induced muscle atrophy: autophagic, AMPK and UPS mechanisms
  2727. Quantitative analysis of paraspinal muscle atrophy after oblique lateral interbody fusion alone vs. combined with percutaneous pedicle screw fixation in …
  2728. PHD3 mediates denervation skeletal muscle atrophy through Nf‐κB signal pathway
  2729. Insulin modulates myogenesis and muscle atrophy resulting from skin scald burn in young male rats
  2730. Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast muscle atrophy and …
  2731. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
  2732. Dual-specificity phosphatase 29 is induced during neurogenic skeletal muscle atrophy and attenuates glucocorticoid receptor activity in muscle cell culture
  2733. Ubiquitin Ligases at the Heart of Skeletal muscle atrophy Control
  2734. Visual Observation of Apparent Infraspinatus muscle atrophy in Male Professional Tennis Players
  2735. Computed tomography evidence of psoas muscle atrophy without concomitant tendon wasting in early sepsis
  2736. High phosphate induces skeletal muscle atrophy and suppresses myogenic differentiation by increasing oxidative stress and activating Nrf2 signaling
  2737. Nox2 Inhibition Regulates Stress Response and Mitigates Skeletal muscle Fiber atrophy during Simulated Microgravity
  2738. Exercise and muscle atrophy
  2739. Endogenous muscle atrophy F-box is involved in the development of cardiac rupture after myocardial infarction
  2740. Angiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal muscle atrophy
  2741. A novel amino acid composition ameliorates short-term muscle disuse atrophy in healthy young men
  2742. Dynapenia and sarcopenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?
  2743. Zinc finger protein 593 is upregulated during skeletal muscle atrophy and modulates muscle cell differentiation
  2744. Age-dependent skeletal muscle transcriptome response to bed rest-induced atrophy
  2745. Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle–specific ubiquitin ligase MuRF1
  2746. Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization
  2747. Neuromuscular electrical stimulation improves muscle atrophy induced by chronic hypoxia-hypercapnia through the MicroRNA-486/PTEN/FoxO1 pathway
  2748. Protective effects of acute exercise preconditioning on disuse-induced muscular atrophy in aged muscle: a narrative literature review
  2749. Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK/SKP2/CARM1 signalling pathway
  2750. … synthase and the PTEN-induced kinase 1 (PINK1)/Parkin pathway for mitochondrial protein degradation in disuse-induced soleus muscle atrophy in adult rats
  2751. Correlation between multifidus muscle atrophy, spinopelvic parameters, and severity of deformity in patients with adult degenerative scoliosis: the …
  2752. Skeletal muscle aging atrophy: assessment and exercise-based treatment
  2753. Astaxanthin Prevents atrophy in Slow muscle Fibers by Inhibiting Mitochondrial Reactive Oxygen Species via a Mitochondria-Mediated Apoptosis Pathway
  2754. Restoration of Sarcoplasmic Reticulum Ca2+ ATPase (SERCA) Activity Prevents Age-Related muscle atrophy and Weakness in Mice
  2755. MicroRNA 322 Aggravates Dexamethasone-Induced muscle atrophy by Targeting IGF1R and INSR
  2756. Linalool Prevents Cisplatin Induced muscle atrophy by Regulating IGF-1/Akt/FoxO Pathway
  2757. Down‐regulation of the mitochondrial i‐AAA protease Yme1L induces muscle atrophy via FoxO3a and myostatin activation
  2758. Testosterone suppression does not exacerbate disuse atrophy and impairs muscle recovery that is not rescued by high protein
  2759. Iliopsoas Release in Hip Arthroscopy: Assessment of muscle atrophy
  2760. Cachexia, a Systemic Disease beyond muscle atrophy
  2761. Spinal muscle atrophy
  2762. Sagittal imbalance, muscle atrophy, and osteoporosis: risk factors for revision posterior lumbar fusion surgery in patients with Parkinson’s disease
  2763. Three-dimensional quantitative measurements of atrophy and fat infiltration in sub-regions of the supraspinatus muscle show heterogeneous distributions: a cadaveric …
  2764. Salidroside mitigates skeletal muscle atrophy in rats with cigarette smoke-induced COPD by up-regulating myogenin and down-regulating myostatin …
  2765. Theaflavins decrease skeletal muscle wasting in disuse atrophy induced by hindlimb suspension in mice
  2766. RNA sequencing (RNA-seq) analysis of gene expression provides new insights into hindlimb unloading-induced skeletal muscle atrophy
  2767. Overexpression of Dnmt3a ameliorates diabetic muscle atrophy by modulating the Pten/Akt pathway
  2768. Effect of muscle atrophy and fatty infiltration on mid-term clinical, and functional outcomes after Achilles tendon repair
  2769. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy
  2770. Early biomarkers of muscle atrophy and of neuromuscular alterations during 10‐day bed rest
  2771. Formononetin ameliorates muscle atrophy by regulating myostatin‐mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease
  2772. Preoperative paraspinal and psoas major muscle atrophy and paraspinal muscle fatty degeneration as factors influencing the results of surgical treatment of lumbar …
  2773. Early Initiation of Awake Veno-Venous Extracorporeal Membrane Oxygenation Can Attenuate muscle atrophy and Weakness in Acute Respiratory Distress …
  2774. Dysregulation of 1-carbon metabolism and muscle atrophy: potential roles of forkhead box O proteins and PPARγ co-activator-1α
  2775. Lactobacillus curvatus CP2998 Prevents Dexamethasone-Induced muscle atrophy in C2C12 Myotubes
  2776. muscle-specific SMN reduction reveals motor neuron–independent disease in spinal muscular atrophy models
  2777. Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy
  2778. Denervated muscle extract promotes recovery of muscle atrophy through activation of satellite cells. An experimental study
  2779. Obligatory role of Schwann cell‐specific erythropoietin receptors in erythropoietin‐induced functional recovery and neurogenic muscle atrophy after nerve injury
  2780. The MRL/MpJ mouse strain is not protected from muscle atrophy and weakness after rotator cuff tear
  2781. Impaired Limb Functional Outcome of Peripheral Nerve Regeneration Is Marked by Incomplete Recovery of Paw muscle atrophy and Brain Functional …
  2782. Reduction of stearoyl-CoA desaturase (SCD) contributes muscle atrophy through the excess endoplasmic reticulum stress in chronic kidney disease
  2783. Metformin ameliorates skeletal muscle atrophy in Grx1 KO mice by regulating intramuscular lipid accumulation and glucose utilization
  2784. Drugs for the Treatment of muscle atrophy
  2785. muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
  2786. Juzentaihoto Suppresses muscle atrophy and Decreased Motor Function in SAMP8 Mice
  2787. Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy
  2788. Oral Administration of Geranylgeraniol Rescues Denervation-induced muscle atrophy via Suppression of Atrogin-1
  2789. Early Postoperative Role of Blood Flow Restriction Therapy to Avoid muscle atrophy
  2790. Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?
  2791. Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
  2792. Massage during muscle unloading increases protein turnover in the massaged and non‐massaged, contralateral limb, but does not attenuate muscle atrophy
  2793. Quantitative Evaluation of Hip muscle atrophy in Patients with Unilateral Slipped Capital Femoral Epiphysis Based on Magnetic Resonance Imaging
  2794. Association of abductor hip muscle atrophy with fall-related proximal femur fractures in the elderly
  2795. Editorial Commentary: Do Patients With Femoroacetabular Impingement Syndrome Already Show Hip muscle atrophy?
  2796. Nutritional Approaches for Attenuating muscle atrophy
  2797. Mitochondria Dysfunction in Aging and Metabolic Diseases: Loss of mitochondrial energetics is associated with poor recovery of muscle function but not mass …
  2798. muscle Phenotype, proteolysis, and atrophy signaling during reloading in mice: Effects of curcumin on the gastrocnemius
  2799. Rotator Cuff Fatty Infiltration and muscle atrophy Do Not Impact Clinical Outcomes After Reverse Total Shoulder Arthroplasty for Glenohumeral Osteoarthritis with …
  2800. Luteolin attenuates dexamethasone-induced skeletal muscle atrophy in male albino rats
  2801. muscle‐specific sirtuin1 gain‐of‐function ameliorates skeletal muscle atrophy in a pre‐clinical mouse model of cerebral ischemic stroke
  2802. A Diet Including Red Bell Pepper Juice and Soy Protein Suppress Physiological Markers of muscle atrophy in Mice
  2803. Paraspinal muscle atrophy after posterior lumbar surgery with and without pedicle screw fixation with the classic technique
  2804. Aspirin alleviates denervation-induced muscle atrophy via regulating the Sirt1/PGC-1α axis and STAT3 signaling
  2805. Therapeutic effect of massage on denervated skeletal muscle atrophy in rats and its mechanism
  2806. Psoas muscle atrophy following unilateral hip arthroplasty
  2807. TAKling GDF-15 and skeletal muscle atrophy in pulmonary hypertension: are we there yet?
  2808. Incidence of tensor fascia lata muscle atrophy after using the modified Watson-Jones anterolateral approach in total hip arthroplasty
  2809. Autophagic and proteasomal mediated removal of mutant androgen receptor in muscle models of spinal and bulbar muscular atrophy
  2810. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease
  2811. Proteomic and transcriptomic changes in hibernating grizzly bears reveal metabolic and signaling pathways that protect against muscle atrophy
  2812. Risk of Psoas muscle atrophy After Endovascular Aneurysm Repair Assessed by Cross-Sectional Psoas muscle Area
  2813. Cellular mechanism of immobilization-induced muscle atrophy: A mini review
  2814. Effect of ultrashort wave treatment on joint dysfunction and muscle atrophy in a rabbit model of extending knee joint contracture: Enhanced expression of myogenic …
  2815. Presbylarynx: Does Body muscle Mass Correlate With Vocal atrophy? A Prospective Case Control Study
  2816. The grade of preoperative subscapularis muscle atrophy as a prognostic factor for postoperative retears: A double-center retrospective series
  2817. Chrysanthemi Zawadskii var. Latilobum Attenuates Obesity-Induced Skeletal muscle atrophy via Regulation of PRMTs in Skeletal muscle of Mice
  2818. Fatty Infiltration and muscle atrophy. What It Means and What Happens After Repair?
  2819. Beta-lapachone attenuates immobilization-induced skeletal muscle atrophy in mice
  2820. Effect of exercise on muscle protein and mitochondrial function in mice model of skeletal muscle atrophy
  2821. High‐intensity interval training changes the expression of muscle RING‐finger protein‐1 and muscle atrophy F‐box proteins and proteins involved in the mechanistic …
  2822. Role of SIRT2 in regulating the dexamethasone-activated autophagy pathway in skeletal muscle atrophy
  2823. Smooth muscle atrophy and colon pathology in SMN deficient mice
  2824. Effect of dietary fish oil intake on ubiquitin ligase expression during muscle atrophy induced by sciatic nerve denervation in mice
  2825. Tensiomyography detects early hallmarks of bed-rest-induced atrophy before changes in muscle architecture
  2826. miR‐29c improves skeletal muscle mass and function throughout myocyte proliferation and differentiation and by repressing atrophy‐related genes
  2827. Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents
  2828. Identification of potential target genes associated with the reversion of androgen-dependent skeletal muscle atrophy
  2829. Effects of neuromuscular electrical stimulation on pulmonary alveola and cytokines in chronic obstructive pulmonary disease (COPD) and skeletal muscle atrophy …
  2830. Risks of muscle atrophy in Patients with Malignant Lymphoma after Autologous Stem Cell Transplantation
  2831. M1 macrophage infiltration exacerbate muscle/bone atrophy after peripheral nerve injury
  2832. Role of Exercise in Skeletal muscle atrophy: A Mechanistic Investigation
  2833. Wide Pulse Width Electroacupuncture Ameliorates Denervation-Induced Skeletal muscle atrophy in Rats via IGF-1/PI3K/Akt Pathway
  2834. Inorganic Arsenic Exposure Decreases muscle Mass and Enhances Denervation-Induced muscle atrophy in Mice
  2835. Exosomes of oral squamous cell carcinoma cells containing miR-181a-3p induce muscle cell atrophy and apoptosis by transmissible endoplasmic reticulum stress …
  2836. Physiological Basis of Low-frequency Electromyostimulation, a Promising Countermeasure against Sarcopenia and Hypogravity-induced muscle atrophy
  2837. Metabolomics Analyses of muscle atrophy Induced by Hind Limb Unloading
  2838. Therapeutic effect of psoralen on muscle atrophy induced by tumor necrosis factor-α
  2839. The ubiquitin–proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders
  2840. Evaluation of paravertebral muscle atrophy and fatty degeneration in patients with axial spondyloarthritis
  2841. Unilateral embolization of the internal iliac artery for endovascular aortic repair does not induce gluteal muscle atrophy
  2842. Combination of exercise training and resveratrol attenuates obese sarcopenia in skeletal muscle atrophy
  2843. Master Regulators of muscle atrophy: Role of Costamere Components. Cells 2021, 10, 61
  2844. SAT-736 Dissecting the Relative Role of Estrogen and Androgen in Fibrosis, Skeletal muscle atrophy, and Inguinal Hernia Formation
  2845. Severe atrophy of the Ipsilateral Psoas muscle Associated with Hip Osteoarthritis and Spinal Stenosis—A Case Report
  2846. Methodological considerations for and validation of the ultrasonographic determination of human skeletal muscle hypertrophy and atrophy
  2847. Pectoral muscle atrophy After Axillary Artery Cannulation for Aortic Arch Surgery
  2848. Inhibitory effects of curcuminoids on dexamethasone-induced muscle atrophy in differentiation of C2C12 cells
  2849. Time course changes in AQP4 expression patterns in progressive skeletal muscle atrophy during the early stage of denervation
  2850. AB0086 NEW METHOD TO ASSESS SKELETAL muscle atrophy IN COLLAGEN INDUCED ARTHRITIS (CIA) MODEL
  2851. The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men
  2852. Water Extract of Lotus Leaf Alleviates Dexamethasone-Induced muscle atrophy via Regulating Protein Metabolism-Related Pathways in Mice
  2853. A case of amyotrophic lateral sclerosis which was diagnosed with progressive dysphagia and muscle atrophy
  2854. Mechanisms of exercise‐induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy‐like mice
  2855. muscle atrophy Classification: The Need for a Pathway-Driven Approach.
  2856. Influence of Infraspinatus and Subscapularis Pathologies on Supraspinatus muscle atrophy-A Retrospective Cohort Study
  2857. Clenbuterol accelerates recovery after immobilization-induced atrophy of rat hindlimb muscle
  2858. Sirtuin 3 deficiency accelerates Angiotensin II-induced skeletal muscle atrophy
  2859. Eicosapentaenoic Acid Improves Cisplatin-Induced muscle atrophy Without Accompanying Body Weight Gain
  2860. Linking liver alanine metabolism and muscle atrophy
  2861. Association between Changes in Sagittal X-ray Measurements and Neck Extensor muscle atrophy after Cervical Laminoplasty
  2862. Recovery of diabetic rats after physical exhaustion: kinetic alterations in muscle inflammation and muscle-signaling proteins to atrophy and hypertrophy
  2863. muscle from aged rats is resistant to mechanotherapy during atrophy and reloading
  2864. AHCC Supplementation Attenuates muscle atrophy via Akt Activation in Hindlimb-suspended Rat
  2865. Lipid accumulation and mitochondrial abnormalities are associated with fiber atrophy in the skeletal muscle of rats with collagen-induced arthritis
  2866. Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle
  2867. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice
  2868. Rectus abdominis muscle atrophy after thoracotomy
  2869. muscle atrophy in Malnutrition Stroke Patients Is a Factor That Causes a Decrease in Physical Function and Activities of Daily Living
  2870. Perioperative physical and nutritional therapy for tongue cancer-induced malnutrition and muscle atrophy: A case report
  2871. atrophy, oxidative switching and ultrastructural defects in skeletal muscle of the ataxia telangiectasia mouse model
  2872. Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study
  2873. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model
  2874. Physiological and molecular responses to thermal stress in red cusk-eel (Genypterus chilensis) juveniles reveals atrophy and oxidative damage in skeletal muscle
  2875. Dynamics of Toll-like receptors signaling in skeletal muscle atrophy.
  2876. Ultrasound Measurement of Septic Shock-induced Acute Skeletal muscle atrophy in Intensive Care Unit
  2877. Somatic piRNAs and Transposons are Differentially Regulated During Skeletal muscle atrophy and Programmed Cell Death
  2878. Impact of disuse muscular atrophy on the compound muscle action potential
  2879. Habitual Exercise Attenuates the Aging Associated muscle atrophy and muscle Strength Decline in SAMP8
  2880. Role of microRNA in muscle regeneration and diseases related to muscle dysfunction in atrophy, cachexia, osteoporosis, and osteoarthritis
  2881. P5396 CRISPR/Cas9 mediated miR-29b editing restores muscle atrophy and exercise capacity in mice
  2882. Fibrous hamartoma of infancy associated with bony remodeling and muscle atrophy
  2883. Molecular factors related to skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis
  2884. Inhibitory Effects of Standardized Leonurus japonicus Extract and Its Bioactive Leonurine on TNF-α-Induced muscle atrophy in L6 Myotubes
  2885. Correction to: Flavonoids: nutraceutical potential for counteracting muscle atrophy
  2886. Relation between skeletal muscle strength and ubiquitin ligase expression in muscle atrophy models in zebrafish larvae (Danio Rerio)
  2887. Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture
  2888. Probiotics Mitigates Skeletal muscle atrophy in Isoproterenol-Induced Heart Failure Adult Rats; by Increasing IGF-I Gene Expression and Improving Insulin Sensitivity
  2889. Systemic bone loss, impaired osteogenic activity and type I muscle fiber atrophy in mice with elastase-induced pulmonary emphysema: Establishment of a COPD …
  2890. Prevention of respiratory muscle dysfunction due to diaphragm atrophy in children with respiratory failure
  2891. TAZ and myostatin involved in muscle atrophy of congenital neurogenic clubfoot
  2892. Herbal complex’Buyang Huanwu Tang’improves motor endplate function of denervated-dependent skeletal muscle atrophy in rat
  2893. Undaria pinnatifida Extracts and Alginic Acid Attenuated muscle atrophy in TNF-α Induced Myoblast Cells through MAFbx Signaling Cascade
  2894. Surgical Decision-Making in Spinal Instability in Facioscapulohumeral Muscular Dystrophy Related with a Spinal muscle atrophy
  2895. Drosophila Model to Study muscle atrophy
  2896. Transcutaneous carbon dioxide application inhibits muscle atrophy after fracture in rats
  2897. The association of reduced bone density with paraspinal muscle atrophy and adipose tissue in geriatric patients: a cross-sectional CT study
  2898. Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
  2899. Cold shock RNA-binding protein RBM3 as a potential therapeutic target to prevent skeletal muscle atrophy
  2900. An endocrine-hepato-muscular metabolic cycle links skeletal muscle atrophy and hyperglycemia in type 2 diabetes
  2901. muscle atrophy: Different Strains of Mice Respond Differently to Single Limb Immobilization
  2902. muscle atrophy: Counteracting muscle atrophy on Earth and in Space via Nanofluidics Delivery of Formoterol (Adv. Therap. 7/2020)
  2903. Trimetazidine Attenuates Dexamethasone-Induced muscle atrophy via Inhibiting NLRP3/GSDMD Pathway-Mediated Pyroptosis
  2904. Effects of combined treatment with blood flow restriction and low‐intensity electrical stimulation on diabetes mellitus‐associated muscle atrophy in rats
  2905. Effects of glucoraphanin in dexamethasone-induced skeletal muscle atrophy in vitro model
  2906. The Protective Effects of Zanthoxylum bungeanum Maxim Pharmacopuncture on Disuse muscle atrophy in Rat Gastrocnemius muscle
  2907. Omega‐3 fatty acid supplementation attenuates skeletal muscle disuse atrophy during two weeks of unilateral leg immobilization in healthy young women
  2908. Developing of a muscle atrophy Model
  2909. Systemic redox biomarkers suggest non-redox mediated processes in the prevention of bed rest-induced muscle atrophy after exercise training: The Cologne RSL …
  2910. Molecular link between insulin resistance and skeletal muscle atrophy in myotonic dystrophies (P2. 4-043)
  2911. Skeletal muscle Recovery from Disuse atrophy: Protein Turnover Signaling and Strategies for Accelerating muscle Regrowth
  2912. Nano PGE1 Enhances Phosphorylation of ERK1/2 and Akt to Promote Recovery from Motor Dysfunction and muscle atrophy Induced by Sciatic Nerve Injury
  2913. Myasthenia gravis and muscle atrophy
  2914. TNFa is involved in the development of disuse muscle atrophy through the acid sphingomyelinase/ceramide up-regulation and pro-oxidant signaling
  2915. miR-29b is Involved in Cartilage Autophagy and muscle atrophy in a Rat Model of Knee Osteoarthritis
  2916. The influence of fatty infiltration and muscle atrophy of the rotator cuff muscles on midterm functional outcomes in total shoulder resurfacing at six years’ follow-up
  2917. Exogenous miR-29a Attenuates muscle atrophy and Kidney Fibrosis in UUO Mice
  2918. Effect of arterial flow on muscle atrophy
  2919. Preventive Effects of Repetitive Peripheral Magnetic Stimulation on muscle atrophy in the Paretic Lower Limb of Acute Stroke Patients: A Pilot Study
  2920. Physical activity during aging–role of physical activity in muscle atrophy and physical impairment during aging
  2921. MicroRNA-140 inhibits skeletal muscle glycolysis and atrophy in endotoxin-induced sepsis in mice via the WNT signaling pathway
  2922. Effect of protocol-based physical therapy on molecular mechanisms leading to muscle atrophy and intensive care unit acquired weakness in critically ill patients
  2923. Effect of blood flow restriction on serum levels of some factors of muscle atrophy in male elite athletes after anterior cruciate ligament reconstruction
  2924. Intrinsic foot muscle atrophy in individuals with chronic plantar heel pain: a cross-sectional investigation using ultrasound imaging
  2925. Diminshed muscle Oxygenation During Exercise in Ambulatory Spinal Muscular atrophy Patients (P4. 4-024)
  2926. Quadriceps muscle atrophy and inflammatory markers in COPD patients
  2927. The Role of Kynurenine, a Tryptophan Metabolite that Increases with Age, in muscle atrophy and Lipid Peroxidation
  2928. The effect of Micro-current electrical stimulation on muscle atrophy caused by sciatic nerve compression
  2929. Skeletal muscle atrophy in Men with Chronic Alcoholic Myopathy (impairment to signal pathways)
  2930. Astaxanthin Prevents atrophy in Slow muscle Fibers by Inhibiting Mitochondrial Reactive Oxygen Species via a Mitochondria-Mediated Apoptosis Pathway …
  2931. Resistance Training’s Ability to Prevent Cancer-induced muscle atrophy Extends Anabolic Stimulus.
  2932. Chronic spinal cord injury persons and the effects of functional electrical stimulation-lower extremity cycling ergometric on body composition and muscle atrophy
  2933. The Efficacy of Protein Supplementation on Attenuating muscle atrophy Following Disuse in the Collegiate Population
  2934. Quantitative MRI measurement of muscle atrophy and fatty infiltration after rotator cuff repair
  2935. the effects of exercise and massage on disuse muscle atrophy in special focus on mechanical stress
  2936. A Comparative Histological and Immunohistochemical Study of the Effect of Oxandrolone and Whey Protein on Disuse Induced muscle atrophy in old aged male rats
  2937. like bilateral sternocleidomastoid muscle atrophy may suggest the occurrence of sustained ventricular tachycardia
  2938. Epigenetic mechanisms for prevention of skeletal muscle atrophy
  2939. Cellular and molecular mechanisms of skeletal muscle atrophy after spinal cord injury
  2940. Acute recovery from disuse atrophy: the role of stretch-activated ion channels in the activation of anabolic signaling in skeletal muscle
  2941. Skeletal muscle atrophy and impaired myogenesis in spinal muscular atrophy
  2942. Evaluation of Multifidus muscle atrophy in MRI Images of Patients with Spinal Pain and its Related Factors
  2943. Effects of electroacupuncture combined with passive stretch exercise on disused muscle atrophy and expression of skeletal troponin in mice
  2944. Author Correction: Proteomic and Transcriptomic Changes in Hibernating Grizzly Bears Reveal Metabolic and Signaling Pathways that Protect against muscle atrophy
  2945. Endurance exercise training restores atrophy-induced decreases of myogenic response and ionic currents in rat skeletal muscle artery
  2946. Histological structure of skeletal muscle in disuse muscle atrophy and role of exercise
  2947. The Suppressive Effects of Daebangfung-tang against Disuse muscle atrophy in Gastrocnemius of Rats
  2948. Miniature Pigs Carrying DMD Exon51 Deletion Suffered from Severe Myocardial Damage, Accelerated muscle atrophy and Malabsorption
  2949. High phosphate levels promote muscle atrophy via myostatin expression in differentiated L6 myotubes
  2950. A case of thyrotoxic myopathy with generalized body muscular atrophy including the tongue muscle, lacking physical manifestations of Basedow disease
  2951. The Vastus Medialis obliquus and The Vastus Lateralis muscle atrophy is Existed in Patients with Patellofemoral Pain Syndrome
  2952. … of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast muscle atrophy and Sarcopenia. Nutrients …
  2953. Evolutionary loss of foot muscle during development with characteristics of atrophy and no evidence of cell death
  2954. A novel PAI-1 inhibitor prevents ageing-related muscle fiber atrophy
  2955. Metabolic Stress and Blood Flow Restriction Training as Interventions for Skeletal muscle atrophy following Musculoskeletal Injury
  2956. Targeting muscle Stem Cells for the Treatment of Spinal Muscular atrophy
  2957. The role of myeloid cells in lung injury‐induced muscle atrophy
  2958. Effect of renalase on dexamethasone-induced muscle atrophy
  2959. Mechanism and clinical research advance of muscle atrophy: thinking based on the 65th Annual Meeting of American College of Sports Medicine
  2960. muscle atrophy and Artery Shrinkage of Residual Limb After Trans-Femoral Amputation: A Morphological Study
  2961. Effect of electroacupuncture on muscular atrophy and expression of microRNAs and muscle satellite cell proliferation related proteins in denervated gastrocnemius …
  2962. SPHINGOLIPID MECHANISMS OF muscle atrophy IN HYPOGRAVITATIONAL UNLOADING
  2963. Bioinformatics analysis of gene spectrum of muscle atrophy after spinal cord injury
  2964. muscle‐specific Nrf2 deficiency exacerbates cancer cachexia‐induced skeletal muscle atrophy
  2965. Calcium Signaling in Skeletal muscle atrophy: A Novel Role for the ERG1alpha K+ Channel
  2966. Molecular Characterization of Hepatocyte Growth Factor Functions in muscle atrophy and Regeneration
  2967. Non-coding RNA basis of muscle atrophy
  2968. The Relationship Between Quadriceps muscle atrophy and Proprioception Function in Knee Osteoarthritis Patients
  2969. Dietary Alaska pollack protein improves skeletal muscle weight recovery after immobilization-induced atrophy in rats
  2970. Passive training improves the recovery of skeletal muscle structure and function in rats with denervated muscle atrophy
  2971. Regulation of skeletal muscle atrophy by the ZEB1 transcription factor
  2972. 1929-P: Role of miR379 in Promoting Skeletal muscle atrophy in Type 1 Diabetes (T1D)
  2973. Bilateral atrophy of the extensor digitorum brevis muscle might be a useful sign for diagnosing diabetic polyneuropathy in Japanese men who do not sit in the …
  2974. In the UPS family, which E2 enzymes collaborate with the E3 ligase MuRF1, a major actor of muscle atrophy?
  2975. … APPROACHES: P. 76 Validation of in vivo and ex vivo readouts in a murine model of hind limb unloading to optimize translational research on skeletal muscle atrophy
  2976. Butyrate ameliorate skeletal muscle atrophy in Diabetic Nephropathy via enhancing gut barrier function and GPR43 mediated PI3K/AKT/mTOR signals
  2977. Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize muscle atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair
  2978. Platelet-rich plasma enhances recovery of skeletal muscle atrophy after immobilization stress in rat: A histological and immunohistochemical study
  2979. Electroacupuncture improves denervated gastrocnemius atrophy by regulating expression of fork-head protein 3A, muscle atrophy F-box and myogenic differentiation …
  2980. 129: EARLY IN-BED CYCLING VERSUS USUAL CARE IN THE ICU ON muscle atrophy AND MOBILITY: A RANDOMIZED TRIAL
  2981. muscle Fiber atrophy With Single‐Limb Immobilization is Associated With a Significant Decrease in muscle‐Derived α‐Klotho of Male Mice
  2982. Effect of AMPK/PGC1 alpha on improving skeletal muscle atrophy in type 2 diabetic rats by aerobic exercise
  2983. Inhibition of lncRNA MAAT contributes to multiple types of muscle atrophy
  2984. SAT-304 EXOSOME-MEDIATED miR-26a TREATMENT ATTENUATES muscle atrophy AND KIDNEY FIBROSIS IN DIABETIC MICE
  2985. Eucommiae Cortex (Eucommia Ulmoides Oliver) Modulates muscle atrophy In Aged Mice
  2986. TACSM Abstract Effects of Community-Based Exercise Training Among Older Individuals with Metabolic Disease, Cardiovascular Disease, or muscle atrophy
  2987. Somatic piRNAs and Transposons are Differentially Regulated During Skeletal muscle atrophy and Programmed Cell Death [preprint]
  2988. muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
  2989. 2481-PUB: Oncostatin M Is Involved in Skeletal muscle atrophy via the STAT3 Pathway
  2990. Modulation of Gene Expression in muscle of Hibernating Arctic Ground Squirrels (Urocitellus parryii) and Attenuation of Disuse muscle atrophy
  2991. Effects Of Community-Based Exercise Training Among Older Individuals With Metabolic Disease, Cardiovascular Disease, Or muscle atrophy
  2992. Blood Flow Restriction Combined with Electrical Stimulation Attenuates Thigh muscle Disuse atrophy
  2993. Relationship between the improvement of muscle atrophy and functional outcomes after arthroscopic rotator cuff repair
  2994. Characterization of 1700029J07RIK, a Novel Nuclear Membrane Associated Protein that is Induced During Skeletal muscle atrophy
  2995. Release of Motor Neuron Exosomes Containing TDP-43 and mTNF-α Near the Neuromuscular Junction Induces Skeletal muscle atrophy and Reduced Contractility in …
  2996. Disuse atrophy Elevates the Release of Skeletal muscle‐derived Extracellular Vesicles but Lowers Serum EV Concentration in Rats
  2997. … Peripheral Nerve Injury‐induced muscle atrophy, Improves Intrinsic muscle Force, and Suppresses the Expression of muscle atrophy‐related Transcription Factors in …
  2998. Seaborne, RA, Hughes, DC, Turner, DC, Owens, DJ, Baehr, LM, Gorski, P, Semenova, EA, Borisov, OV, Larin, AK, Popov, DV, Generozov, EV, Sutherland, H …
  2999. Fam83d is Induced During Neurogenic Skeletal muscle atrophy and Modulates MAP Kinase and AKT Signaling
  3000. Spinal Muscular atrophy Type 3 Showing a Specific Pattern of Selective Vulnerability on muscle Ultrasound
  3001. Exploring the Role of Mitochondria in muscle Weakness and atrophy in a Mouse Model of Cancer Cachexia
  3002. muscle-Secreted Factors in Spinal Muscular atrophy: CTRP3 at the Interface of muscle and Neuron
  3003. Myostatin Inhibition Attenuates T3‐induced Skeletal muscle atrophy
  3004. FGGY Carbohydrate Kinase Domain Containing is Induced During Skeletal muscle atrophy and Modulates Map Kinase and AKT Signaling
  3005. Activating the MasR/Ang1‐7 Pathway Reduces muscle atrophy and Function Loss Following Denervation
  3006. Effect of Soybean Peptides for Nutritional Intervention on Prevention and Treatment for muscle atrophy Induced by Stimulating Weightlessness in Tail-Suspension …
  3007. Effect of two years of treatment with Givinostat on muscle atrophy and fat infiltration assessed by MRI in Patient with Duchenne muscular dystrophy (DMD).
  3008. Effects of Electrical muscle Stimulation for preventing Deltoid muscle atrophy after Rotator Cuff Repair: Preliminary Results of a Prospective, Randomized …
  3009. muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
  3010. Corrigendum to” Neuromuscular Electrophysiological Disorders and muscle atrophy in Mechanically-Ventilated Traumatic Brain Injury Patients: New Insights From a …
  3011. OR09-3 11β-HSD1 Mediates a Partial Suppression of muscle atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids
  3012. Age-Related Phagocytic Defect in Resident muscle Macrophages Drives Decreased Capacity for Recovery from Influenza-Induced muscle atrophy
  3013. Effects of Dexamethasone on HDAC4 Expression and Cellular Localization in C2C12 Cell‐Derived Myotubes: Implications for Skeletal muscle atrophy
  3014. Effect of electroacupuncture on denervated skeletal muscle atrophy and expression of IGF-1/PI3K/AKT in rats
  3015. Interleukin‐8 is Released from Human Pancreatic Tumor and Stromal Cells, and Causative in Skeletal muscle atrophy
  3016. Biosensor-based cell therapies for the treatment of experimental liver injury, muscle atrophy and diabetes
  3017. The Effect of Special Exercises Using Isometric Style and Aiding Devices For Rehabilitating Thigh muscle atrophy in Soccer Players After Surgical Intervention Of …
  3018. Investigating the Function of Co‐activator‐associated Arginine Methyltransferase 1 (CARM1) During Denervation‐induced Skeletal muscle atrophy
  3019. 11 [beta]-HSD1 mediates muscle atrophy induced by glucocorticoid therapy in chronic inflammatory disease
  3020. HMGB1 Initiates Inflammasome Mediated Pyroptosis, atrophy and Adverse muscle Remodeling
  3021. 1943-P: The Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Can Suppress muscle atrophy in Db/Db Mice by Suppressing the Expression of Foxo1
  3022. Dual Specificity Phosphatase and Pro Isomerase Domain Containing 1 (Dupd1) is Upregulated During Neurogenic Skeletal muscle atrophy and is Differentially …
  3023. Angiotensin 1‐7 reduces muscle atrophy and function loss following 16 week denervation
  3024. Phosphoproteomic identification of Xin as a novel requirement for skeletal muscle disuse atrophy
  3025. Crosstalk between glucocorticoid receptor and obestatin/GPR39 system in skeletal muscle: an avenue for the treatment of muscular atrophy
  3026. Ubiquitin Specific Peptidase 3 (USP3) is Expressed in Skeletal muscle and is Upregulated in Response to Neurogenic atrophy
  3027. Growth Differentiation Factor-15 (GDF-15) is Involved in muscle atrophy of Patients With Cardiovascular Diseases
  3028. Transferrin receptor 1 plays an important role in muscle development and denervation-induced muscular atrophy
  3029. UBR5 is a Novel E3 Ubiquitin Ligase involved in Skeletal muscle Hypertrophy and Recovery from atrophy
  3030. A Newly Built rAAV-SaCas9 Genome Editing System Enables muscle-Directed Gene Editing to Improve Muscular atrophy
  3031. In Vitro Simulation of Microgravity Induced muscle Loss Successfully Increases Expression of Key In Vivo atrophy Markers
  3032. Exercise-induced signaling in skeletal muscle of spinal muscular atrophy mice
  3033. Effects of conservative treatment of 2-week rigorous bed rest on muscle disuse atrophy in osteoporotic vertebral fracture patients
  3034. Insulin-dependent Diabetes Mellitus Enhances Microvascular Permeability and Induces atrophy of Rat Skeletal muscle ̶ In vivo Imaging using Two-photon Laser …
  3035. Does Functional Neuromuscular Electrical Stimulation (NMES) Influence Calf atrophy Following Achilles Tendon Surgery? Prospective Double-Blind Randomized …
  3036. Comparison of isometric muscle training and electrical stimulation supplementing isometric muscle training in the recovery after major knee ligament surgery: A …
  3037. Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice
  3038. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids.
  3039. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
  3040. Electrical stimulation prevents apoptosis in denervated skeletal muscle
  3041. Blood Flow–Restricted Training for Lower Extremity muscle Weakness due to Knee Pathology: A Systematic Review
  3042. α-Ionone attenuates high-fat diet-induced skeletal muscle wasting in mice via activation of cAMP signaling
  3043. Identification of a modified Wiener–Hammerstein system and its application in electrically stimulated paralyzed skeletal muscle modeling
  3044. A novel nutritional supplement prevents muscle loss and accelerates muscle mass recovery in caloric-restricted mice
  3045. Long non-coding RNA myoparr regulates GDF5 expression in denervated mouse skeletal muscle
  3046. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities
  3047. Intermittent whole-body vibration attenuates a reduction in the number of the capillaries in unloaded rat skeletal muscle
  3048. Effects of chronic low frequency stimulation on contractile and elastic properties of hindlimb suspended rat soleus muscle
  3049. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases
  3050. Role of IGF-I in skeletal muscle mass maintenance
  3051. Low-intensity resistance training attenuates dexamethasone-induced atrophy in the flexor hallucis longus muscle
  3052. Maintaining muscle mass during extended disuse: aestivating frogs as a model species
  3053. Electrical impedance as a novel biomarker of myotube atrophy and hypertrophy
  3054. Reloading functionally ameliorates disuse-induced muscle atrophy by reversing mitochondrial dysfunction, and similar benefits are gained by administering a …
  3055. Preventive effects of Chlorella on skeletal muscle atrophy in muscle-specific mitochondrial aldehyde dehydrogenase 2 activity-deficient mice
  3056. Electrical stimulation using sine waveform prevents unloading-induced muscle atrophy in the deep calf muscles of rat
  3057. 7 Food Functions preventing muscle atrophy
  3058. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome
  3059. Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence
  3060. Effects of blood flow restriction on muscle size and gene expression in muscle during immobilization: A pilot study
  3061. High-intensity flywheel exercise and recovery of atrophy after 90 days bed-rest
  3062. High fat diet-induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: implications on oxidative stress, ubiquitin proteasome …
  3063. MicroRNA in skeletal muscle development, growth, atrophy, and disease
  3064. The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice
  3065. Low-intensity Pulsed Ultrasound Improves muscle atrophy in Hindlimb Unloading Rats and its Metabolic Mechanism
  3066. Differential atrophy of the postero-lateral hip musculature during prolonged bedrest and the influence of exercise countermeasures
  3067. Intracellular signaling in ER stress‐induced autophagy in skeletal muscle cells
  3068. Stable atrogin-1 (Fbxo32) and MuRF1 (Trim63) gene expression is involved in the protective mechanism in soleus muscle of hibernating Daurian ground squirrels …
  3069. The anatomical basis for surgical preservation of temporal muscle
  3070. Targeted inhibition of TGF-β results in an initial improvement but long-term deficit in force production after contraction-induced skeletal muscle injury
  3071. Acupuncture plus low-frequency electrical stimulation (Acu-LFES) attenuates diabetic myopathy by enhancing muscle regeneration
  3072. Effect of resistance ladder training on sparc expression in skeletal muscle of hindlimb immobilized rats
  3073. Insulin resistance and muscle metabolism in chronic kidney disease
  3074. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders
  3075. Fatigue and non-fatigue mathematical muscle models during functional electrical stimulation of paralyzed muscle
  3076. Effects of electrical stimulation on skeletal muscle of old sedentary people
  3077. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
  3078. Effects of home-based interval walking training on thigh muscle strength and aerobic capacity in female total hip arthroplasty patients: a randomized …
  3079. GENOME-WIDE TRANSCRIPTOMICS AS A PLATFORM FOR UNDERSTANDING THE UNUSUAL RESISTANCE TO muscle atrophy IN HIBERNATING …
  3080. Antimuscle atrophy effect of nicotine targets muscle satellite cells partly through an α7 nicotinic receptor in a murine hindlimb ischemia model
  3081. Effect of thalidomide on the skeletal muscle in experimental heart failure
  3082. Direct muscle neurotization after end-to end and end-to-side neurorrhaphy: An experimental study in the rat forelimb model
  3083. Concise review on clinical applications of conditioned medium derived from human umbilical cord-mesenchymal stem cells (UC-MSCs)
  3084. Effectiveness of intermittent -Gx gravitation in preventing deconditioning due to simulated microgravity
  3085. Moderate exercise suppresses NF-κB signaling and activates the SIRT1-AMPK-PGC1α axis to attenuate muscle loss in diabetic db/db mice
  3086. Shoulder and arm muscle activity during elastic band exercises performed in a hospital bed
  3087. Cosmetic and functional reconstruction achieved using a split myofascial bone flap for pterional craniotomy
  3088. Effect of electrical stimulation on denervated muscle
  3089. Musculoskeletal atrophy in an experimental model of knee osteoarthritis: the effects of exercise training and low-level laser therapy
  3090. Conditioned medium derived from umbilical cord mesenchymal stem cells regenerates atrophied muscles
  3091. Effect of electrical muscle stimulation on upper and lower limb muscles in critically ill patients: a two-center randomized controlled trial
  3092. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia
  3093. Matrix metalloproteinases and skeletal muscle: a brief review
  3094. Development and Testing of Multi-mode Elbow Joint muscle Strength Training Device
  3095. Resistance training and sarcopenia
  3096. Modified Cranioplasty Technique Using 3-Dimensional Printed Implants in preventing Temporalis muscle Hollowing
  3097. Remodeling of the skeletal muscle and postsynaptic component after short-term joint immobilization and aquatic training
  3098. Early exercise after spinal cord injury (‘Switch-On’): study protocol for a randomised controlled trial
  3099. Alternative signaling pathways from IGF1 or insulin to AKT activation and FOXO1 nuclear efflux in adult skeletal muscle fibers
  3100. Molecular mechanisms and treatment options for muscle wasting diseases
  3101. Ubiquitin ligase Cbl-b and inhibitory Cblin peptides
  3102. Development of Human muscle Protein Measurement with MRI
  3103. Protective Effect of Melatonin against TNF-α Toxicity in the L6 muscle Cell Line
  3104. Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy
  3105. Efficacy of belt electrode skeletal muscle electrical stimulation on muscle flexibility of lower limbs: A randomized controlled pilot trial
  3106. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice
  3107. Glutamine interferes with glucocorticoid-induced expression of glutamine synthetase in skeletal muscle
  3108. Elevated urinary titin and its associated clinical outcomes after acute stroke
  3109. Blood flow restriction exercise: considerations of methodology, application, and safety
  3110. Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy
  3111. Rehabilitation in haemophilia—options in the developing world
  3112. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy
  3113. Morphological responses of human skeletal muscles to decreased mechanical loading
  3114. Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage?
  3115. muscle atrophy
  3116. Growth Hormone Enhanced Recovery After Chronic Denervation Injury: Augmenting Axonal Regeneration, Promoting Motor Reinnervation, and Improving muscle …
  3117. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions
  3118. Application of Air Suction System to Mouse Soleus muscle During Weightlessness
  3119. Effect of DHEA administration alone or exercise combined with DHEA before steroid treatment on rat hindlimb muscles
  3120. Stem cell and research in plastic surgery
  3121. Magnolol attenuates the cisplatin-induced muscle wasting via M2c macrophage activation
  3122. Effects of treadmill exercise on muscle fibers in mice with steroid myopathy
  3123. Mechanisms of muscle wasting in chronic kidney disease
  3124. Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
  3125. Electroacupuncture alleviates neuromuscular dysfunction in an experimental rat model of immobilization
  3126. Unexpected regulation pattern of the IKKβ/NF‐κB/MuRF1 pathway with remarkable muscle plasticity in the Daurian ground squirrel (Spermophilus dauricus)
  3127. Reconstruction of the temporalis muscle for pterional and cranio-orbital craniotomies
  3128. The effect of high intensity interval training on some atrophic and anti-atrophic gene expression in rat skeletal muscle with diabetes
  3129. Resistance Training and Sarcopenia
  3130. DISUSE atrophy OP QUADRICEPS FEMORIS AS A RESULT OF LOWER EXTREMITY IMMOBILIZATION
  3131. Electrical Stimulation
  3132. Application of wiener-hammerstein system identification in electrically stimulated paralyzed skeletal muscle modeling
  3133. InACTIVatINg cancer cachexia
  3134. atrophy of the postero-lateral hip and lower-limb musculature during bed-rest and the influence of two different resistive countermeasure exercises
  3135. The effect of histone deacetylase inhibitor on the restoration of atrophying aged skeletal muscles
  3136. Motor neurotization by segmental epineurectomy and implantation: lateral muscular neurotization
  3137. Organ culture of frog muscle: maintenance of mass, enzyme levels, and contractile force
  3138. Long bone fracture management in a sandhill crane: a case report
  3139. muscle oxygenation dynamics in response to electrical stimulation as measured with near‐infrared spectroscopy: A pilot study
  3140. A low temperature environment delays the changes in muscle fiber type composition induced by unloading
  3141. Quantifying Biomechanical Characteristics of Jumping Exercises in 1G and in Simulated and True Microgravity
  3142. Using Whole-Body Vibration for Countermeasure Exercise
  3143. Spasticity and preservation of skeletal muscle mass in people with spinal cord injury
  3144. Interfascial approach for pterional craniotomy: technique and adjustments to prevent cosmetic complications
  3145. Agomelatine increases muscle strength and reduces the expression of inflammatory cytokines in mdx dystrophic mice (P7. 097)
  3146. Role of nerve and tension in maturation of posthatching slow‐tonic muscle in chicken
  3147. RELATIONSHIP BETWEEN FUNCTION AND MORPHOLOGY AFTER HINDLIMB SUSPENSION: EFFECTS OF ELECTRICAL STIMULATION
  3148. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease
  3149. Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest
  3150. Effects of Growth Hormone/IGF-I and Exercise on Unloaded Bones
  3151. Loss of skeletal muscle mass after stroke: a systematic review
  3152. Regulation of skeletal muscle growth in fish by the growth hormone–insulin-like growth factor system
  3153. Fatigue and Non-Fatigue Mathematical muscle Models During Functional Electrical Stimulation of Paralyzed muscle
  3154. The Role of Dynamic muscle Contractions on Bone Loss and muscle atrophy in a Functional Disuse Mouse Model
  3155. Development of Human muscle Protein Measurement
  3156. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in locomotor and respiratory muscles during experimental sepsis in mice
  3157. Rehabilitation Techniques after Anterior Cruciate Ligament (ACL) Reconstruction the Indian Approach
  3158. 20 (s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of …
  3159. Resistance training attenuates the increase of skeletal muscle SPARC level in hindlimb immobilized rats.
  3160. OR-015 The changes of p-Akt/MuRF1 proteins expressions in rats’ soleus muscle following three preconditioning exercise under simulated acute microgravity
  3161. Effects of intermittent weight-bearing and clenbuterol on disuse atrophy of rat hindlimb muscles
  3162. The efficacy of temporal mesh plate floating technique for keyhole site depression after frontotemporal craniotomy
  3163. Prevention of skeletal muscle myopathy
  3164. Benefit of a Modified muscle Pedunculated Pterional Craniotomy
  3165. Animal models for cancer cachexia
  3166. Factors that influence muscle weakness following stroke and their clinical implications: a critical review
  3167. Potential of autologous adipose‐derived stem cells to regenerate atrophied muscle in a rat model
  3168. Electrical Stimulation of Vastus Medialis in the rehabilitation of patients undergoing total knee arthroplasty
  3169. Disuse of the musculo-skeletal system in space and on earth
  3170. Bionic Gym-Is it Good for Exercise?
  3171. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal …
  3172. muscle loss in space: physiological consequences
  3173. The effects of low frequency electrical stimulation on satellite cell activity in rat skeletal muscle during hindlimb suspension
  3174. Blood flow restriction by low compressive force prevents disuse muscular weakness
  3175. Embryonic stem cell–derived motor neurons preserve muscle after peripheral nerve injury
  3176. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486
  3177. Study of the Effects of Lower Limb muscle Strengthening Exercises on Hospitalized Pregnant Women on Bed Rest for Prevention of Miscarriage
  3178. Physical strategies to prevent disuse-induced functional decline in the elderly
  3179. The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
  3180. Size and X-ray density of normal and denervated muscles of the human leg and forearm
  3181. One-piece pedunculated frontotemporal orbitozygomatic craniotomy by creation of a subperiosteal tunnel beneath the temporal muscle
  3182. Histochemical changes in muscle of individuals with spinal cord injury following functional electrical stimulated exercise training
  3183. Efficacy and Safety of the Babysitter Procedure With Different Percentages of Partial Neurectomy
  3184. Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training
  3185. Effects of pulse duration on muscle fatigue during electrical stimulation inducing moderate‐level contraction
  3186. Resistance Training With Excessive Training Load and Insufficient Recovery Alters Skeletal muscle Mass–Related Protein Expression
  3187. Tenodesis of the long head of biceps brachii: cyclic testing of five methods of fixation in a porcine model
  3188. Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt
  3189. Treadmill with Electro-acupuncture Promotes Nerve Fiber Regeneration with Retaining muscle Activity after Sciatic Nerve Injury in Rat
  3190. Inhibition of calpain prevents muscle weakness and disruption of sarcomere structure during hindlimb suspension
  3191. The effects of resistance exercise on skeletal muscle abnormalities in patients with advanced heart failure
  3192. Cortical osteotomy technique for mobilizing the temporal muscle in pterional craniotomies
  3193. Neuromuscular electrical stimulation in neurorehabilitation
  3194. Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats
  3195. Anchoring the detached temporalis muscle in craniofacial surgery
  3196. Transcriptional profiling of rat skeletal muscle hypertrophy under restriction of blood flow
  3197. A simple method for reconstruction of the temporalis muscle using contourable strut plate after pterional craniotomy: introduction of the surgical techniques …
  3198. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases
  3199. Regeneration of skeletal muscle after eccentric injury
  3200. Ursolic Acid and Maslinic Acid
  3201. Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1
  3202. Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats
  3203. Ferulic Acid Promotes Growth of Both Fast Glycolytic and Slow Oxidative Skeletal muscles in Corticosteroid-Induced Rat Myopathy
  3204. Differences in transversus abdominis muscle function between chronic low back pain patients and healthy subjects at maximum expiration: measurement with real …
  3205. IGF-1 potentiates sensory innervation signalling by modulating the mitochondrial fission/fusion balance
  3206. muscle injuries: optimising recovery
  3207. Estrogen Receptor β Controls muscle Growth and Regeneration in Young Female Mice
  3208. Metabolic inflexibility is an early marker of bed-rest–induced glucose intolerance even when fat mass is stable
  3209. Effectiveness of temporal augmentation using a calvarial onlay graft during pterional craniotomy
  3210. Less invasive reconstruction of the temporalis muscle for pterional craniotomy: modified procedures
  3211. Massive Temporalis muscle Swelling after Decompressive Craniectomy: Case Report
  3212. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle
  3213. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study
  3214. Electrical stimulation based on chronaxie reduces atrogin‐1 and myoD gene expressions in denervated rat muscle
  3215. Genistein–a supplement improving efficiency of the human body: A review
  3216. The Effect of Calpain-Inhibitor on Muscular Degeneration after Rotator Cuff Tear: A Randomized Clinical Trial in Sheep
  3217. Early speech therapy intervention in a patient with facial paralysis after otomastoiditis
  3218. Osteoplastic pterional craniotomy revisited
  3219. Orbitozygomatic craniotomy
  3220. Resistance training and timed essential amino acids protect against the loss of muscle mass and strength during 28 days of bed rest and energy deficit
  3221. Combination treatment with exogenous GDNF and fetal spinal cord cells results in better motoneuron survival and functional recovery after avulsion injury with …
  3222. Effects of aerobic exercise combined with panaxatriol derived from ginseng on insulin resistance and skeletal muscle mass in type 2 diabetic mice
  3223. Repetitive restriction of muscle blood flow enhances mTOR signaling pathways in a rat model
  3224. Sarcopenia and age-related endocrine function
  3225. The effect of sitting position changes from pedaling rehabilitation on muscle activity
  3226. A community‐based fitness and mobility exercise program for older adults with chronic stroke: A randomized, controlled trial
  3227. Elevated expression of protein biosynthesis genes in liver and muscle of hibernating black bears (Ursus americanus)
  3228. Can unconventional exercise be helpful in the treatment, management and prevention of osteosarcopenic obesity?
  3229. Extended use of diaphragm pacing in patients with unilateral or bilateral diaphragm dysfunction: a new therapeutic option
  3230. Mechanisms involved in 3′, 5′-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle
  3231. Drug screening and drug repositioning as promising therapeutic approaches for Spinal Muscular atrophy treatment
  3232. The Role of Bone in muscle Wasting
  3233. High-Tone External muscle Stimulation pazienti con CKD e sarcopenia High-Tone External muscle Stimulation in pazienti con CKD e sarcopenia muscle …
  3234. Regeneration of mammalian skeletal muscle: basic mechanisms and clinical implications
  3235. Yes-Associated Protein is up-regulated by mechanical overload and is sufficient to induce skeletal muscle hypertrophy
  3236. Effects of electromyostimulation on muscle and bone in men with acute traumatic spinal cord injury: A randomized clinical trial
  3237. The TORC1/P70S6K and TORC1/4EBP1 signaling pathways have a stronger contribution on skeletal muscle growth than MAPK/ERK in an early vertebrate …
  3238. Prediction of muscle loss after stroke by analysis of corticospinal tract
  3239. Comparison between lateral supraorbital approach and pterional approach in the surgical treatment of unruptured intracranial aneurysms
  3240. Taurine enhances skeletal muscle mitochondrial function in a rat model of resistance training
  3241. Adult Male Status Post Chronic Traumatic Brachial Plexus Injury: A Case Report
  3242. Effect of resistance training with blood flow restriction on follistatin to myostatin ratio, body composition and anaerobic power of trained-volleyball players
  3243. Safe Zones for Temporal muscle Hook Retraction: A Technical Note
  3244. Effect of Autologous Adipose-Derived Stem Cells on Atrophied muscle by Denervation in Rats
  3245. Utility of Neuromuscular Electrical Stimulation to Preserve Quadriceps muscle Fiber Size and Contractility After Anterior Cruciate Ligament Injuries and Reconstruction …
  3246. Effect of hindlimb unloading on resting intracellular calcium in intrafusal fibers and ramp-and-hold stretches evoked responsiveness of soleus muscle spindles in …
  3247. Peripheral nerve regeneration: experimental strategies and future perspectives
  3248. Anti-cytokine strategies for the treatment of cancer-related anorexia and cachexia
  3249. Clinicians’ perceptions of rationales for rehabilitative exercise in a critical care setting: A cross-sectional study
  3250. Current methods for skeletal muscle tissue repair and regeneration
  3251. A clinical pilot study to assess functional return following continuous muscle stimulation after nerve injury and repair in the upper extremity using a completely …
  3252. MANAGEMENT OF THE RECUMBENT DOG By Laurie Edge-Hughes, BScPT, MAnimSt (Animal Physio), CAFCI, CCRT The Canine Fitness Centre Ltd …
  3253. Rehabilitation following hip arthroscopy
  3254. Green tea extract attenuates muscle loss and improves muscle function during disuse, but fails to improve muscle recovery following unloading in aged rats
  3255. muscle hypertrophy in quadriplegics with combined electrical stimulation and body weight support training
  3256. Facial nerve trauma: evaluation and considerations in management
  3257. Effect of electrical stimulation of the cranial tibial muscle after end-to-side neurorrhaphy of the peroneal nerve in rats
  3258. Temporal augmentation with calvarial onlay graft during pterional craniotomy for prevention of temporal hollowing
  3259. Rehabilitation after hip arthroscopy
  3260. Effects of two intensities of treadmill exercise on neuromuscular recovery after median nerve crush injury in Wistar rats
  3261. A muscle growth promoting treatment based on the attenuation of activin/myostatin signalling in young mice results in long-term testicular abnormalities
  3262. Evaluation of temporal muscle trophism in relation to the manipulation time and infiltration of 0.5% isobaric bupivacaine through a pterional approach
  3263. Glucocorticoid receptor activation during exercise in muscle
  3264. Impaired ribosome biogenesis could contribute to anabolic resistance to strength exercise in the elderly
  3265. Ultrasound Imaging of the Vastus Intermedius and Vastus Medialis Oblique Thickness for Assessment of Early Torque Development During Knee Extension
  3266. Ursolic acid and maslinic acid: novel candidates for counteracting muscle loss and enhancing muscle growth
  3267. Electrical stimulation of hindlimb skeletal muscle has beneficial effects on sublesional bone in a rat model of spinal cord injury
  3268. Ginsenoside Rg1 augments oxidative metabolism and anabolic response of skeletal muscle in mice
  3269. Biportal endoscopic spinal surgery for lumbar spinal stenosis
  3270. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis
  3271. Selective vagus-recurrent laryngeal nerve anastomosis in thyroidectomy with cancer invasion or iatrogenic transection
  3272. Modified osteoplastic orbitozygomatic craniotomy
  3273. Neuromuscular electrical stimulation prior to presleep protein feeding stimulates the use of protein-derived amino acids for overnight muscle protein synthesis
  3274. Comparison of the effect of three combined training method (aerobic and resistance) with and without vascular occlusion on some indices of hypertrophy in elderly …
  3275. A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy
  3276. Investigation of the expression of myogenic transcription factors, microRNAs and muscle-specific E3 ubiquitin ligases in the medial gastrocnemius and soleus …
  3277. Zinc Signaling in Skeletal muscle
  3278. Interaction between muscle and bone, and improving the effects of electrical muscle stimulation on amyotrophy and bone loss in a denervation rat model via …
  3279. Autologous vascularized dural wrapping for temporalis muscle preservation and reconstruction after decompressive craniectomy: report of twenty-five cases
  3280. Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization
  3281. Using Combined Microgravity and Radiation to Simulate Skeletal muscle Damage in Space
  3282. Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury
  3283. Differential effects of heat stress on fibre capillarisation in tenotomised soleus and plantaris muscles
  3284. Expression of myocyte enhancer factor-2 and downstream genes in ground squirrel skeletal muscle during hibernation
  3285. Cardiovascular responses to skeletal muscle stretching:“Stretching” the truth or a new exercise paradigm for cardiovascular medicine?
  3286. The inhibition of CTGF/CCN2 activity improves muscle and locomotor function in a murine ALS model
  3287. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age‐related muscle wasting
  3288. Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation
  3289. muscle Size and Strength Benefits of Functional Electrical Stimulation-Evoked Cycling Dosage in Spinal Cord Injury: A Narrative Review
  3290. Pterional keyhole approach to middle cerebral artery aneurysms through an outer canthal skin incision
  3291. Systemic regulators of skeletal muscle regeneration in obesity
  3292. Evaluacion y Validacion del Papel de la Estimulacion Electrica Funcional del Hueso y la Articulacion Utilizando el Modelo de Marcha Musculoesqueletico.
  3293. Effect of aerobic exercise on muscle structure and expression of proteins promoting hypertrophy and metabolism in aged rats
  3294. Lifelong treadmill training improves muscle function detected by a modified grip strength test during aging in BALB/c mice
  3295. Electromyographic evaluation of countermeasures during the terrestrial simulation of interplanetary spaceflight in Mars500 project
  3296. Liquid metal as reconnection agent for peripheral nerve injury
  3297. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle
  3298. CRISPR-based activation of endogenous neurotrophic genes in adipose stem cell sheets to stimulate peripheral nerve regeneration
  3299. Cellular and morphological changes with EAA supplementation before and after total knee arthroplasty
  3300. bta-miR-23a Regulates the Myogenic Differentiation of Fetal Bovine Skeletal muscle-Derived Progenitor Cells by Targeting MDFIC Gene
  3301. Changes in maximum muscle strength and rapid muscle force characteristics after long-term special support and reconnaissance missions: a preliminary report
  3302. Effects of invasive ventilation on the respiratory muscles
  3303. Intubation difficulty in patient with pseudoankylosis of temporo-mandibular joint after pterional craniotomy
  3304. Frontozygomatic titanium cranioplasty in frontosphenotemporal (“pterional”) craniotomy
  3305. Hyperthermic Conditioning’s Role In Increasing Endurance, muscle Mass, and Neurogenesis
  3306. Multichanneled nerve guidance conduit with spatial gradients of neurotrophic factors and oriented nanotopography for repairing the peripheral nervous system
  3307. Fascicular phrenic nerve neurotization for restoring physiological motion in a congenital diaphragmatic hernia reconstruction with a reverse innervated latissimus dorsi …
  3308. Depressed mood and body mass index as predictors of muscle strength decline in old men
  3309. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study
  3310. Minipterional craniotomy for treatment of unruptured middle cerebral artery aneurysms. A single-center comparative analysis with standard pterional approach as …
  3311. A newly designed key-hole button
  3312. Spinal cord injury and physical activity: preservation of the body
  3313. Firearms-related skeletal muscle trauma: pathophysiology and novel approaches for regeneration
  3314. Postcraniotomy function of the temporal muscle in skull base surgery: technical note based on a preliminary study
  3315. Strength training prior to muscle injury potentiates low-level laser therapy (LLLT)-induced muscle regeneration
  3316. Prevent Age-Related muscle Loss, Frailty and Risk Factors for Falls
  3317. muscle injuries: biology and treatment
  3318. Supraorbital craniotomy for parasellar lesions
  3319. The effects of exercise and conjugated linoleic acid intake on IGF-1 and pro-inflammatory cytokines in atrophied skeletal muscle of rats
  3320. Conservative management of peripheral nerve injuries utilizing selective electrical stimulation of denervated muscle with exponentially progressive current forms
  3321. Rotator cuff repair: a review of surgical techniques, animal models, and new technologies under development
  3322. The effects of Neuro-Muscular Electrical Stimulation (NMES) on shoulder subluxation in flaccid hemiplegic patients
  3323. The usefulness of the frontolateral approach as a minimally invasive corridor for clipping of anterior circulation aneurysm
  3324. Combined subgaleal/myocutaneous technique for temporalis muscle dissection
  3325. Physiologically adaptive changes of the L5 afferent neurogram and of the rat soleus EMG activity during 14 days of hindlimb unloading and recovery
  3326. Physiological basis for contractile dysfunction in heart failure
  3327. A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
  3328. The skeletal muscle as an active player against cancer cachexia
  3329. IGF-1 gene transfer into denervated rat laryngeal muscle
  3330. Ursolic acid and maslinic acid: novel candidates for counteracting muscle loss and improving body composition
  3331. Effect of early low-intensity exercise on rat hind-limb muscles following acute ischemic stroke
  3332. Oral administration of Ajuga decumbens extract has a synergetic effect with glucosamine on cartilaginous injury in a rabbit osteoarthritis model
  3333. The Effect of Ankle Foot Orthosis’ Design and Degree of Dorsiflexion on Achilles Tendon Biomechanics: Tendon Displacement, Lower Leg muscle Activation, and …
  3334. Effect of foot and ankle immobilization on leg and thigh muscles’ volume and morphology: A case study using magnetic resonance imaging
  3335. Rehabilitation and Maximizing Function
  3336. The hibernating South American marsupial, Dromiciops gliroides, displays torpor-sensitive microRNA expression patterns
  3337. THE ROLE OF THE PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION TECHNIQUES IN THE RECOVERY OF PATIENTS WITH LEFT HEMIPARESIS
  3338. Surgical reinnervation
  3339. Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise
  3340. Targeted muscle reinnervation technique in below-knee amputation
  3341. The frontotemporal-orbitozygomatic approach: reconstructive technique and outcome
  3342. Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise
  3343. Update on mitochondria and muscle aging: all wrong roads lead to sarcopenia
  3344. Effects of strength training, using a gravity-independent exercise system, performed during 110 days of simulated space station confinement
  3345. Regulation of extracellular matrix elements and sarcomerogenesis in response to different periods of passive stretching in the soleus muscle of rats
  3346. Modulation of the Myostatin/Follistatin Axis by Deacetylase Inhibitors: Improvement of TNFα-Induced Myotube atrophy But Not of Experimental Cancer Cachexia
  3347. The effect of time interval between electrical stimulation on the denervated rat muscle
  3348. Combined Technique of Temporal muscle Augmentation for muscle Reconstruction in Case of Small to Medium Anatomic Defects
  3349. A single session of neuromuscular electrical stimulation does not augment postprandial muscle protein accretion
  3350. 494 SA MEDICAL JOWRNAL 18 June 1949 possible. be avoided. The only means of avoiding this• stunning’is to give a higher voltage than necessary. In curarized …
  3351. Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 …
  3352. Limited effect of fly-wheel and spinal mobilization exercise countermeasures on lumbar spine deconditioning during 90 d bed-rest in the Toulouse LTBR study
  3353. Reshaping the zygomatic complex: A “small step” in frontotemporal craniotomy and a “big leap” in exposure
  3354. Transzygomatic approach plus mini-peeling of middle fossa for devascularization of sphenoid wing meningiomas. Technical note
  3355. The denervated muscle
  3356. The Effects of Heat Acclimation on Endurance
  3357. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly
  3358. Protein Nutritional Support: The Classical and Potential New Mechanisms in the Prevention and Therapy of Sarcopenia
  3359. Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine
  3360. Electrical stimulation as a therapeutic tool to restore motor function
  3361. Rehabilitation After Hip Arthroscopy
  3362. Using the Hephaistos orthotic device to study countermeasure effectiveness of neuromuscular electrical stimulation and dietary lupin protein supplementation …
  3363. The “agnes fast” craniotomy: the modified pterional (osteoplastic) craniotomy
  3364. Protocol for randomized controlled trial of electric stimulation with high-volt twin peak versus placebo for facial functional recovery from acute Bell’s palsy in patients …
  3365. Effect of belt electrode-skeletal muscle electrical stimulation on immobilization-induced muscle fibrosis
  3366. Effects of metabolic acidosis on skeletal muscle
  3367. Effects of isometric muscle training on residual limb volume, strength, and gait of below-knee amputees
  3368. Experimental study of denervated rat muscle. Part II: The effects of electrical stimulation on the denervated rat muscles.
  3369. Functional overload enhances satellite cell properties in skeletal muscle
  3370. Effects of exercise training on the autophagy-related muscular proteins expression in ovariectomized rats
  3371. Complete reversal of muscle wasting in experimental cancer cachexia: additive effects of activin type II receptor inhibition and β‐2 agonist
  3372. Technique for fixing a temporalis muscle using a titanium plate to the implanted hydroxyapatite ceramics for bone defects
  3373. Space physiology
  3374. New orbitozygomatic approach by craniotomy
  3375. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy
  3376. Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons
  3377. Preserving the facial nerve during orbitozygomatic craniotomy: Surgical anatomy assessment and stepwise illustration
  3378. The minipterional craniotomy for anterior circulation aneurysms: initial experience with 72 patients
  3379. Distal transsylvian keyhole approach for unruptured anterior circulation small aneurysms
  3380. Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries
  3381. Cortisone‐induced changes in myosin heavy chain distribution in respiratory and hindlimb muscles
  3382. Prevention and treatment of pressure ulcers using electrical stimulation
  3383. Increased levels of leukemia inhibitory factor mRNA in muscular dystrophy and human muscle trauma
  3384. Traumatic muscle fibrosis: from pathway to prevention
  3385. Deep dissection plane for endoscopic-assisted comminuted malar fracture repair
  3386. Training effects on soleus of cats spinal cord transected (T12–13) as adults
  3387. Neuromuscular electrical stimulation increases postprandial muscle protein accretion during overnight sleep
  3388. Fatigue of muscles weakened by death of motoneurons
  3389. The Down Side of Prone Positioning: The Case of a COVID-19 Survivor
  3390. Leucine Supplementation Increases muscle Strength and Volume, Reduces Inflammation, and Affects Wellbeing in Adults and Adolescents with Cerebral Palsy
  3391. Comparison of exercise intensity during four early rehabilitation techniques in sedated and ventilated patients in ICU: a randomised cross-over trial
  3392. Unacylated ghrelin restores insulin and autophagic signaling in skeletal muscle of diabetic mice
  3393. Lateral supraorbital versus pterional approach: analysis of surgical, functional, and patient-oriented outcomes
  3394. Novel therapies targeting inner mitochondrial membrane—from discovery to clinical development
  3395. Clinical aspects of functional foods and nutraceuticals
  3396. The down side of prone positioning: the case of a coronavirus 2019 survivor
  3397. Chiara Fritegotto, Chiara Ferrati
  3398. Exposure of titanium mesh after cranioplasty for microvascular decompression surgery: two case reports
  3399. Physical and occupational therapy in palliative care
  3400. Reverse end-to-side nerve transfer: from animal model to clinical use
  3401. Overexpression of Neuregulin-1 (NRG-1) gene contributes to surgical repair of brachial plexus injury after contralateral C7 nerve root transfer in rats
  3402. The adipose tissue stromal vascular fraction secretome enhances the proliferation but inhibits the differentiation of myoblasts
  3403. Effects of kinesiotherapy in ischemic lesion and reperfusion in rats
  3404. Biomarker-based assessment of the muscle maintenance and energy status of anurans from an extremely seasonal semi-arid environment, the Brazilian Caatinga
  3405. Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function
  3406. Rejuvenation of the ageing upper lip and nose with suspension lifting
  3407. Tai Chi Quan and Stroke Prevention and Rehabilitation
  3408. The effect of time interval between electrical stimulation on the denervated rat muscle.
  3409. A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway
  3410. Immediate effect of a wearable foot drop stimulator to prevent foot drop on the gait ability of patients with hemiplegia after stroke
  3411. Analysis of Factors Associated with Temporal Hollowing after Pterional Craniotomy
  3412. Rehabilitation considerations in the care of the acute burn patient
  3413. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men
  3414. Age-related differences in the effect of weight bearing on the rat Soleus muscle subjected to hindlimb suspension
  3415. Mitochondrial metabolism in cancer cachexia: novel drug target
  3416. Protection Device Made of a Modified Syringe for muscle Protection During Cranial Perforation
  3417. A single session of neuromuscular electrical stimulation does not augment postprandial muscle protein accretion 2
  3418. Cranial suture anchor temporalis resuspension: a new technique to reconstruct temporal hollowing after craniotomy
  3419. The clinical effects of cold application on the production of electrically induced involuntary muscle contractions
  3420. Tomographic evaluation of size and x-ray density of normal and denervated human muscles
  3421. Sciatic nerve regeneration in rats by a promising electrospun collagen/poly (ε-caprolactone) nerve conduit with tailored degradation rate
  3422. Factors affecting volume change of myocutaneous flaps in oral cancer
  3423. ACTH/MSH (4–10) analog bim 22015 aids regeneration via neurotrophic and myotrophic attributes
  3424. Avoiding Loss of Lean muscle Mass (Sarcopenia)
  3425. Effects of multi-joint angle changes on EMG activity and force of lower extremity muscles during maximum isometric leg press exercises
  3426. Assisted ventilation modes reduce the expression of lung inflammatory and fibrogenic mediators in a model of mild acute lung injury
  3427. Exercise countermeasure to weightlessness during manned spaceflight
  3428. Biomimetic electrospun tubular PLLA/gelatin nanofiber scaffold promoting regeneration of sciatic nerve transection in SD rat
  3429. Molecular Mechanisms of Skeletal muscle Hypertrophy
  3430. Effects of low frequency functional electrical stimulation with 15 and 50 Hz on muscle strength in heart failure patients
  3431. Superficial temporal artery-sparing mini-pterional approach for cerebral aneurysm surgery
  3432. Rotator cuff tear with concomitant long head of biceps tendon (LHBT) degeneration: what is the preferred choice? Open subpectoral versus arthroscopic …
  3433. Role of Activity in Defining Metabolic and Contractile Adaptations After SCI
  3434. Basic Aspects in Prevention of Posttransplant Bacteremia by Branched Chain Amino Acids
  3435. Electrical muscle stimulation (EMS) training of the hamstrings
  3436. Aerobic exercise training improves skeletal muscle function and Ca2+ handling-related protein expression in sympathetic hyperactivity-induced heart failure
  3437. The dual role played by p21 may influence the apoptotic or anti-apoptotic fate in cancer
  3438. Calpains in skeletal muscle: Generation of an inhibitory overexpression system and analysis of degradation in simulated microgravity
  3439. Modified pterional craniotomy without “MacCarty keyhole”
  3440. Distinct microbial assemblages associated with genetic selection for high-and low-muscle yield in rainbow trout
  3441. Role of Insulin-Like Growth Factor Receptor 2 across muscle Homeostasis: Implications for Treating Muscular Dystrophy
  3442. Association Between Length of Stay in the Intensive Care Unit and Sarcopenia Among Hemiplegic Stroke Patients
  3443. The application of neuromuscular electrical stimulation training in various non-neurologic patient populations: a narrative review
  3444. Denervation studies in research of neurotrophic relationships
  3445. Miracle workers
  3446. The effectiveness of the functional magnetic stimulation therapy in treating sciatica syndrome
  3447. Use of Bioabsorbable Plates for Cranial Fixation—Technical Note—
  3448. Electrical Stimulation of Denervated muscle
  3449. Effect of electrotherapy on denervated muscles in rabbits: an electrophysiological and morphological study
  3450. Conservative treatment of severe limited mouth opening after transtemporal craniotomy
  3451. Three-piece orbitozygomatic approach
  3452. Tissue injury and repair
  3453. Altitude training and muscular metabolism
  3454. iTRAQ-based quantitative proteomic analysis of longissimus muscle from growing pigs with dietary supplementation of non-starch polysaccharide enzymes
  3455. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle
  3456. Neurotrophic effects of dental pulp stem cells in repair of peripheral nerve after crush injury
  3457. Technique of Arthroscopic Suprapectoral Tenodesis of the Long Head of the Biceps With Interference Screw
  3458. Use of neuromuscular electrical stimulation in the treatment of neonatal brachial plexus palsy: A literature review
  3459. Calcitonin gene‐related peptide regulation of glial cell‐line derived neurotrophic factor in differentiated rat myotubes
  3460. Remodeling of lumbar motor circuitry remote to a thoracic spinal cord injury promotes locomotor recovery
  3461. Anatomy of the nuchal ligament and its surgical applications
  3462. Bite force and electromyography evaluation after cranioplasty in patients with craniosynostosis
  3463. Nutritional interventions in sarcopenia in older adults: a review of the literature
  3464. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III
  3465. A versatile LabVIEW-based toolbox design and man-machine interface for the electrical stimulation system
  3466. Hip fractures in a geriatric population-rehabilitation based on patients needs
  3467. Modified plate-only open-door laminoplasty versus laminectomy and fusion for the treatment of cervical stenotic myelopathy
  3468. Influence of the availability of iron during hypoxia on the genes associated with apoptotic activity and local iron metabolism in rat H9C2 cardiomyocytes and …
  3469. Does Proteasome Activity Impact Skeletal muscle Hypertrophy?
  3470. Surgical experience of minipterional craniotomy with 102 ruptured and unruptured anterior circulation aneurysms
  3471. Effects of hindlimb suspension on contractile properties of young and old rat muscles and the impact of electrical stimulation on the recovery process
  3472. Spaceflight-induced Bone Loss: Countermeasures & their Evaluations
  3473. Black tea high-molecular-weight polyphenol-rich fraction promotes hypertrophy during functional overload in mice
  3474. The SINE compound KPT-350 blocks dystrophic pathologies in DMD zebrafish and mice
  3475. Functional, diagnostic and therapeutic aspects of gastrointestinal hormones
  3476. Treatment of muscle wasting: an overview of promising treatment targets
  3477. Effects of electrical stimulation on risk factors for developing pressure ulcers in people with a spinal cord injury: a focused review of literature
  3478. Neuromuscular regeneration: perspective on the application of mesenchymal stem cells and their secretion products
  3479. Sarcopenia and its intervention
  3480. LXXIV Electrodiagnostic-Therapeutic Modalities in Facial Nerve Paralysis
  3481. Comparative efficacy and safety of oral or transdermal opioids in the treatment of knee or hip osteoarthritis: a systematic review and Bayesian network meta-analysis …
  3482. Rehabilitation and Return to Sports After Conservative and Surgical Treatment of Upper Extremity Injuries
  3483. Rehabilitation for dogs with cranial cruciate ligament rupture
  3484. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men
  3485. Skeletal muscle growth factor response to cutaneous stimulation of the plantar surface of the foot
  3486. Modifications to the orbitozygomatic approach
  3487. Electrical stimulation of a denervated muscle promotes selective reinnervation by native over foreign motoneurons
  3488. Time-course response in serum markers of bone turnover to a single-bout of electrical stimulation in patients with recent spinal cord injury
  3489. Comparison between frontolateral approach and pterional approach in the surgical treatment of paraclinoid aneurysms
  3490. Effects of passive and active training paradigms on bone and muscle recovery after spinal cord injury
  3491. Passive Mobilization: An Orthotist’s Overview
  3492. Design and performance of an automated bioreactor for cell culture experiments in a microgravity environment
  3493. Medical and surgical supervision of competitive athletics
  3494. Optimal human functioning requires exercise across the lifespan: mobility in a 1g environment is intrinsic to the integrity of multiple biological systems
  3495. Nutritional approach to sarcopenia
  3496. Advancements in Managing Intracerebral Hemorrhage: Transition from Nihilism to Optimism
  3497. Early high-intensity rehabilitation following total knee arthroplasty improves outcomes
  3498. Influence of lower complete denture use on masseter muscles and masticatory function: a longitudinal study
  3499. Immersive surgical anatomy of the pterional approach
  3500. Planning strategies for development of effective exercise and nutrition countermeasures for long-duration space flight
  3501. Minimally Invasive Surgical Treatment vs. Classic Pterional Craniotomy in Ruptured Intracranial Aneurysms of the Anterior Circulation.
  3502. Bioenergetics mechanisms regulating muscle stem cell self-renewal commitment and function
  3503. Publication trends in cachexia and sarcopenia in elderly heart failure patients
  3504. Arthroscopically assisted treatment of acute septic knees in infants using the Micro-Joint Arthroscope
  3505. Early Patient Mobility in the Ventilated Patient
  3506. Body protein sparing in hibernators: a source for biomedical innovation
  3507. Legg-Calvé-Perthes’ Disease
  3508. Pedicled Latissimus Dorsi Myocutaneous Flap-an Effective Reconstructive Option for Extensive Buccal Cancer Resection in Resource Constrained and Salvage …
  3509. Osteo-core Plasty: A Minimally Invasive Approach for Subchondral Bone Marrow Lesions of the Knee
  3510. Intramedullary Nailing of Long Bone Fractures
  3511. Myotendinous rupture of temporalis muscle: a rare injury following seizure
  3512. A PI3K/PKB-Independent activation of mTOR signaling is sufficient to induce skeletal muscle hypertrophy
  3513. The minipterional approach for ruptured and unruptured anterior circulation aneurysms: Our initial experience
  3514. Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors
  3515. Biomimetic scaffolds in skeletal muscle regeneration
  3516. Getting a fix on orthopedic care
  3517. Comparative Study on the Effectiveness of Early or Delayed Weight-Bearing After Anterior Cruciate Ligament Reconstruction
  3518. FOXO1 Nucleo-Cytoplasmic Distribution and Regulation
  3519. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
  3520. Influence of 14-day hind limb unloading on isolated muscle spindle activity in rats
  3521. Use of Neuromuscular Electrical Stimulation in the Treatment of Neonatal Brachial Plexus Palsy: A
  3522. Rehabilitation of neonatal brachial plexus palsy: integrative literature review
  3523. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia
  3524. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction
  3525. Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: a retrospective study of 76 …
  3526. Effects of steroid hormones on skeletal muscle
  3527. Planning for crew exercise for deep space mission scenarios
  3528. OPTIMISM GROWS FOR FUNCTIONAL RECOVERY FROM SPINAL CORD INJURY: ACTIVITY-BASED THERAPY, NEURAL REPAIR ADVANCES ENCOURAGE …
  3529. The role of muscle in amyotrophic lateral sclerosis: pathogenesis and therapeutic potential
  3530. A novel electrospun nerve conduit enhanced by carbon nanotubes for peripheral nerve regeneration
  3531. The minipterional craniotomy: technical description and anatomic assessment
  3532. Functional electrical stimulation in rehabilitation engineering: A survey
  3533. Dietary protein and muscle mass: translating science to application and health benefit
  3534. Sarcopenic obesity and inflammation in the InCHIANTI study
  3535. Anterior communicating artery aneurysms
  3536. Exercises following anterior cruciate ligament reconstructive surgery: biomechanical considerations and efficacy of current approaches
  3537. Biomechanical properties of high-density polyethylene for pterional prosthesis
  3538. Usefulness of robotic gait training plus neuromodulation in chronic spinal cord injury: a case report
  3539. Long term outcome of early single stage surgery in multi-ligamentous injuries of knee
  3540. Repetitive strain injuries in youth
  3541. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled …
  3542. Orbitozygomatic Approach to the Sellar Region
  3543. Remedying muscle disorders by targeting muscle apoptosis and autophagy pathways
  3544. Research Development of Sarcopenia and Nursing of Sarcopenia
  3545. Rehabilitation after arthroscopic repair of intra-articular disorders of the hip in a professional football athlete
  3546. The interaction effects of dietary lipid, vitamin E and vitamin C on growth performance, feed utilization, muscle proximate composition and antioxidant enzyme activity …
  3547. New study on the neuromuscular dystrophy rehabilitation program
  3548. Dental Tissue-Derived Human Mesenchymal Stem Cells and Their Potential in Therapeutic Application
  3549. Label-free proteomics of tilapia fillets and their relationship with meat texture during post-mortem storage
  3550. Open-or closed-kinetic chain exercises after anterior cruciate ligament reconstruction?
  3551. Intensive gait training in toddlers with cerebral palsy: A pilot study
  3552. Irradiation effect of polarization direction and intensity of semiconductor laser on injured peripheral nerve
  3553. MiR-2014-5p and miR-1231-5p regulate muscle growth of Larimichthys crocea by targeting MSTN gene
  3554. MINIPTERIONAL INTERFASCIAL APPROACH FOR MICROQUIRURGICAL TREATMENT OF RUPTURED AND UNRUPTURED ANTERIOR CIRCULATION …
  3555. Application of implantable wireless biomicrosystem for monitoring nerve impedance of rat after sciatic nerve injury
  3556. Movement Issues with Chronically Ill or Chronic Pain Patients
  3557. Application of neuromuscular electrical stimulation of the lower limb skeletal muscles in the rehabilitation of patients with chronic heart failure and chronic …
  3558. Identifying Protein–metabolite Networks Associated with COPD Phenotypes
  3559. Effect of whole body resistance training on arterial compliance in young men
  3560. Different stimulation patterns affect contractile properties of denervated rat soleus muscles
  3561. NEUROLOGISTS MAKE SPORTS AND FITNESS PART OF WORK AND PLAY
  3562. Efficacy of functional electric stimulation cycle ergometry training on lower limb muscles in spinal cord injured individuals
  3563. Salvage of an exposed cranial prosthetic implant using a transposition flap with an indwelling antibiotic irrigation system
  3564. Pterional Approach: Operative Technique and Surgical Applications
  3565. Molecular adaptations of skeletal and cardiac muscle in the hibernating thirteen-lined ground squirrel, Spermophilus tridecemlineatus
  3566. Late evening snack, branched chain amino acids, and cirrhosis
  3567. A literature review of role of obesity in adult health with reference to Africa
  3568. Selected health promotion strategies: Potential (S) and challenges
  3569. Non-Contact Femoral Fracture in a Collegiate Football Player
  3570. Facial nerve axonal analysis and anatomical localization in donor nerve: optimizing axonal load for cross-facial nerve grafting in facial reanimation
  3571. Ultrasound imaging and rehabilitation of muscle disorders: part 1. traumatic injuries
  3572. A Highlights from MBoC Selection: A Phosphatidylinositol 3-Kinase/Protein Kinase B-independent Activation of Mammalian Target of Rapamycin Signaling Is …
  3573. The influence of growth factors on neuromuscular junction regeneration
  3574. Neuromuscular electrical stimulation improves energy substrate metabolism and survival in mice with acute endotoxic shock
  3575. Universal spectral profile and dynamic evolution of muscle activation: a hallmark of muscle type and physiological state
  3576. Comprehensive rehabilitation of herniated disc in the lumbar section of the spine
  3577. The effects of novel anti-inflammatory nutritional and pharmaceutical supplementation during resistance training on muscle and bone in older adults
  3578. Chronic inflammation and sarcopenia: A regenerative cell therapy perspective
  3579. The effects of ipsilateral forearm movement and contralateral hand grasp on the spastic hand opened by electrical stimulation
  3580. Is non-invasive neuromuscular electrical stimulation effective in severe chronic neurogenic dysphagia? Reporton a post-traumatic brain injury patient
  3581. Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women
  3582. Extradural anterior clinoidectomy: Technical nuances from a learner’s perspective
  3583. Zygomatic transmandibular approach
  3584. Rehabilitation Challenges in Limb-Girdle Muscular Dystrophies
  3585. The relationship between body mass index and self‐reported functional limitation among older adults: a gender difference
  3586. Acute effect of passive cycle-ergometry and functional electrical stimulation on nitrosative stress and inflammatory cytokines in mechanically ventilated …
  3587. Don’t Call Me ‘Madman’-The Curse of Anti-NMDA Receptor Encephalitis
  3588. Internal maxillary bypass for complex pediatric aneurysms
  3589. Synergistic effects of dual-presenting VEGF-and BDNF-mimetic peptide epitopes from self-assembling peptide hydrogels on peripheral nerve regeneration
  3590. Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetes patients
  3591. Frontotemporal-orbitozygomatic approach
  3592. Controlled exercise in equine rehabilitation
  3593. The Mediating Role of C‐Reactive Protein and Handgrip Strength Between Obesity and Walking Limitation: [See Editorial Comments by Drs. Hermes Florez and …
  3594. Current concepts in the rehabilitation of the overhead throwing athlete
  3595. Morphometric Differences in the Recurrent Laryngeal Nerve in Patients with Vocal Fold Paralysis
  3596. The management of the long head of the biceps in rotator cuff repair: A comparative study of high vs. subpectoral tenodesis
  3597. Early Quantitative Partial Weight-Bearing Exercise After Periarticular Fractures of the Tibia Using a Lower-Body Positive-Pressure Treadmill: A Case Series
  3598. Modified osteoplastic orbitozygomatic craniotomy in the pediatric population
  3599. Spinal cord injuries in children and adolescents: a review
  3600. Hemodynamics and tolerability of lower‐limb intermittent pneumatic compression devices and neuromuscular stimulation
  3601. Aggressive Management of Rheumatoid Arthritis in the Elderly
  3602. A synthetic oxygen carrier-olfactory ensheathing cell composition system for the promotion of sciatic nerve regeneration
  3603. Experimental research on the influence of aerobic exercise combining resistance exercise on the physical health of middle-aged and elderly people
  3604. Measuring muscle Fatigue associated with tourniquet use using Accelerometer-Based Mechanomyography: A Pilot Study
  3605. Regenerative rehabilitation of catastrophic extremity injury in military conflicts and a review of recent developmental efforts
  3606. A robust iterative learning switching controller for following virtual constraints: application to a hybrid neuroprosthesis
  3607. Hypoenergetic diet-induced reductions in myofibrillar protein synthesis are restored with resistance training and balanced daily protein ingestion in older men
  3608. RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion
  3609. Trophic influences of neurogenic substances on skeletal muscle differentiation and growth in vitro
  3610. Three-Piece Orbitozygomatic Craniotomy: Anatomical and Clinical Findings
  3611. Lesions confined to the sphenoid ridge: differential diagnosis and surgical treatment
  3612. Comparison of electrical stimulation and isometric training on isokinetic strength of knee extensors: A randomized clinical trial
  3613. Chinese medicine in diabetic peripheral neuropathy: experimental research on nerve repair and regeneration
  3614. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
  3615. The influence of stimulus phase duration on discomfort and electrically induced torque of quadriceps femoris
  3616. Hand-made articulating spacers in two-stage revision for infected total knee arthroplasty: good outcome in 30 patients
  3617. Glenohumeral osteoarthritis: overview, therapy, and rehabilitation
  3618. Exercise & Sport Science Initiative, University of Michigan, Ann Arbor, MI, United States, 9 Department of Physiology and Pharmacology, University of Calgary, Calgary …
  3619. Category Archives: Endocrine system
  3620. Therapeutic and lifestyle approaches to obesity in older persons
  3621. Assessment and Management for Speech in Facial Palsy: A Review Study.
  3622. The role of Lynx1, an endogenous modulator of cholinergic transmission, in NMJ development, maintenance, and repair
  3623. Hypertrophy and explosive-reactive functioning in sedentary men after 10 weeks of whole-body vibration
  3624. Changes in mood status and neurotic levels during a 20-day bed rest
  3625. Musculoskeletal Changes After Spinal Cord Injury: Effects of Body Weight Supported Treadmill Training
  3626. Surgical indications for long head biceps tenodesis: a systematic review
  3627. Sustained muscle contractions maintained by autonomous neuronal activity within the human spinal cord
  3628. Nerve regeneration in rat peripheral nerve allografts: Evaluation of cold‐inducible RNA‐binding protein in nerve storage and regeneration
  3629. Rehabilitation in the Setting of Neurotrauma
  3630. Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes
  3631. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons
  3632. The pterional approach
  3633. Design of Finger Bending Angle Detection System and FES System Based on Finger & Wrist Rehabilitation Robot
  3634. Cycling induced by functional electrical stimulation in neurological patients: systematic review of the literature and results of a randomized controlled study
  3635. New electrical stimulation techniques in dynamic myopasty
  3636. Melanotropins as Growth Factorsa
  3637. A Comparison of Heat Shock Protein Expression in Rat Skeletal muscle After Lengthening or Shortening Contractions
  3638. Endoscopic gluteus medius repair with concomitant arthroscopy for labral tears: a case series with minimum 5-year outcomes
  3639. Perioperative physiotherapy for total ankle replacement in patients with inherited bleeding disorders: outline of an algorithm
  3640. Journal of Respiratory and CardioVascular Physical Therapy
  3641. muscle Preservation in Denervation Injury Using Continuous Implantable Electrical Stimulation
  3642. Tibiotalocalcaneal arthrodesis in rheumatoid arthritis using the supracondylar nail
  3643. Trunk kinematics during cross country sit-skiing ergometry: skiing strategies associated to neuromusculoskeletal impairment
  3644. Treatment with oxandrolone and the durability of effects in older men
  3645. Pterional, Trans-Sylvian Approach for Aneurysm Surgery.
  3646. The classical and a modified Boston brace: description and results
  3647. Oxtr/TRPV1 expression and acclimation of skeletal muscle to cold-stress in male mice
  3648. Treatment of Exposed Fractures in Hemophiliac Patients
  3649. Realizing efficient EMG-based prosthetic control strategy
  3650. Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women
  3651. Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with pluronic block copolymers
  3652. Epigenetic targets for therapeutic approaches in COPD and asthma. Nutrigenomics–possible or illusive
  3653. A pilot study: The effects of ice massage on an individual’s pain tolerance level to electrical stimulation
  3654. Immune-Mediated Myositis in Horses: From phenotype to genotype
  3655. The effect of additional neuromuscular electrical stimulation applied to erector spinae muscles on functional capacity, balance and mobility in post stroke patients
  3656. Surgical outcomes in patients with anterior communicating artery aneurysms
  3657. Rehabilitation, walking aids, functional electrical stimulation and overcoming spasticity
  3658. Experimental Study on Set-Point Regulation of Human Elbow Joint by Electric Stimulation Under Various Visual Feedback Rate
  3659. The Role of Awake Extracorporeal Membrane Oxygenation as Bridging Therapy for Lung Transplantation: A Retrospective Cohort Study
  3660. Management of isolated and complex craniosynostosis residual deformities: What are the maxillofacial tools?
  3661. Suspended in time: Molecular responses to hibernation also promote longevity
  3662. Cleaved Caspase-3 Response to Acute Resistance Exercise in Young and Old Men and Women: Relationship to muscle Glycogen Content and 5′-AMP-Activated …
  3663. muscle Plasticity and Repeatability to Alterations in Mechanical Loading Conditions
  3664. Liquid Metal as Electronic Medium to Recover Damaged Nerves’ Function
  3665. Interval and continuous aerobic exercise training similarly increase cardiac function and autonomic modulation in infarcted mice
  3666. Enhanced recovery in intestinal surgery
  3667. Recent developments on the extraction and application of ursolic acid. A review
  3668. Examining the Role of L-Type Amino Acid Transporter 1 (SLC7A5) in Myoblasts
  3669. The effects of cryotherapy versus cryostretching on clinical and functional outcomes in athletes with acute hamstring strain
  3670. Warm needling on the four knee acupoints combined with Chinese herb in the treatment of knee pain after stroke
  3671. Bracing Adult Scoliosis: From Immobilization to Correction of Adult Scoliosis
  3672. Fighting the Cause of Alzheimer’s and GNE Myopathy
  3673. and Makoto Kanzaki1, 4 1Division of Biomaterials, Tohoku University Biomedical Engineering Research Organization (TUBERO), 221st COE program” …
  3674. The application of the Neurac technique vs. manual therapy in patients during the acute phase of subacromial impingement syndrome: A randomized single-blinded …
  3675. Operational guidelines
  3676. Trophic factor expression in phrenic motor neurons
  3677. E-mail: shixen@ sina. com
  3678. Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice.
  3679. Middle meningeal artery to premeatal anterior inferior cerebellar artery bypass via anterior petrosectomy: an anatomic feasibility study
  3680. The anoxia resistant crayfish: a profile of stress response
  3681. The classical and a modified Boston Brace: Description
  3682. A within-stride switching controller for walking with virtual constraints: Application to a hybrid neuroprosthesis
  3683. A new model of short acceleration‐based training improves exercise performance in old mice
  3684. Relationship between aerobic capacity and disease activity in children with Juvenile Idiopathic Arthritis: a review
  3685. Multi-channel functional electrical stimulation with motor point tracking for sustainable muscle contraction
  3686. Effect of Electrical Stimulation on muscle Recruitment as it Relates to Maximal Voluntary Contraction
  3687. Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury
  3688. Current concepts in the assessment and rehabilitation of the thrower’s shoulder
  3689. The orbitozygomatic craniotomy and its judicious use
  3690. A comparison of blood flow changes in tissues treated with therapeutic ultrasound and electrical stimulation
  3691. GRAD 2 MEDIAL MENISCUS INJUR
  3692. Disorders of the pelvic limb: diagnosis and treatment
  3693. ε-SVR-based estimation for the motion trajectory of human lower limb using acceleration signals
  3694. Frontotemporal orbitozygomatic craniotomy to expose the cavernous sinus and its surrounding regions: Microsurgical anatomy
  3695. Evoked EMG-based torque prediction for muscle fatigue tracking and closed-loop torque control in FES
  3696. A Revolutionary Step Towards the Prevention of Pressure Ulcer: from Bench to Bedside
  3697. Metabolic control of longevity
  3698. 16 Omega-3 Fatty Acids and Bone Metabolism
  3699. Transcutaneous Electrical Stimulation and Dysphagia Rehabilitation: A Narrative Review
  3700. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
  3701. Antimicrobial Peptides of Salmonid Fish: From Form to Function
  3702. Regulation of sarcomere number in the growing rabbit tibialis anterior
  3703. The contribution of the biceps brachii on glenohumeral muscle activation
  3704. A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.
  3705. Exciting perspectives for Translational Myology in the Abstracts of the 2018Spring PaduamuscleDays: Giovanni Salviati Memorial–Chapter IV-Abstracts of …
  3706. Myogenic and Anabolic Gene Expression in Red and White muscle of Sablefish (Anoplopoma fimbria) During Grow Out
  3707. Challenges in Subtrochanteric Femur Fracture Management: A Case Report of Inappropriate Implant Choice Leading to Fixation Failure and Update on Management …
  3708. Using RNA-Seq to Explore the Repair Mechanism of the Three Methods and Three-Acupoint Technique on DRGs in Sciatic Nerve Injured Rats
  3709. Drugs and Dysphagia
  3710. Quantitative and topographic analysis by immunohistochemical expression of ghrelin gastric cells in patients with morbid obesity
  3711. Functional electrical stimulation of lower limbs in patients with chronic heart failure
  3712. Home-based rehabilitation programs: Promising field to maximize function of patients with traumatic spinal cord injury
  3713. A Manual for Caregivers of Infants with Brachial Plexus Injuries
  3714. Does size matter? Decompressive surgery under review
  3715. Nutritional concerns and possible countermeasures to nutritional issues related to space flight
  3716. Effects of rusa deer (Cervus timorensits) velvet antler extract on muscle fatigue and exercise endurance capacity in male wistar rats
  3717. Differentiation of adipose-derived stem cells into Schwann cell-like cells through intermittent induction: potential advantage of cellular transient memory …
  3718. Neurophysiology of vocal fold paralysis
  3719. Neuromuscular manifestations of viscoelastic tissue degradation following high and low risk repetitive lumbar flexion
  3720. A novel sensitive electrochemical method for the detection of ractopamine in meat food via polycitrulline-modified electrode
  3721. Noninvasive characterization of skeletal muscle damage and repair in murine models of muscular dystrophy
  3722. Differential effects of activity dependent treatments on axonal regeneration and neuropathic pain after peripheral nerve injury
  3723. Scalp Incisions
  3724. Aspen Antler-Revivify
  3725. Analysis of Tissue Sparing and Circuit Regeneration in Spinal Cord Injuries Treated with Biomaterials and Gene Therapy
  3726. Aspen Antler Research
  3727. CHANGING CONCEPTS IN DEVELOPMENTAL NEUROBIOLOGYºk
  3728. Use and evaluation of assistive technologies for upper limb function in tetraplegia
  3729. Application of Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-induced Cachexia
  3730. National Leprosy Eradication Program
  3731. Concomitant use of computer image guidance, linear or sigmoid incisions after minimal shave, and liquid wound dressing with 2-octyl cyanoacrylate for tumor …
  3732. Loading of shoulder girdle muscles in consequence of a glenohumeral arthrodesis
  3733. Design and Characterization of Flexible and Implantable Electrodes
  3734. Effect of local and systemic dimethylsulfoxide on peripheral nerve repair: a controlled randomized experimental study
  3735. WO03/000338A2|
  3736. Autophagy as a therapeutic target in cardiovascular disease
  3737. Effect of an EMG–FES Interface on Ankle Joint Training Combined with Real-Time Feedback on Balance and Gait in Patients with Stroke Hemiparesis
  3738. A stimuli-responsive platform for muscle stem cell culture
  3739. thinSmaL asljO k 6bO utBZopcaik
  3740. Nerve root reimplantation in brachial plexus injuries
  3741. Antipsychotic inductors of brain hypothermia and torpor-like states: perspectives of application
  3742. How does the new diagnostic criteria for protein-energy wasting in chronic kidney disease compare with the ICD-10 AM definitions?
  3743. Orbitosphenoid meningiomas
  3744. Helping couples with neurological disabilities: A job description for clinical sociologists
  3745. Role of Macrophages in muscle Transfection with pDNA/PLURONIC Formulation
  3746. PILOT PHASE 1/2, OPEN-LABEL, CLINICAL TRIAL TO InVESTIGATE CT38 iN THE TREATMENT OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE …
  3747. The effects of hot water immersion on recovery, performance and adaptation to resistance exercise
  3748. Critical care nursing: science and practice
  3749. Cardiac and vascular responses to thigh cuffs and respiratory maneuvers on crewmembers of the International Space Station
  3750. Prevention of immobility complications through early rehabilitation
  3751. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
  3752. Posture compensation of a walking assistive device using zero-moment point to stabilize motions on stairs
  3753. Frontotemporal Approach
  3754. Risks and athletic injuries in North American sports
  3755. One piece orbitozygomatic approach based on the sphenoid ridge keyhole: anatomical study
  3756. Anatomy of the orbit and its surgical approach
  3757. Achilles tendon loading and deformation during rehabilitation and use of ankle foot orthoses
  3758. Risks and athletic injuries in North
  3759. Non-Invasive Approaches to Functional Recovery after Spinal Cord Injury: Therapeutic Targets and Multimodal Device Interventions
  3760. Endoscopically assisted targeted keyhole retrosigmoid approaches for microvascular decompression: quantitative anatomic study
  3761. Mammalian endocrinology and male reproductive biology
  3762. Vitamin D and foot and ankle trauma: an individual or societal problem
  3763. SCI rehabilitation: Concepts, mobility, functional electrical stimulation, spasticity
  3764. Study on the application of nanotube combined exercise rehabilitation therapy in the treatment of knee arthritis patients
  3765. EFFECT OF WHOLE BODY VIBRATION TRAINING ON SELECTED HEALTH RELATED COMPONENTS AMONG AMATEUR PLAYERS IN THE POLYTECHNIC …
  3766. Upper Extremity Electromyography During Activities of Daily Living in Control’s and Children with Unilateral Limb Loss
  3767. Analysis of surgical freedom variation across the basilar artery bifurcation: towards a deeper insight into approach selection for basilar apex aneurysms
  3768. The G-connection: harness gravity and reverse aging
  3769. Gonococcal and Nongonococcal Bacterial Infections
  3770. The use of extra-corporeal membrane oxygenation post-cardiotomy: the survival benefits
  3771. The Effect of Thalidomide on Cachexia in Upper Gastrointestinal Cancer
  3772. The Effect of Rehabilitation Exercise Program on Health Status Outcomes of Patients with Multiple Sclerosis
  3773. Meniscal injury associated with cranial cruciate ligament rupture in dogs: a retrospective case study
  3774. Energy needs of the elderly
  3775. Mitohormesis, an antiaging paradigm
  3776. The effect of compliance to a Rigo System Cheneau brace and a specific exercise programme on idiopathic scoliosis curvature: a comparative study …
  3777. Metabolic Control of Longevity
  3778. Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field
  3779. TASK-ORIENTED METHODOLOGY FOR OBJECTIVE ASSESSMENT OF HAND REHABILITATION WITH ROBOTICS THERAPY
  3780. Worth the Weight: Adipose Stem Cells in Human Disease
  3781. THE GUT-ADIPOSE TISSUE CROSSTALK: UNRAVELLING THE MECHANISMS OF GHRELIN-MEDIATED REGULATION OF ADIPOSE TISSUE ANGIOGENESIS
  3782. MS Thesis Research Paper
  3783. The use of extracorporeal membrane oxygenation postcardiotomy—A systematic review
  3784. Computational Analysis of the Lumbar Spine Kinetics
  3785. The nature of involvement of physiotherapists in South Africa in the weaning of mechanically ventilated patients
  3786. Clinical Small Animal Care: Promoting Patient Health Through Preventative Nursing
  3787. Knee ligament function and failure
  3788. Abdominal functional electrical stimulation to improve respiratory function in acute and sub-acute tetraplegia
  3789. Design and Control of a Hand-Assist Robot with Multiple Degrees of Freedom for Rehabilitation Therapy
  3790. Estimates of load rates on the lower limb joints using smartphone accelerometers during physical activity
  3791. Growth and ageing
  3792. Improving Axonal Regeneration: Side-to-Side Bridges Coupled with Local Delivery of Glial Cell Line-Derived Neurotrophic Factor (GDNF)
  3793. Artificial gravity: evaluation of adaptation to head movements during short-radius centrifugation using subjective measures
  3794. Internet of Things (IoT) System and Field Sensors for Exercise Intensity Measurements
  3795. Metabolic Cost of Underwater Treadmill Walking in Individuals with Incomplete Spinal Cord Injury
  3796. Neural crest‐like stem cells for tissue regeneration
  3797. Characterisation of nerve excitability in experimental models of peripheral neuropathy
  3798. Vibration, static standing, dynamic standing, and spasticity in individuals with spinal cord injury
  3799. Sports Medicine And Exercise Science
  3800. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review
  3801. Physical Activities in the NYS/BYA Program on the Turtle Mountain Chippewa Reservation: A Resource Guide for Adaptation
  3802. Physical activity and health in the elderly
  3803. The Influence of Resistance Training on Primary Hemostatic Responses
  3804. Microsurgical anatomy of subtotal temporal bone resection en bloc with the parotid gland and temporomandibular joint
  3805. Ventral root or dorsal root ganglion microstimulation to evoke hindlimb motor responses
  3806. Active Anti-Shear Device for Knee Rehabilitation after ACL (Anterior Cruciate Ligaments) Surgery
  3807. Developmental disorders: an action-based account
  3808. Global Priorities and Local Realities: Exploring what happens to children identified with Acute Flaccid
  3809. Exercising horses on water treadmills: Understanding the workload, mechanics, and conditioning effects of water treadmill exercise.
  3810. Myopain’04: Abstracts from the 6th World Congress of Myofascial Pain and Fibromyalgia, Munich, Germany, July 18
  3811. Metabolic determinants of longevity: dietary supplementation and mitochondria
  3812. Return-to-Play Outcomes for Overhead Throwing Athletes with Ulnar Collateral Ligament Injuries Treated with Platelet Rich Plasma Injections and Conservative …
  3813. Roles of proteasome, arachidonic acid, and oxytocin in bovine myoblast proliferation and differentiation
  3814. Advanced Periodontal Therapy for Veterinarians and Technicians
  3815. Hip arthroscopy outcomes: a longitudinal study
  3816. Critical literature review: Clinical effectiveness in allied health practices
  3817. The Impact of Anterior Cruciate Ligament Reconstructive Surgery on Neuromotor Function
  3818. Interactive Effects of Nutrition, Environment, and Processing on Fresh Pork Quality, Intestinal Biomarkers of Heat Stress in Swine, and Career Success Factors for …
  3819. Functional anatomy of sensorimotor integration in the human brain and perspectives in neurorehabilitation
  3820. Screening triterpenoid compounds with potential to treat retinal diseases
  3821. Spasticity and Pain After Spinal Cord Injury: Relationships to Physiological, Functional, and Quality of Life Measures
  3822. The Fordyce Bathhouse, Hot Springs National Park, Arkansas
  3823. Special Series: Quality Care Symposium ORIGINAL CONTRIBUTION Special Series: Quality Care Symposium ORIGINAL CONTRIBUTION
  3824. Cardiovascular complications in CKD 5D
  3825. Extracellular microenvironment for the regulation of endothelial angiogenic responses
Related Posts

Extends Lifespan

Smallpox

Apoptosis

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping